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SUMMARY
This study describes the preparation of cell cultures 
and brain smears as substrates for the analysis of Mab 
reaction patterns. Using Lagos bat, Mokola, Duvenhage, 
Denmark bat and Finman viruses as immunogens, a panel of 36 
anti-nucleoprotein Mabs was generated. The panel was used to 
examine 64 rabies-related and 118 rabies viruses from 
southern Africa, the Soviet Union and Germany where rabies 
-related and classical rabies viruses are known to co-exist. 
Additionally, over 1000 British bats were examined for the 
presence of these viruses.
Twenty nine reaction patterns, some of which were 
identical but from viruses of different geographical regions, 
were identified. The original distinctions between the 
rabies-related virus groups recognized by specific 
hyperimmune sera were maintained in the Mabs analyses. In 
addition, twelve reaction patterns (of seven Lagos bat, eight 
Mokola, three Duvenhage (Africa), forty two "serotine" bat, 
one Finman and three Myotis dasycneme bat viruses) within 
these virus groups were also defined. The results showed that 
the Duvenhage viruses of Africa and the "Duvenhage-like" 
viruses of European bats are clearly distinguishable. They 
also revealed the presence of a second bio-type in European
11
bats and a relationship between the Finman virus, the virus 
from Myotis dasycneme bats of Holland and the Mokola viruses 
from Africa. No rabies or rabies-related virus was detected 
in British bats.
The results also showed that a distinction can be made 
between the "wildlife" viruses of southern Africa and Asian 
regions of the Soviet Union and the "canine" viruses of 
southern Africa and other regions of the Soviet Union. Both 
of these "virus types" were found in foxes of Germany.
In conclusion, anti-nucleoprotein Mabs prepared from 
rabies-related viruses proved to be a very useful tool in the 
typing of rabies and rabies-related viruses and suggest that 
sub-types of rabies viruses additional to those already 
defined may exist.
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STUDIES OF THE ANTIGENIC RELATIONSHIPS OF RABIES AND 
RABIES - RELATED VIRUSES USING ANTI - NUCLEOPROTEIN 
MONOCLONAL ANTIBODIES
Chapter 1. Review of Literature.
1.1. Introduction.
Rabies, which in man is amongst the most severe of 
all communicable diseases and which in both man and dogs has 
been recorded for at least 4000 years, is an awesome disease; 
its origins are lost in antiquity. According to Steele 
(1975) f Plutarch accredited Athenodorus with the first 
observation of rabies in man in the days of Asclepiadiae, the 
descendents of Asculapius, the god of medicine. In Greek 
mythology, Acteon the hunter was t o m  to pieces by his hounds 
when he surprised Diana and her attendants at the bath and it 
is believed that his dogs were rabid. Sirius, the dog star, 
was associated with mad dogs throughout the eastern 
Mediterranean and Egypt. In the legal documents of 
Mesopotamia in the 23rd century BC the owner of a biting dog 
causing death was liable for compensation to the victim's 
relatives.
In ancient Chinese writings there are indications that 
rabies in dogs was recognised centuries before the birth of 
Christ (TheodorideSr 1986) but the first recorded description
of canine rabies is thought to have been made by Democritus 
some 500 years before Christ. By the 4th century BC it was 
recognized that a wide range of animals was susceptible to 
the disease, Aristotle having stated that the bite of a dog 
with furious rabies would transmit the disease to animals of 
all other species with fatal results. For unknown reasons, 
however, Aristotle had reservations about the susceptibility 
of man (Wilkinson, 1988).
The infectivity of the saliva of rabid dogs was 
described by Celsus in the first century AD. Moreover he 
wrote on preventive measures which included cauterizing the 
wound and keeping it open in order that the saliva may run 
freely from it.
In contrast, Pliny favoured therapy which included 
applying to the wound ash from the burnt head of a dog, or 
axle-grease pounded with lime. Amongst the more palatable 
"wholesome" therapeutic drinks was that "recently revealed 
by an oracle" - a decoction of the root of the dog rose. The 
supposed spontaneous origin of the disease and Pliny's ideas 
of therapy survived at least until the nineteenth century 
despite the realization that the disease could be transmitted 
by saliva.
Frascatoro (1478-1553) in 1546 published the first known 
treatise devoted exclusively to contagious diseases and in 
his chapter on rabies ('cited by Wilkinson, 1988) he 
emphasized that it is not possible to contract rabies by
simple "contact, or by foames, or at a distance, but only 
when the outer skin is so t o m  by the bite of a dog that 
blood is drawn; as though contagion takes place in the blood 
itself through contact with the teeth and foam from the mouth 
of the rabid animal". He believed that rabies, like other 
contagions, was caused by production in the animal of 
putrefaction from which arose germs which were transmitted to 
other individuals to begin again a cycle of putrefaction and 
germ production. More than three centuries elapsed, however, 
before the aetiology of the disease was more fully 
understood.
In 1804, Zinke, by the inoculation of rabid dog saliva 
on a small brush into incisions made on the paws of healthy
dogs, cats and rabbits succceeded in transmitting the disease
to them. Magendie in 1813 transmitted the disease to dogs
from human saliva and the fact that Magendie was a pioneer
neurophysiologist may be taken as a reflection of the growing 
interest in the neurotropic character of the disease at that 
time. Galtier (1879a,b) conducted successful transmission 
experiments in rabbits and the use of rabbits, which develop 
the predominantly paralytic form of rabies, was to provide 
the basis for Pasteur's work on a vaccine. Pasteur had 
established the principle of prophylactic inoculation with 
attenuated material in his studies with chicken cholera and 
anthrax; now he was able to establish two important facts; 
the neurotropic character of rabies virus and its ability to
assume different biological properties on passage - to change 
from a causative organism of variable disease incubation 
period to one of a well defined , shortened "fixed" 
incubation period. After years of experiments in dogs and 
rabbits Pasteur and his colleagues had developed a vaccine 
which would protect dogs and which was later to be used in 
the celebrated case of Joseph Meister who had been severely 
bitten by a rabid animal but survived without developing 
clinical rabies (Pasteur, 1885),
In 1903 Remlinger demonstrated the filterability of the 
agent and in the same year Negri described specific 
intracytoplasmic inclusions in the ganglion cells of rabid 
animals - an observation which gave rise to a rapid 
microscopical diagnosis of the disease. Two further technical 
developments which have allowed more detailed studies of 
rabies pathogenesis and immunity to infection were the 
successful propagation of virus in developing chick embryos 
(Dawson, 1939; Bemkopf and Kligler, 1940) and the growth of 
rabies virus in primary mouse kidney cultures (Vieuchange et 
al., 1956a), followed two years later by serial passage of 
both street and fixed virus in primary hamster kidney cells 
(Kissling, 1958). Nowadays there are a number of cell lines 
and cell strains available for the regular production of 
large quantities of rabies virus. Rabies virus particles were 
first described following visualization in the electron 
microscope using infected hamster kidney cell culture and
negative staining techniques (Almeida at al.,1962).
Thus, there are few viruses, if any, as successful as 
rabies virus: it has survived for millenia; today it thrives
in most parts of the world; it can replicate in all warm 
blooded animals, within which it secretes itself from their 
immunological defences; almost invariably the resultant 
disease is fatal, yet the virus ensures its own survival by 
causing the afflicted, when close to death, to find another 
host and victim. Even so, throughout history the virus has 
caused epizootics of disease which have appeared and then 
inexplicably disappeared, only to reappear again at a later 
date. For example, rabies disappeared from central Europe at 
the beginning of this century, only for the present epizootic 
to arise in wildlife in the mid-1940s (Wandeler, 1988).
These peculiar modulations suggest that either the virus 
is able to change its properties to adapt to new environments 
(eg species) or some change in the host itself permits the 
virus to succeed without itself changing. Historical disease 
syndromes such as "Oulo-fato" (Chalmers and Scott, 1969) and 
Derriengue (Johnson, 1948) were suggestive of some virus 
variation, but the similarity of the clinical disease 
throughout the world and in such a wide variety of species 
led to the generally held view that it was caused by a single 
virus type, and that variations in the epidemiological 
pattern of disease were due to differences in species 
susceptibility. Not until the discovery of Lagos bat (Boulger
and Porterfield, 1958), Mokola (Shope et al., 1970) and 
Duvenhage (Meredith et al.,1971) viruses, the rabies-related 
viruses (Shope et al.,1970) which could be distinguished from 
each other and from classical rabies viruses on the basis of 
cross-protection tests in mice, was this view seriously 
challenged.
Rabies virus is remarkable in its apparent ability to 
infect and kill all mammalian species. The virus is regarded 
as highly neurotropic, yet in the infected animal after 
replication in the central nervous system it spreads 
centrifugally to many organs of the body, in which it is able 
to replicate efficiently. It is not surprising, therefore, 
that in vitro rabies virus can grow in a wide variety of 
cells and since the 1950s cell culture systems have been 
developed which have led to the understanding of much of the 
structure and biology of the virus and have also made it 
possible to grow the virus in sufficient quantities for 
vaccine production. Nevertheless, in many cell systems the 
virus requires considerable periods of adaptation and 
prolonged passaging before substantial virus yields can be 
obtained.
In general, no specific cytopathogenic effect (CPE) 
accompanies the production of the virus in cell culture and 
since it has a clearly established endpsymbiotic relationship 
with the host cells, which are able to continue growing and 
replicating as efficiently as control uninfected cells
(Majer, 1977) methods such as immunofluorescence staining 
must be employed for its detection.
In 1978 Wiktor and Koprowski used somatic cell 
hybridization techniques to produce hybridoma cell lines 
secreting monoclonal antibodies (Mabs) against inactivated 
rabies vaccine. With these antibodies they were able to 
detect subtle antigenic variants amongst rabies viruses. This 
was a major step forward; they had prepared Mabs which 
recognized antigenic determinants of viral coat proteins 
only, of viral nucleocapsid only and antigenic determinants 
of unknown specificity recognized only by the binding of 
antibody to rabies infected cells in radio-immune assays.
Subsequent to their work and by the use of a variety of 
immmunizing rabies viruses many workers have produced Mabs 
which react either with antigenic determinants (or epitopes) 
of the glycoprotein surface protein (Mab-Gs) or of the 
nucleocapsid internal proteins N (nucleo) and NS 
(non-structural) (Mab-Ns). Since N-proteins are produced in 
abundance in the brain cells of naturally infected animals 
and in cells cultured in the laboratory, the relatively 
simple techniques of Mab-N analysis are more frequently used 
to study rabies viruses than are those of Mab-G analysis. In 
practice, a panel of Mab-Ns is used to establish 
characteristic reaction patterns for viruses within a given 
geographical area; identical reaction patterns suggest 
inter-species transmission but consistent differences suggest
independent cycles of virus transmission (Smith, 1989).
Perhaps the most conclusive evidence for the value of 
the combination of Mabs reactivity patterns and surveillance 
data in the assessment of disease trends in a given 
geographical area has been provided by studies carried out in 
the USA (Smith et al., 1984). Tests on 427 isolates revealed 
that they could be identified as belonging to four groups and 
the geographical distribution of these groups generally 
corresponded to the separate species-defined enzootic areas 
recognized by surveillance data. As an example, a single 
reaction pattern was found in all 76 isolates from rabid 
terrestrial animals in the raccoon rabies enzootic area of 
the mid-Atlantic states and the same pattern was also seen in 
95 isolates from raccoon rabies areas of the southeastern 
states but was not found elsewhere in North America. It was 
known that raccoons were transported from the southeastern to 
the mid-Atlantic states for hunting purposes.
Rabid bats have been reported in all of the continental 
United States but no geographical outbreak areas can be 
defined. This is not surprising, since the natural range of 
some of these bats may extend for thousands of miles (Findley 
and Jones, 1964). Reaction patterns of 114 bats permitted the 
identification of six different reaction groups (Smith and 
Baer, 1988) but there was more variability within these 
patterns than in those of terrestrial animal isolates.
A panel of 20 Mab-Ns was used to examine 204 strains of
Street virus originating from Europe, Africa and Asia (Sureau 
et al., 1983). A definite pattern of reactivity was observed 
with strains of the same geographic origin with the exception 
of strains originating from Madagascar, Thailand and Iran 
which were more diversified.
Elsewhere, Mab-N and Mab-G panels allowed the 
determination of the geographical origin of imported cases of 
animal and human rabies (Rollin and Sureau, 1984).
1.2. The Rhabdoviruses.
The rhabdoviruses occur in vertebrate, invertebrate and 
plant hosts and since their structure throughout this
spectrum is so remarkably similar it has been suggested that 
some rhabdoviruses that infect plants may also infect 
vertebrates (Johnson et al., 1969). Although the name 
rhabdovirus is derived from the Greek word "rhabdos", meaning 
rod, this is something of a misnomer since in fact they have 
a bullet shape or bacilliform morphology. More than one 
hundred rhabdoviruses have been identified since the first
morphological studies of vesicular stomatitis virus (VSV)
which causes a disease clinically resembling that of foot and 
mouth disease, were made (Chow et el., 1954; Bradish et al., 
1956). The rhabdovirus morphology of rabies virus was first 
demonstrated in 1962 (Almeida et al., 1962) and the disease 
importance of VSV and rabies led to a more detailed study of
a few bullet shaped viruses which cause other important 
diseases of animals, fish and plants (Brown, 1987).
The infectious units of the rhabdoviruses which are 
found in vertebrates and invertebrates measure about 180nm in 
length and 65nm in width. However, defective interfering (DI) 
particles are commonly found in uncloned preparations and 
although the particle width is similar to that of the 
infectious particle the length may vary from 80nm to 50nm 
depending upon the amount of viral RNA that has been deleted 
(Huang and Baltimore, 1977). All DI particles are subgenomic 
deletion mutants that arise due to replicative polymerase 
errors. Electron microscopic analyses reveal that they are 
composed of tightly coiled nucleocapsid surrounded by a 
membrane (the envelope) with protruding spike-like structures 
that can be readily removed by exposure to proteases (Wagner, 
1987). The nucleocapsid of infectious VSV, the most 
extensively studied of the rhabdoviruses, is approximately 
3500nm long (Howatson, 1970), whereas the nucleocapsids of 
its DI particles vary from one-third to one-half of this 
length. DI particle interference was first described as 
lowered infectivity for mice of influenza viruses passaged 
undiluted in embryonated chicken eggs (Henle and Henle, 1943) 
and this phenomenon was extensively investigated by von 
Magnus (1951, 1954). Cooper and Bellet (1959) and Bellet and
Cooper (1959) analyzed the DI particle phenomenon in some 
detail using VSV in cell cultures and since the first
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reported isolation of rabies virus DI particles (Crick and 
Brown, 1974), their production by many rabies virus strains 
in many cell systems has been generally recognized.
The genetic information of the rhabdovirus is contained 
in a non-infectious unsegmented single RNA strand. There are 
three nucleocapsid proteins, N (=nucleo), L (=large) and NS 
(=non-structural, although this terminology is not strictly 
correct). Both the L and the NS proteins as well as the N 
protein-RNA complex are essential for transcriptase activity 
(Emerson and Yu, 1975).
The membrane of VSV is composed of 50% lipid, derived 
from the host cell and 50% protein (McSharry and Wagner, 
1971). The protein contains externally orientated internal 
glycoprotein (G) and a peripheral matrix (M) protein that 
lines the inner surface of the virion membrane (Patzer et 
al., 1979, Volk et al., 1982). The M protein appears to serve 
as the "glue" that attaches the nucleocapsid to the cell 
plasma membrane vdiere the G protein is inserted (Wagner,
1987).
In 1955 Maramorosch observed that replication of many 
rhabdoviruses took place in arthropods with subsequent 
transmission to either a vertebrate animal or a plant and he 
concluded that arthropods may therefore be the unifying life 
form in the natural history of these viruses. However, a few 
rhabdoviruses such as rabies and some of the fish viruses 
have adapted completely to vertebrates and no longer infect
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arthropods. Of the more than seventy rhabdoviruses of 
vertebrates so far isolated, rabies, VSV, Bovine Ephemeral 
Fever (BEF) and some of the fish rhabdoviruses are recognized 
because they cause diseases of serious consequence to man 
(Shope and Tesh, 1987). Although usually the diseased animal 
is a dead-end host, rabies is different in that its 
transmission depends on the furious state of the rabid animal 
driving it to bite and thus transmit the disease to a new 
host (Johnson, 1970).
Two provisional genera of rhabdoviruses are currently 
recognized - vesiculoviruses and lyssaviruses (Calisher et 
al., 1989) and they are summarized in Table 1.1. However many 
other rhabdoviruses, although they can be placed into 
serogroupings, cannot as yet be placed into either genus 
since, for example, little is known of their pathogenicity 
for humans and for domesticated and wild animals.
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Table 1.1. Provisional Placement of Viruses in Genera
Vesiculovirus and Lyssavirus*.
Vesiculovirus
VSI, VSNJ, VSA, BeAn 157575, Boteke, Calchaqui, 
Carajas, Chandipura, Cocal, Gray Lodge, Isfahan, ISS Phi 
116, Jug Bogdanovac, Jurona, Klamath, Kwatta, La Joya, 
Malpais Springs, Maraba, Mt. Elgon bat, Perinet, Piry, 
Porton, Tupaia, Sigma (probable member).
Lyssavirus
Rabies, bovine ephemeral fever, Adelaide River, 
Berrimah, Bivens Arm, Charleville, Coastal Plains, 
Duvenhage, Humpty Doo, Kimberley, Kolongo, kotonkan, Lagos 
Bat, Malakal, Mokola, Nasoule, Ngaingan, Obodhiang, 
Oak-vale. Parry Creek, Puchong, Rochambeau, Sandjimba, 
Sweetwater Branch, Tibrogargan.
* Adapted from Calisher et al., 1989.
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1.3. Rabies Virus Structure and Function.
Many rabies strains are derived from Pasteur's rabid cow 
isolate, passaged several times in rabbit brain and which now 
possess a "fixed" incubation period. These viruses differ 
from "street" viruses, isolated from naturally infected 
animals in which the incubation period may be very variable. 
Of the two genera of the rhabdoviridae, VSV is the prototype 
of the genus Vesiculovirus and a derivative of Pasteur's 
virus (CVS-24) is the prototype of the Lysssaviruses. Both 
prototypes have been extensively studied and there are a 
number of important features which distinguish them, for 
examples, rabies virus is clearly more neurotropic than VSV, 
and shows little (Week and Wagner, 1979) or no (Tuffereau and 
Martinet-Edelist, 1985) inhibition of cellular macromolecular 
synthesis compared with VSV; rabies replicates much more 
slowly in cell culture and virus production is lower (Ermine 
and Flamand, 1977).
Although the first morphological studies using electron 
microscopy in the 1950s concerned examination of Negri bodies 
in the brain of infected animals, thin section electron 
microscopy in 1962 allowed the first observation of the virus 
in the Ammon's horn of mouse brain (Roots, 1962; Matsumoto, 
1962; Almeida et al.,1962). As chronicled above, the rabies 
particle is bullet shaped, of average diameter 80nm and of 
variable length but averaging 180nm.
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"The virion is bounded by a lipoprotein membrane or 
envelope 7.5-10nm wide, from which spike-like projections 9nm 
long and separated by 5nm intervals extend to the outside. 
The projections exhibit a knob-like distal extremity and are 
usually absent from the planar end of the particle. The viral 
envelope encloses an helical ribonucleocapsid forming a 
cylinder 50nm wide and approximately 165nm long. The 
periodicity of the helix being around 4.5nm, 30 to 35 coils
are necessary to form the total cylinder. In some degraded 
preparations it is possible to observe partially disrupted 
virions in which the internal helix unwinds into a wavy 
ribbon from the planar end of the particle" (Tordo and Poch,
1988).
Each spike-like projection is formed by the association 
of three monomeric units of the glycoprotein (Dietzschold et 
al., 1978) and when the virion is treated with trypsin the 
projections are removed, leaving a small hydrophobic 
polypeptide in the viral envelope (Delagneau et al., 1981). 
When the virion is treated with nonionic detergents (for 
example, NP40) the glycoprotein is almost totally extracted 
together with two other proteins which are partially 
extracted - phosphoprotein Ml and matrix protein M2 (Perrin 
and Atanasiu, 1981). Only the latter is membrane associated. 
Ml being in a more internal position, most probably 
associated with the helical ribonucleocapsid (Delagneau et 
al., 1981; Zaides et al., 1979; Cox et al., 1981). This
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phosphoprotein (Ml) appears to be mostly associated with the 
RNA genome, forming the template required for transcription 
and replication, whilst the ribo-nucleocapsid associated 
RNA-dependent RNA polymerase L encodes the majority of the 
viral enzymatic activities such as RNA synthesis, capping, 
méthylation, polyadenylation and at least part of the 
phosphoprotein phosphorylation (Tordo and Poch, 1988).
Since the genomic RNA is of negative polarity, 
immediately after penetration into the cell it must be 
transcribed into complementary positive sense molecules 
capable of producing viral proteins. This is the function of 
the RNA polymerase. Transcription occurs from the 3 to the 5 
prime end of the template (Flamond et al., 1978) and 
sequentially produces monocystronic transcripts - a small 
uncapped, non-polyadenylated leader RNA (Kurilla et al.,
1984) and five capped and polyadenylated messenger RNAs 
corresponding to the five known structural proteins of the 
virus. After translation of the monocystronic messengers into 
rabies proteins, replication can begin.
The rabies virus nucleoprotein N, unlike that of VSV, is 
phosphorylated (Sokol and Clark, 1973, 1975; Tuffereau et
al., 1985). Its function in the viral replication mechanism 
is not fully understood but it must be involved in this 
mechanism since Mabs directed against the N or Ml proteins 
block rabies virus replication in vitro (Lafon and Lafage, 
1987). It may also be involved in immunity since rabies RNP
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will protect animals against a peripheral challenge with 
infectious virus (Dietzschold et al., 1987).
The rabies Ml protein which has more recently been 
called NS (non-structural) corresponds to the NS protein of 
VSV - but both terms are not quite accurate since the M 
originally referred to a matrix or membranous position 
whereas it is now known to be in a more internal position. 
The role of Ml protein in transcription or replication is not 
well understood.
The matrix M2 protein, located on the inner side of the 
envelope, appears to be an intermediate protein able to 
interact with both the lipid bilayer and the 
ribonucleoprotein core.
The transmembrane glycoprotein G is responsible for the 
induction and binding of virus neutralizing antibodies 
(Wiktor et al., 1973) and for the stimulation of T cells 
(Wiktor et al., 1985). It also mediates the attachment of 
virus to the host cells (Perrin et al., 1982).
The RNA - dependent RNA polymerase occupies 54% of the 
genomic length (Tordo et al., 1988) and possesses most of the 
enzymic activities necessary for transcription and 
replication.
A comparison of all the sequence data so far available 
shows that rabies strains are highly related, showing between 
90% and 98% of amino acid identity (Poch et al., 1989). As 
would be expected for the major viral antigen, the G protein
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is the most variable, but the majority of mutated amino acids 
are located in the hydrophobic signal and transmembrane 
segments or in the hydrophilic cytoplasmic domain (Tordo and 
Poch, 1988).
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1.4. Epidemiology and Epizootiology.
Almost all of the human deaths from rabies occur in the 
tropics, where some three-quarters of the world's population 
lives. In general terms, within this region canine rabies 
predominates, whereas in temperate regions sylvatic
(wildlife) rabies is nowadays more common. Uniquely among 
viruses, rabies virus can infect all warm blooded animals and 
the classical disease is almost invariably fatal. With the 
exceptions of Antarctica and Oceania, certain islands such as 
Japan and the British Isles and other "isolated" geographical 
areas such as Norway and Sweden, the disease is endemic in 
most parts of the world.
It is maintained in two interrelated cycles, urban and 
sylvatic. The urban cycle, because it is maintained in feral 
cats and dogs, is by far the most dangerous to man. It has 
spread as human and domestic animal populations have 
increased in size. In 1988 the World Health Organization 
(WHO) reported that dog rabies accounted for more than 99% of 
all recorded human rabies cases and for 90% of all human 
post-exposure treatments (anon., WHO/Rab. Res. 88/25). Yet 
where the will and resources exist dog rabies can be 
controlled or even eliminated. Thus countries like Japan and 
Britain, with no sylvatic rabies, have been able to eradicate 
urban rabies and maintain their disease-free status by strict 
import control and vaccination within quarantine premises.
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Sylvatic rabies has been reported in Europe since the 
Middle Ages but, as in North America, it has been intensively 
studied here only since its current upsurge began 
(concomitantly with the virtual disappearance of urban 
rabies). It is characterized by the involvement of one or two 
main species (small carnivores, mustelids) in particular 
locations and this pattern remains stable over many years 
(Chalmers and Scott, 1969). In areas where the disease is 
established in the wildlife its elimination has proved 
virtually impossible, although recent trials in Europe with a 
live oral vaccine supplied in bait to foxes show that this 
situation may one day be changed (anon., WHO/Rah.Res. 87, 
1987).
In areas of sylvatic rabies, domestic animals may be 
attacked and infected by rabid wild animals and it is often 
cows rather than cats or dogs which are most frequently the 
victims. Whether this is due to behavioural characteristics 
(for example, curiosity) or husbandry techniques (for 
example, grazing in open fields at night) can only be 
surmised. In some regions sufficient numbers of cattle become 
infected to cause economic problems.
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1.4.1. Europe, Turkey and the Soviet Union.
High quality data are available from Europe where most 
countries submit epidemiological statistics to the WHO Rabies 
Collaborating Centre, Tubingen , Federal Republic of Germany 
(FDR), where they are published in a quarterly journal 
(Rabies Bulletin Europe). Turkey is now the only European 
country which regularly reports substantial numbers of canine 
rabies (in 1990, 431, with only 10 cases in wildlife ). The
present species distribution of rabies in mainland Europe is 
in marked contrast to that in Turkey and to that which 
prevailed during and immediately after the First World War. 
For example, in Germany during the period 1915-1924, 74% of
the confirmed cases were in dogs and infection was rarely 
detected in foxes (Schoop, 1966). On the other hand in 
Germany (East and West) in 1990 whilst there were 192 cases 
confirmed in dogs there were 4489 cases in wildlife species, 
of which 3937 were in red foxes (Vulpes vulpes). In Europe 
as a whole (excluding Turkey and the USSR) in 1990 of 17,322 
cases, only 455 were in dogs. However, the 1279 cases 
recorded on cattle, horses, sheep and goats represent an 
economic burden for the farming community.
Rabies spread throughout most of the Soviet Union from a 
focus of fox rabies in the 1940s in the Astrakhan region of 
the Volga delta, where there was a dense population of 
raccoon dogs (Nyctereutes procyonoides), foxes and wolves
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(Isakov, 1949). In some Republics urban and sylvatic rabies 
now co-exist. The raccoon dog is native to eastern Siberia, 
Manchuria and parts of China, but through transportation 
westwards for hunting purposes it has become well established 
in European parts of the Soviet Union, Poland, Finland and 
many more westerly European countries. Many rabies cases are 
now reported in this species. In some regions of the Soviet 
Union, as in neighbouring Iran, Iraq and Afghanistan the wolf 
and the dog are both important vectors of the disease, 
whereas in polar regions the arctic fox (Alopex lagopus) is 
the main vector and victim.
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1.4.2. Asia, excluding Turkey and the Soviet Union.
Figures for the incidence of the disease in both humans 
and animals vary considerably between Asian countries and are 
greatly influenced by the availability or otherwise of a 
reliable infrastructure for data collection. However, it is 
clear that urban rabies predominates in India, Pakistan, 
Thailand, Indonesia and Vietnam and collectively canine and 
therefrom human rabies cases are annually reported in tens of 
thousands. The cost of this endemic in terms of domestic and 
wildlife animals is largely unknown. Yet also in the Far 
East, Brunei, Darussalam, Malaysia-Sabah, the Maldives and 
Singapore stated that in 1988 they were rabies-free (anon., 
mo/Rah.Res./91/202). In China most of the human rabies cases 
are the result of dog bites and the incidence of the disease 
in the Philippines is reported to be amongst the highest in 
the world.
In 1988 the Gulf States of Bahrain, Qatar and Oman 
reported that they were free from rabies. In contrast, 
sylvatic (fox and wolf) rabies is regularly reported in small 
numbers from other countries of the Middle East including 
Israel which has few cases annually but usually more in foxes 
than in dogs. Within the same region Iran reports the highest 
incidence of the disease not only among dogs but in large 
numbers of wolves, foxes and jackals and hence also amongst 
domestic animals.
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1.4.3. Africa
Among all the African countries taking part in the WHO 
World Survey of Rabies only the island of Mauritius, Djibouti 
and Somalia are rabies-free. Urban rabies predominates, but 
in Southern Africa sylvatic rabies cycles occur which may be 
independent of canine rabies cycles. For example in Namibia 
an outbreak of non-bite transmucosal rabies transmission in 
kudu (Tragalaphus strepsiceros) which commenced in 1977 
resulted in an estimated loss of up to 50,000 of these 
animals in 1982. Since 1983 this outbreak has regressed, but 
severe losses have been experienced in eland antelope 
(Taurotragus oryx) since 1982 (Schneider, 1985). A further 
sylvatic cycle may occur in the yellow mongoose (Cynictis 
penicillata) which is the principle wildlife vector on the 
central plateau of the Republic of South Africa, and it has 
been suggested that a cycle of jackal (Canis adustus and 
Canis mesomelas) rabies independent of canine rabies may be 
developing in Zimbabwe (Foggin, 1986).
All of the rabies-related viruses, Lagos bat, Mokola 
and Duvenhage (Serotypes 2, 3 and 4), Obodhiang and kotonkan 
were first isolated on the African continent, and elsewhere 
only in European bats has a rabies-related Duvenhage-like 
virus been recognized.
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1.4.4. The Americas.
The highest density of reported animal rabies in North 
America occurs in the agricultural lands of southern Ontario, 
Canada, and most wildlife cases are in the red fox although 
the striped skunk (Mephitis mephitis) is an important vector. 
In this region there is no evidence that rabies among 
domestic animals is acquired from any source other than foxes 
or skunks. For unknown reasons an outbreak of rabies which 
occurred in grey foxes (Urocyon cinereoargenteus) and red 
foxes and extended from southern New York County to the 
coastal plain in Alabama and Florida diminished dramatically 
during the 1970s. Rabies in skunks has been recognized in the 
valleys of the Mississippi river and its major tributaries 
since the early days of European settlement in North America 
and is still widespread in the states of Minnesota, Iowa and 
Texas.
In contrast, rabies in raccoons (Procyon lotor) was not 
observed until the 1950s in Florida, and a new epizootic 
which began in 1979 on the Virginia-West Virginia border 
spread northwards through Maryland and by 1985 into 
Pennsylvania. This outbreak has stimulated great local 
interest since it is believed to have arisen from the 
transportation (for hunting purposes) of raccoons which were 
incubating the disease, and it has produced many animal 
rabies cases in urban environments. The number of wildlife
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cases reported in Canada and the USA is probably a small 
proportion of the infections, since only those animals that 
have been observed to have human or domestic animal contact 
and are submitted for laboratory diagnosis are included 
(Smith and Baer, 1988).
Dog rabies still dominates the case statistics from 
Mexico to southern South America to such an extent that there 
is only limited information about transmission of rabies 
among terrestrial wildlife in this large area and in parts of 
Central and South America rabies in dogs has increased as 
rapidly as human populations have grown. Within a region of 
latitude from approximately 26 degrees North to 36 degrees 
South (from northern Mexico southwards to northern Argentina) 
vampire bat rabies is the cause of severe losses of cattle.
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1.5. Pathogenesis.
Early studies of the pathogenesis of rabies, usually for 
convenience carried out in rats and mice, involved infection 
of the animals followed by surgical procedures and virus 
re-isolation. These studies quickly established the neural 
route to the CNS, the rapidity of movement of virus in 
peripheral nerves and movement of virus through the CNS 
followed by peripheral dissemination. The advent of 
sophisticated techniques such as electron microscopy, 
immunofluorescence, monoclonal antibodies and molecular 
biology has improved understanding of pathogenesis and 
suggested the reasons for cellular specificity and 
neurotropism of the virus.
The disease is most frequently spread by the bite of a 
rabid animal and for many years it was assumed that a viral 
replicative cycle took place in non-nervous tissue before 
entering peripheral nerves. However, mice inoculated into the 
footpad with a virulent strain of virus succumbed to the 
disease when the foot was amputated only eight hours later 
(Dean et al., 1963) and since this period is of insuffficient 
duration to allow replication in and release from non-nervous 
tissue, virus must have entered peripheral nerves directly.
Such evidence begs the question of how the virus enters 
the peripheral nerves. Mice inoculated intramuscularly with 
CVS virus had immunofluorescent foci in the endomysium of
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inoculated muscle one hour later and the foci were similar in 
form and distribution to neuromuscular junctions (NMJ), as 
determined by acetylcholinesterase staining (Watson et al., 
1981). Despite this apparently strong evidence for a role for 
the NMJ in virus uptake, the reason for lack of foci in areas 
remote from them is unexplained and indeed in skunks 
inoculated intramuscularly (IM) with street virus, 
localization to foci consistent with NMJs was not observed 
(Charlton and Casey, 1979). Thus the precise mechanism of 
virus entry into peripheral nerve has not been determined and 
an alternative route to direct acetylcholine receptor (AChR) 
uptake could be indirect entry following virus binding to 
myocyte AChR to induce endocytosis by muscle cells (Lentz et 
al., 1986). Although AChRs may be one membrane component 
which facilitates virus uptake it cannot be the only 
component since infection occurs in vitro in cell lines 
which do not have AChRs.
Evidence for virus binding to other components of cell 
membranes has been found, for example neuraminic acid 
(Superti et al., 1984), carbohydrate moieties (Conti et al., 
1986) and phospholipids including phosphatydyl serine and 
gangliosides (Halonen et al., 1974; Seganti et al., 1983; 
Sinibaldi et al., 1984). It may be that differences in virus 
strains enable the use of different cellular receptors since, 
for example, it is known that CVS virus reaches the CNS after 
peripheral inoculation much more quickly than does many
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Street viruses.
It has been shown with a variety of rabies viruses 
including Lagos bat virus that infection of myocytes at the 
site of inoculation can occur (Murphy et al., 1973a) and 
using a skunk street virus it has been shown that infection 
of myocytes occurs at the inoculation site of skunks 
(Charlton and Casey, 1979); antigen was detected in muscle 
fibres at seven days and before it was detectable in the CNS. 
Nevertheless it is still possible that virus can have direct 
entry to peripheral nerves, particularly as a bite wound 
usually results in t o m  and severed nerve fibres.
Infection via the oral mucosa in nature is thought to be 
a rare occurrence but it has been shown experimentally in 
mice on many occassions (for example, Correa - Giron et al., 
1970); in rats (Remlinger, 1908); in hamsters, guinea pigs 
and rabbits (Fischman and Ward, 1968; Remlinger, 1959); in 
foxes (for example. Black and Lawson, 1973); in skunks 
(Ramsden and Johnston, 1975) and in cats (Svrcek, 1980).
Similarly, the intranasal route of infection has been 
shown experimentally in a wide variety of species and it has 
been suggested that an outbreak of rabies in a laboratory 
colony of foxes occurred via this route (Johnson, 1982). 
Immunofluorescence tests on the mucosa of naturally infected 
bats were positive (Constantine et al., 1972) as were tests 
on mucosal epithelial and nerve cells in the submucosa of 
mice inoculated intranasally (Fischman and Schaeffer, 1971).
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Since the olfactory epithelial cell is a bipolar neuron with 
the cell body in the olfactory mucosa, one process extending 
to the olfactory bulb and the other to the surface of the 
epithelium, it has been suggested that virus travels 
centripetally along olfactory and/or trigeminal nerves 
(Hronovsky and Benda, 1969).
Several instances of rabies virus infection following 
comeal transplantation have been recorded and 
experimentally, using fixed and street virus in rabbits on 
abraded cornea, all of 102 rabbits succumbed to the disease 
(Centani and Muzio, 1898). After inoculation of the anterior 
chamber with CVS virus the primary uptake sites were shown to 
be intraocular parasympathetic oculomotor, retinopetal and 
optic nerve fibres (Kucera et al., 1985).
That the peripheral centripetal pathway of involvement 
of the CNS is via peripheral nerves has been proven
conclusively by a number of experimental studies (cited by
Charlton, 1988). Neurectomy proximal to the inoculation site 
before or shortly after inoculation of rabies virus and 
amputation soon after inoculation, generally prevented 
development of clinical disease. In addition paresthesias 
that develop in human rabies (Van Rooyen and Rhodes, 1948) 
and the self - mutilation in regions approximating to the 
inoculation site of experimentally infected foxes (Soulehot
et al., 1982) support these observations.
Within the CNS virus replication occurs mainly in
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neurons and the cell-to-cell spread of infection results in 
extensive dissemination of antigen in the brain and spinal 
cord. The rapidity of spread may be related to the virus 
strain - in laboratory small animals 70-80 hours are required 
for spread of street virus throughout the CNS but only 24 
hours for fixed virus (Schneider, 1975). During the spread of 
virus through the CNS there is simultaneous centrifugal 
movement of infection in peripheral nerves and it is this 
movement which leads to the presence of virus in some tissues 
and fluids before the onset of clinical signs. Many 
non-neural cells may then become infected, the most important 
being those of the salivary glands since these are involved 
in the spread of disease. Infectious virus may be present in 
the saliva before the onset of clinical signs, such 
preclinical periods ranging from about 3 days in cats (Vaughn 
et al., 1963) to 13 days in a dog with an Ethiopian virus 
(Fekadu et al., 1982). The different mechanisms responsible 
for paralytic and furious rabies have not been clearly 
established.
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1.6. Diagnosis.
Throughout the world rabies diagnostic procedures are 
governed by a number of scarcely scientific factors such as 
climate, economy and the availability of laboratory animals. 
The quickest and easiest procedure is the use of a suitable 
dye contained in a fixative for the detection of Negri bodies 
in a brain smear, and a positive diagnosis can be obtained 
within half an hour after the receipt of the specimen 
(Kaplan, 1973). Sadly in some countries and ironically where 
there is the most frequent need for accurate diagnosis, this 
technique, with its limitations, is all that is attempted.
If Negri bodies are not seen, a full histopathological 
examination should be made by the examination of at least six 
sections stained after embedding by a rapid method. The 
sections should be taken from the Ammon's horn (both sides of 
the brain), the cerebral cortex (motor area) the cerebellum 
and neuronophagia. Signs of meningo-encephalomyelitis give a 
tentative diagnosis of rabies but Negri bodies, found 
especially in the central pyramidal layer of Ammon's horn 
(hippocampus major) and in the neurons of the cerebellum 
(where they may be abundant but smaller in size) are 
pathognomonic of rabies (Tierkel, 1973).
In industrialized countries diagnostic procedures 
consist of immunofluorescent staining of brain tissue and 
inoculation of brain tissue into mice or cell cultures.
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Routinely results of brain smears can be obtained within two 
to four hours (allowing good time for fixation in cold 
acetone), and the advantage of fluorescence microscopy is 
that inclusion bodies of other diseases do not fluoresce and 
hence lead to mis-diagnoses. Additionally, the "star-dust" 
small aggregates of rabies nucleocapsid antigen - are 
characteristic of rabies virus infection and leave the 
experienced fluorescence microscopist in no doubt of the 
result.
The immunofluorescence technique was developed in the 
late 1950s (Goldwasser and Kissling, 1958). Conjugates 
(specific antibody chemically bound to a fluorochrome) can 
now be prepared by using purified virus or sub-virion 
components, for example ribonucleoprotein, as immunizing 
agents. Latterly mixtures of monoclonal antibodies (Mabs) 
which are commercially produced have been used since they 
give conjugates of greater specificity. Whilst reaction with 
acetone fixed smears or cell cultures form the bulk of 
diagnostic tests carried out worldwide it is possible to 
stain formalin fixed brain tissue provided it has been 
digested with trypsin and/or pepsin to unmask the 
immunoreactive sites. This technique is particularly useful 
when retrospective diagnosis is required (Geeslin et al.,
1985), but for the most part only the larger aggregations or 
inclusions are seen, the "dust-like" particles do not stain 
well (Webster and Casey, 1988).
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In many countries mice are routinely inoculated 
intracerebrally with a 10% suspension of brain tissue and are 
observed for mortality for at least 21 days. Mice which die 
during this period are examined for the presence of rabies 
antigen by immunofluorescence techniques, or for the presence 
of Negri bodies. The observation period may be reduced if 
sufficient numbers of mice are inoculated such that one mouse 
can be killed and examined each day following inoculation. 
Diagnosis of rabies may then be made well in advance of the 
appearance of clinical signs (Webster et al., 1976; 
Takerhara, 1986).
In recent years the standard mouse inoculation test has 
been replaced in some laboratories by cell culture 
techniques. These have been shown to be as sensitive as the 
mouse test and have the advantages of speed and relative 
cheapness. Neuroblastoma cells are more sensitive to rabies 
street viruses than are BHK-21 cells or mice (Smith et al., 
1978; Rosenau et al., 1986) and virus replication may be 
detected in acetone fixed cultures by immunofluorescence 
techniques within 24 hours.
Ante-mortem diagnosis (comeal impressions, skin biopsy) 
in humans and animals has been frequently reported and is 
successful when material is received in the laboratory in 
very good condition. Experimentally inoculated mice examined 
sequentially were positive by skin biopsy some time before 
the onset of clinical signs (Umoh and Blenden, 1982; Ciuchini
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et al., 1984). In my laboratory rabies virus was isolated 
from 6 of 7 saliva samples taken daily from a woman who had 
been bitten by her dog in Zambia. No virus was isolated from 
saliva samples taken on the three days immediately proceeding 
death, but a rising antibody titre was observed in serum 
taken on these days {King, unpublished data).
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1.7. Control.
This topic was recently reviewed (Gardner and King, 1991).
1.7.1. Urban Rabies.
Several excellent vaccines are available which will 
prevent the development of the disease in humans following 
exposure to an infected animal, but they do not deal with the 
source of the problem, the animal reservoir. Since most human 
post-exposure treatments are due to dog bites, dogs are the 
prime target for control measures. Canine rabies accounts for 
more than 99% of all human rabies cases and over 90% of all 
human post-exposure treatments recorded worldwide. Yet in the 
past, even before Pasteur, Scandinavian countries were able 
to rid themselves of it by sanitary measures including stray 
dog control. Other countries, including the UK, have used 
these techniques allied with quarantine and/or vaccination to 
eradicate and then maintain freedom from the disease.
Currently the importation of mammals into the UK is 
controlled by the Rabies (Importation of Dogs, Cats and Other 
Mammals) Order 1974 (as amended). It applies to a wide range 
of mammals but excludes farm livestock including horses, 
which are covered by separate regulations. These exempted 
animals may become subject to controls under the Importation 
order if they have been in contact with any of those species 
subject to quarantine regulations. Under the Order, the
36
animals must be licenced in advance to authorized quarantine 
premises and must be landed at a port or airport designated 
in the Order and transported to the quarantine premises by an 
authorized carrying agent, where they must be detained for a 
period of six months (life in the case of vampire bats and 
their progeny). Dogs and cats must be vaccinated on arrival 
at the quarantine station.
In North America canine rabies has been reduced from 
about 8000 cases a year shortly after the last war to fewer 
than 200 cases a year for the past few years, and human 
deaths therefrom have concomitantly declined from 94 in the 
four-year period 1946-49 to fewer than ten in the 1980s 
(anon.. Rabies Surveillance, 1983; 1990).
In Latin America, however, attempts to control dog 
rabies are but in their infancy and on the basis of 
surveillance data the trend is of increasing numbers of 
canine rabies cases, albeit in limited (urban) areas of the 
affected countries (anon., WHO, Rab/89/199, 1989). In Greater 
Buenos Aires, with a population of over seven million, an 
urban rabies control programme initiated in 1976 reduced 
canine rabies cases from over 4000 in the first year to zero 
by 1985. At the same time the number of human deaths from 
rabies fell from ten in the first year to only one between 
1980 and 1985 and the need for post exposure treatment fell 
from 45,000 in the first year to less than 16,000 in 1985 
and continues to fall (Larghi et al., 1988). Success for the
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progamine was dependant as much upon the degree of health 
education (the avoidance of the image of dog killers), legal 
support for the programme, the concentration of resources in 
areas of high epizootiological importance and door-to-door 
vaccination rather than vaccination clinics, as upon the 
availability of good vaccines.
Dogs are responsible for the persistence and 
dissemination of rabies in North, East, West and Central 
African regions, but consistent under-reporting from most 
areas is a reflection of the scarcity of diagnostic 
facilities, and economic, social and political changes over 
the past decade or so have affected rabies control 
programmes. For example, western Kenya, from where canine 
rabies had been eradicated, is now re-infected.
In Asia there is an almost inestimable number of human 
and canine rabies cases each year yet there is virtually no 
attempt to control either dog populations or the disease 
within them. Malaysia is one of the few examples where rabies 
has been brought under control - by the compulsory 
vacccination of all dogs in rabies infected states and the 
destruction of unowned and unvaccinated dogs (anon., WHO, 
Rabies/ 84.194., 1984).
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1.7.2. Wildlife Rabies.
Canine rabies can be controlled because in general, dogs 
live in close association with man and are therefore within 
physical reach. This is rarely the case with wildlife. The 
reduction of stray dog and wildlife populations in order to 
break the chain of natural transmission has not succeeded, 
chiefly because wildlife species are able to repair their 
losses at a fast rate.
The finding that primary infection of experimental mice 
could take place in the buccal mucosa (Correa-Girron et al., 
1970) and that live attenuated virus given orally could 
immunize foxes (Black and Lawson, 1970; Baer et al., 1971) 
together formed the seed from which has blossomed the 
present-day programmes of wildlife rabies control. In the 
meantime research has been directed towards the development 
of vaccines efficacious for target species (the fox in 
Europe); safety for target and non-target species (vaccine 
was tested in all the rodent species indigenous to central 
Europe (Wandeler et al., 1982) and effective measures to
deliver the vaccine to the target species in the form of a 
bait.
Despite the satisfactory nature of all the proving 
trials, it was a courageous decision to disseminate live 
attenuated rabies virus in an attempt to create an immune 
barrier at the entrance to the Rhone Valley in 1978. The
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vaccine virus was contained in small plastic blister packages 
fixed under the skin of chicken heads used as bait, and 4,050 
of these were distributed by hand over an area of 
approximately 335 km^ (Wandeler, 1988). Rabies did not enter 
the Rhone Valley.
With continued field trials, Switzerland has been freed 
of rabies except for incursions from highly endemic areas 
along its borders. The Federal Republic of Germany, following 
their introduction of a machine-manufactured bait, has 
cleared the disease from large parts of the country. Italy, 
Austria, Belgium, Luxembourg and France have been 
collaborating in other field trials. Pilot field trials of a 
similar nature, but with variations in immunizing virus and 
bait presentation form, are also underway in Canada (Perry,
1989) The next step forward involves the use of recombinant 
vaccines and several of these are under investigation:
In 1988 a construct (RCPRG) was prepared of rabies (CVS 
virus) glcoprotein (G) gene and raccoon pox isolated from 
Maryland in 1964. Rabies neutralizing antibodies developed 
when the recombinant was fed to a variety of animals and 
these animals resisted challenge with a street rabies virus. 
No adverse reaction was noted in any animal fed RCPRG. A 
pathogenicity study in raccoons showed that the principal 
entry organs were oral and pharyngeal structures, 
particularly tonsils, and that antigen remained in tonsillar 
tissue for at least 14 days after feeding (Baer, 1990).
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The natural host range of avipox viruses is restricted 
to avian species but abortive infection can be initiated in 
vitro in cell lines of non-avian species. Recombinant 
avipox-viruses expresssing the rabies G gene are derived by 
inserting rabies G cDNA into subgenomic fragments of 
avipox-viruses under the transcriptional control of an 
early/late vaccinia virus promoter. By using "in vivo" 
recombination, recombinants are derived and plaque-purified. 
Such recombinants when inoculated into a number of non-avian 
species including cats and dogs induced an immune response 
and provided protection against a lethal rabies virus 
challenge (Desmettre, 1990).
A human adenovirus type 5 recombinant with rabies (ERA 
strain) G gene (Ad5 RGl) inserted in the deleted E3 region 
was given to skunks and foxes. Generally there were high 
rates of seroconversion and all challenged animals survived. 
Trials with baits indicate that this vaccine has considerable 
potential as a wildlife oral rabies vaccine in both skunks 
and foxes. Work is also in progress to develop a recombinant 
rabies vaccine based on canine adenovirus type 1 (CAV-1)
(Wandeler, 1990).
Vaccinia-vectored vaccines are ideal for the expression 
of foreign (e.g. hepatitis, herpes, influenza, rabies etc.) 
genes. For example, V-RG cannot cause rabies but leads to 
high levels of neutralizing antibody and to protection 
against challenge with several antigenically distinct street
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rabies viruses. It has been tested in captivity in more than 
six avian and 35 mammalian species including the majority of 
global rabies reservoir hosts. All animals have remained 
clinically normal with no overt gross or histopathological 
lesions. With oral deposition of V-RG, tonsils and local 
lymph nodes appear to be key sites for early viral reception 
and the vaccine is cleared relatively quickly (48 hours) and 
is not excreted. True biological transmission has not been 
observed although mechanical transmission is a predictable 
event. No potential abortifacient, teratogenic or oncogenic 
effects of V-RG vaccine have been realized (Rupprecht, 1990).
+Note; The above references (Baer, Desmettre, Wandeler 
and Rupprecht) are summaries of papers given at a WHO meeting 
held in Geneva, July 1990 and do not constitute full literary 
references.
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1.8. Chiropteran Rabies.
With the exception of the rodents there are more 
species of bats than any other mammal; they are also more 
widely distributed than any species except man. Bats not only 
inhabit caves and caverns in remote places, but many also use 
trees and man made structures as roosting sites. Some species 
eat fruit or seeds, nectar and pollen; others take blood or 
fish or even other small vertebrates, but insects form the 
major proportion of the diet of European species. Many bat 
species have developed the ability to become torpid or to 
hibernate in adverse climatic conditions, thus reducing their 
energy requirements.
One characteristic which separates bats from all other 
mammals is their ability to fly. Unlike the flight of birds, 
however, bat flight is achieved by the synchronous use of 
legs and wings so that they "swim" through the air. Flight 
not only enables capture of food "on the wing" but can also 
allow migration in search of food when it becomes locally 
scarce, or for more equitable sites for nursery purposes, or 
in response to increased population pressures. Most migratory 
species move to warmer climes for the winter but some migrate 
to avoid excessive heat. Migration distances may be merely 
from the cellar to the attic of the same dwelling, but some 
species are capable of flight over distances well in excess 
of 1,000 Km (Strelkov, 1969), and many show remarkable homing
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instincts. Although some European species migrate, many do 
not do so because they have developed the ability to 
hibernate.
Records of bat bites leading to the death of man and 
animals in Central and South America in the sixteenth century 
are almost certainly the earliest indications of rabies in 
bats. Not until 1911 however did Carini note Negri bodies 
(pathognomonic of rabies) in histological sections from the 
brains of cattle dying of an undiagnosed disease in southern 
Brazil. Subsequently Haupt and Rehaag (1921) established the 
relationship between bites of rabid bats and paralytic rabies 
in cattle in the same area. Bovine paralytic rabies, spread 
by vampire bats whose sole diet consists of blood, is of 
considerable importance in most countries of the Americas 
from northern Mexico southwards to northern Argentina.
Pawan observed Negri bodies in the brain of a fruit 
eating (Artebeus planirostris) bat which was caught whilst 
flying in a chemist's shop in Trinidad in 1931 (Pawan, 1936). 
Subsequently, of 69 infected bats captured in the area, 64 
were vampires, four were frugivorous and one was of an 
insectivorous species (Diclidurus albus). From his studies 
with other fruit bats, Pawan concluded that they could not 
only transmit the disease by biting, but they sometimes 
recovered from the furious form of the disease and could 
then, while asymptomatic, continue to transmit virus for long 
periods (Pawan, 1948). These were highly significant
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findings, and yet the fact that bats other than vampires 
could be infected with rabies received little further 
attention until 1953 when a boy in Florida was attacked by a 
rabid insectivorous (Lasiurus intermedius) bat (Venters et 
r 1954). Within a decade bat rabies in insectivorous 
species was also reported from most Central and South 
American countries and from Canada.
Despite the enormous numbers of bats known to inhabit 
the countries of the Far East bat rabies appears to occur 
there only rarely. Smith et al., (1967) reported the 
isolation of rabies from Cynopterus brachyotis bats of
Thailand, but some doubt has now been cast upon the validity 
of their results (G.M.Baer, pers. comm.). One of two bats 
examined for rabies from Khonken Province, Thailand in 1986 
was positive (V. Meesomboon, pers. comm.). The first case of 
hydrophobia following a bat bite in India was of a pointsman 
in the Srikakulam District of Andhra Pradesh who was bitten 
on the forearm near the wrist as he attempted to replace an 
injured bat on to the branch of a tree. He died of rabies
three months later (Veeraraghavan, 1954).
Until 1970 the many species of African bats were
considered to be rabies free, and although in 1958 Boulger 
and Porterfield had reported the isolation of a virus, which 
they designated Lagos bat virus, from frugivorous bats in 
Nigeria their experimental results had led them to conclude 
that it was not a rabies virus. Subsequently this and other
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isolates of Lagos bat virus, together with isolates of Mokola 
virus (Shops et al., 1970) and Duvenhage virus (Meredith et 
al., 1971), have come to be known as the rabies-related 
viruses. Mokola virus has not so far been isolated from bats.
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1.9. The Rabies-related Viruses._
This topic was recently reviewed (King and Crick, 1988).
1.9.1. The Rabies Serogroup.
Classical rabies, Lagos bat, Mokola, Duvenhage, 
Obodhiang and kotonkan viruses (Table 1.2.) together form the 
established genus Lyssavirus within the family Rhabdoviridae. 
All have a characteristic bullet shape. Unlike the major 
members of the serogroup, Obodhiang and kotonkan are 
classified as Arboviiruses - viruses which are maintained in 
nature principally, or to an important extent, through 
biological transmission between susceptible vertebrate hosts 
by haematophagous arthropods; they multiply and produce 
viraemia in the vertebrates, multiply in the tissues of 
arthropods, and are passed on to new vertebrates by the bites 
of arthropods after a period of extrinsic incubation.
Since the relationship of the arthropod-borne members to 
the others is distant and only through Mokola virus, Bauer 
and Murphy (1975) have suggested the need for further 
physico-chemical characterization to determine if they should 
be placed in a separate serogroup. However, in a recent 
review (Shope and Tesh, 1987) it was considered that these 
viruses should be included in two separate serotypes within 
the lyssaviruses.
47
Table 1.2. Distribution of the Genus LYSSAVIRUS
Serotype 1, 
Rabies
Serotype 2. 
Lagos bat
Serotype 3. 
Mokola
Serotype 4. 
Duvenhage
Serotype 5 
Finman
Geographical
Distribution
Worldwide except Australia 
New Zealand, Japan, United 
Kingdom, Antarctica, parts 
of Scandinavia, Hawaii and 
some other islands
Nigeria, Central African 
Republic, Republic of South 
Africa, Zimbabwe, Senegal
Nigeria, Cameroun, Zimbabwe, 
Central African Republic
Republic of South Africa, 
Zimbabwe, Europe
(Provisional)
Finland
Species from 
vAiich isolated
Dogs, cats, wild 
carnivores, bats 
cattle, humans
Fruit bats, cats
Shrews, humans, 
cats, dog, 
rodent
Bat, human
Human, ex bat?
Not Typed. 
Obodhiang
kotonkan
Sudan
Nigeria
Mansonia
mosquitoes
Culicoides
midges
* Adapted from King and Crick, 1988
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1.9.1.1. Serotype 1 ; Rabies Virus.
The prototype strain of the serotype is Challenge Virus 
Standard CVS-24, which was derived from Pasteur's virus. This 
serotype also includes the majority of street viruses, 
whether isolated from dogs or cats among domestic animals, or 
from wild animals such as foxes, skunks and raccoons. Viruses 
isolated from bats in the Americas are included in this 
serotype, as are the viruses from historical disease 
syndromes such as "Oulo-fato" (Chalmers and Scott, 1969), 
Nigerian Horse Disease (Staggers) (Porterfield et al., 1958) 
and Derrienge in vampire bats (Johnson, 1948).
1.1.9.2. Serotype 2 : Lagos Bat Virus.
The knowledge that rabies virus may be carried by 
insectivorous and non-sanguinivorous bats suggested to 
Boulger and Porterfield (1958) that an examination of 
frugivorous bats on Lagos Island in Nigeria might be of 
interest. A single shot from a twelve-bore shotgun was fired 
into a colony of bats roosting in a tree (Porterfield, pers. 
comm. ). They isolated a virus from the pooled brains of six 
Eidolon helvum bats, which are gregarious fruit eaters, 
usually roosting in colonies of twenty to several hundred and 
sometimes as many as several thousand. The virus was 
pathogenic for 21-28 day-old mice, and though examination of
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infected mouse brains revealed cuffing of blood vessels and 
neuronal degradation, no Negri bodies were seen. 
Additionally, since the virus was not neutralized by a potent 
rabies immune serum prepared in rabbits, they concluded that 
it was not a rabies virus. However, later it was demonstrated 
that the virus was related to rabies virus and that the 
degree of cross-reactivity among rabies, Lagos bat and Mokola 
viruses was sufficient to substantiate a distinctive 
serogrouping within the Rhabdoviridae (Shope et al., 1970). 
It was in their paper that the term "rabies-related viruses" 
was first used; it has remained in common usage ever since.
In 1974, a second isolation of Lagos bat virus was made 
from a Micropterus pusilus bat in the Central African 
Republic (Sureau et al., 1977, 1980). These dwarf epauletted 
bats are also fruit eating, but they normally roost singly or 
in small groups and are seldom if ever found in association 
with other bat species.
In 1980, several isolations were made of Lagos bat virus 
from Epomophorus wahlbergi bats from around Durban, Natal 
(Meredith and Standing, 1981; Crick et al., 1982). These 
epauletted fruit bats roost in groups of up to 50, are common 
garden residents in the sub-tropical towns of Natal, and make 
local migrations in search of ripe fruit. According to the 
authors, there is overlap between the migratory ranges of 
Eidolon and Epomophorus bats.
Two further isolates (SA 2 and SA 3) from unidentified
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South African bats, originally reported to be Mokola virus 
(Schneider et al., 1985) were later shown to be Lagos bat 
virus (J.S.Smith, pers. comm.). Lagos bat virus was also 
identified in my laboratory from the brain of a domestic cat 
which died in the Republic of South Africa (King, unpub. 
data) and from a cat in Zimbabwe (C.M.Foggin, pers. comm.).
1.9.1.3. Serotype 3 : Mokola Virus.
During the course of a surveillance programme designed 
to detect viral infections in the wildlife of Nigeria in 
1968, virus was isolated from three shrews (Cricidura sp. ) 
captured in the district of Mokola in Ibadan. The isolates, 
of which Ib An 27377 was selected as the reference strain 
(Shope et al., 1970), were grown in mice from shrew lung, 
liver, spleen and heart tissue pools, and intracerebral 
passage in 3-day-old mice resulted in their death in 4 days. 
Within a short time, three further isolations of Mokola virus 
were made in Nigeria; from a liver and spleen tissue pool 
from a shrew found dead in laboratory grounds (Kemp et al.,
1972); from the cerebrospinal fluid of a three year old girl 
with "aseptic meningitis" (Familusi and Moore, 1972) and from 
a six year old girl with symmetrical paralysis of the 
extemities who died after nine days of illness (Familusi et 
al., 1972). A further isolation of Mokola virus from a shrew 
was made in 1971 in Cameroon (Le Gonidec et al., 1978).
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In 1981, Mokola virus isolations from domestic animals 
were described (Foggin, 1982). Over a period of several 
months, a dog which had been vaccinated previously with a 
potent inactivated rabies vaccine of tissue culture origin, 
and six cats, all from the same locality of Bulawayo in 
Zimbabwe, apparently died of rabies. Most had displayed the 
symptoms of dumb rabies but some showed slight aggressiveness 
when handled. Neutralization index tests performed in mice 
confirmed that all seven isolates were antigenically 
indistinguishable and different from classical rabies virus. 
Mokola virus (An RB3247) was isolated from a rodent 
(Lophuromys sikapusi), one of over three thousand rodents 
examined over a twenty year period in the Central African 
Republic (Saluzzo et al., 1984).
Mokola virus antibodies have been demonstrated in the 
serum of one of five Eidolon helvum bats shot near Sokoto in 
northern Nigeria, several other mammalian species, including 
man, and a great reed warbler (Kemp et al., 1972).
1.9.1.4. Serotype 4 ; Duvenhage virus.
Duvenhage virus was isolated in mice from the brain of a 
thirty-one year old man who died five weeks after he had been 
bitten on the lip, while asleep, by an unidentified bat 
(Meredith et al., 1971). He came from the farm Tooyskraal 
some 100km northeast of Pretoria, Republic of South Africa.
52
Repeated tests with fluorescent anti-rabies serum on his 
brain were negative, as were similar tests on the brains of 
the inoculated mice which died. However, Negri bodies were 
seen in numerous Purkinje cells of his cerebellum and in the 
mouse brains.
Eleven years later, a second isolation (SA 29) of the 
virus was made from a bat (Schneider et al., 1985) from Louis 
Trichardt, about 250km north of the farm Tooyskraal. This bat 
was also unidentified but was thought to be insectivorous. A 
third isolate, in 1986, from a Nycterus thebaica bat in 
Zimbabwe (C.M.Foggin, pers. comm.), completes the list of 
isolations of Duvenhage virus in Africa to date.
In the same year (1954) that a serotype 1 virus was 
first reported in an insectivorous bat in the U.S.A. (Venters 
et al., 1954; Scatterday, 1954), rabies was observed in 
three Nyctalus noctula bats in Yugoslavia (Nicolic and 
Jeselic, 1956). These bats are insectivorous as are all 
European bat species. A further case in the same species was 
reported in 1957 (Nikolitsch, 1957). Rabies was reported in a 
Rhinolophus ferrum-eguinum (horseshoe) bat in Turkey 
(Tuncman, 1958). Whether or not the viruses which caused 
death in these bats were of serotype 1 or of serotype 4 is 
unknown since no material from the bats is available for 
analysis, and there have been no further reports of infected 
bats from either country.
In an enlightened observation, Mohr drew attention to
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the fact that even in latitudes as far north as Hamburg, bats 
may be infected with rabies (Mohr, 1957). His subject was the 
isolation in 1954 of a rabies virus from a bat in Hamburg 
which died the day after it bit a boy on the finger as he 
removed it from a tree. No Negri bodies were seen in the bat 
brain, but large numbers were seen in mouse brains at the 
second passage. Subsequent events suggest that the bat 
infection was caused by a serotype 4 Duvenhage virus, but no 
material remains for analysis. A second isolation was made 
from a bat in the same city fourteen years later in which the 
"biological properties of the virus isolated were found in 
part to differ considerably from known street virus 
infections" (Wersching and Schneider, 1969). In neither 
incident was the species of bat identified, nor was that of a 
third infected bat found in 1970 at Stade, about 35km west of 
Hamburg.
Although rabies was reported in a Myotis myotis bat in 
Berlin (Henschke and Heilman 1975) bat rabies was not 
diagnosed again in the Federal Republic of Germany until
1982, when an unidentified infected bat was found in
Bremerhaven, nearly 100km west of Hamburg. A further case was 
diagnosed in an Eptesicus serotinus (serotine) bat in 1983, 
and by the end of 1985 it was clear that the disease had 
established itself in serotine bats in the Federal Republic 
of Germany and it has continued to be reported.
Characterization of the Stade virus with Mabs identified it
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as a serotype 4 Duvenhage virus. In the meantime "rabies" was 
isolated from a serotine bat in the German Democratic 
Republic (DDR) (Pitzschke, 1965).
Five incidents of bat rabies have been recorded in the 
U.S.S.R., two of which led to human fatalities. In 1964, 
the isolation of rabies virus from a bat which died twenty 
five days after biting a man in Kiev (who was given vaccine 
and survived) was reported (Selimov et al., 1986). In 1977, a 
young woman of Voroshilovograd died some thirty five days 
after she was bitten on the forefinger by a bat, and in 1985 
a child (Yuli) died twenty seven days after she was bitten on 
the face by a bat in Belgorod. Rabies was also confirmed in 
1985 in a bat from Omsk which died five months after capture, 
and in a bat caught in Novosibirsk. It was concluded from 
Mabs studies that the Yuli virus isolate was a serotype 4 
virus (King et al., 1990).
In 1974 the first incident of rabies in a serotine bat 
from the region of Krakow in Poland was reported (Komorowski 
et al., 1974). A second case was recorded in 1985 (Twardowski 
and Baranewicz, 1986) when examination of a bat which had 
bitten a three year old child in Gdansk, the Baltic sea port 
nearly 500km north of Krakow, revealed a serotype 4 virus.
Towards the end of 1985, a serotine bat which had bitten 
a woman in Jutland was found to be infected with a virus 
belonging to the rabies group but not to serotype 1 (Bitsch 
et al., 1986). In that year nine further serotine bats were
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found to be infected, and by the end of 1987 the disease was
shown to be endemic in Denmark.
Rabies in bats in the Netherlands was observed for the 
first time in May 1987 and by the end of September the
disease had been confirmed in 78 serotines and three Myotis 
dasycneme hats (H.U.Neuwenhuis, pars. comm.). Also in 1987, 
bat rabies was confirmed on two occassions in Spain, in
Grenada and in Valencia (W.W.Mueller, pers. comm.) : one of
these isolates was a serotype 4 virus (J.S.Smith, 
pers. comm. ). Rabies in a serotine bat was reported for the 
first time in France in 1989 (M. Lafon, pers. comm.).
The genus Eptesicus is comprised of about thirty species 
and is nearly worldwide in distribution. In the western 
hemisphere it is found from Alaska to Argentina and Uruguay 
in South America, the Antilles, Africa, Madagascar, Europe, 
Asia and Australia (Walker, 1975). The colour of serotines is 
dark brown to black above and is usually paler below; the 
average weight is eight to eighteen grams.
Serotines are not strictly "cave-bats" although the 
hibernation site may be a cave. They often winter in city 
houses, buildings and storm sewers. There is usually 
movements of varying distances from winter to summer 
quarters. In summer, they often roost in hollow trees and 
under the roofs of houses.
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1.9.1.5. Serotype 5 ; (Provisional) Finman Virus
Rabies was confirmed in a man in Helsinki, Finland, in 
1985 (Lumio et al., 1986). He had been bitten by a bat in 
Malaysia over four years earlier, by other bats in 
Switzerland one year and in Finland fifty-one days before his 
death. In preliminary studies with Mabs, the virus isolated 
was shown to be related to the rabies viruses isolated 
earlier from bats in Germany.
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1.9.2. Other Rabies-related viruses :
Obodhiang and kotonkan.
Schmidt (1965) proposed the name Obodhiang for one of 
four immunologically distinct viruses isolated in 1965 in 
infant mice from man-biting Mansonia uniformis mosquitoes 
collected at Malakal, Sudan. In Ibadan, Nigeria, a 
rhabdovirus (Ib AR 23380) was isolated in 1967 from a pool of 
about 250 Culicoides sp. midges. The virus was named as 
kotonkan, the Yoruba word for small biting gnats and meaning 
"almost nothing" (Kemp et al., 1973). Obodhiang virus was 
isolated on three separate occassions from unengorged 
Mansonia uniformis mosquitoes. The virus has not been 
associated with clinical disease in nature but newborn mice 
inoculated intracerebrally died four to fourteen days later 
(Bauer and Murphy, 1975).
Kotonkan virus has been isolated once only, but it may 
be the cause of a disease in cattle that resembles BEF (Kemp 
et al., 1973). A mild clinical illness was induced in a 
susceptible calf (Tomori et al., 1974) and neutralizing 
activity for the virus has been found in Nigeria in a high 
percentage of the sera of cattle, and also in the sera of 
man, rats, sheep, horses, rodents and hedgehogs (Kemp et al., 
1973). Both Obodhiang and kotonkan viruses replicate in 
mosquito cells (Buckley and Tignor, 1975) and in mosquitoes, 
in which they pass into the salivary glands (Aitken et al..
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1984).
The relationship of these two viruses with Mokola 
virus, shown initially with complement - fixation tests (Kemp 
et al., 1973) was confirmed (Bauer and Murphy, 1975). The 
two arthropod-borne viruses were passaged intracerebrally 
several times in infant mouse brains before adaptation to 
vertebrate cell cultures, and the uncloned stocks were then 
used to infect suckling mice from which brain impressions 
were made. Indirect fluorescent antibody tests using 
dilutions of immune ascitic fluid revealed low levels of 
cross-reactivity between Obodhiang, kotonkan and Mokola 
viruses, but no reaction with Lagos bat and two classical 
rabies viruses used as controls. No cross-reactivity was 
found by neutralization tests or surface immunofluorescence.
Working with cloned material, however, some degree of 
relatedness between the same three viruses by cross-plaque 
neutralization reduction tests in Vero cells was shown 
(Buckley and Tignor, 1975). Mokola antiserum reduced 
Obodhiang and kotonkan plaque formation by 68% and 39% 
respectively, but the cross-reactivity was one way since 
neither Obodhiang nor kotonkan antiserum reduced Mokola virus 
plaque formation (Buckley, 1975).
The viruses are of interest since to date no other 
relationship has been established between rabies and 
insect-borne viruses. Mokola virus multiplies in both 
vertebrate and invertebrate cell cultures (Buckley, 1975) and
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experimentally in mosquitoes (Aitken et al., 1984), 
indicating that this virus may be a biological and 
serological bridging virus between rabies and the viruses 
Obodhiang and kotonkan (Buckley, 1975).
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1.9.3. Structural relationships.
Rabies, Lagos bat, Mokola and Duvenhage viruses are 
morphologically and morphogenetically very similar (Murphy 
and Harrison, 1979), all usually having uniformly cylindrical 
forms and a honeycomb structure which can be seen easily by 
electron microscopy (Bauer and Murphy, 1975). Obodhiang and 
kotonkan viruses are characterized by cone shaped particles, 
another feature which has also led to speculation that they 
may be more suitably grouped with BEF virus, which sometimes 
has cone-shaped particles (Della-Porta and Snowdon, 1979). 
However, electron microscopic observations may not be of too 
much significance when relating these viruses within the 
Rhabdoviridae since some rhabdovirusus of fish are also 
characterized by the honeycomb surface structure (Hill et 
al., 1975) and the completely unrelated Marco virus also has 
cone-shaped particles (Monath, 1979; Holland, 1987). In my 
own laboratory Flury LEP virus cultured in BHK-21 cells 
frequently produced cone-shaped particles (King and Crick, 
1988).
One of the characteristics of the rhabdoviruses is 
their ability to produce DI particles which, while 
antigenically similar to the parent, contain only part of the 
genomic RNA (Crick and Brown, 1974). It has been postulated 
that DI particles may have a role in the outcome of the 
infection in vivo (Huang and Baltimore, 1970) but there is
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still no clear evidence on this point (Holland, 1987; Wunner, 
1987). However, the ability of DI particles to interfere with 
virus production in vitro is regarded as specific for that 
particular virus. DI particles produced by a classical rabies 
virus (Flury LEP) interfered with the production not only of 
the homologous virus but also with that of Nigerian Horse 
(Staggers) virus and Lagos bat virus, suggesting a degree of 
genetic homology between them (Crick and King, 1988).
At the genomic level, little is known of the 
interrelationships between serotypes 1-4. The limited amount 
of information available concerning genome homologies between 
the viruses was cited in 1979 (Clewley and Bishop, 1979), but 
since then the techniques of hybridization on which these 
studies were based have been largely superseded by cloning 
and sequencing studies. The complete genome of at least one 
of the classical rabies strains has been sequenced (Tordo et 
al., 1988) and the primary structure of the glycoprotein of 
another fully established (Yelverton et al., 1983). Similar 
data for serotypes 2-4 would be of considerable value in 
complementing the information available from Mabs studies so 
that more meaningful relationships within the Lyssaviruses 
could be established.
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1.9.4. Pathogenesis.
In an elegant study of the comparative pathogeneses of 
rabies and rabies-like viruses (Murphy et al., 1973a,b), 
young hamsters were used as a model host system for street, 
Lagos bat and Mokola virus infections. All aspects of viral 
pathogenesis in the central nervous system (CNS) and in the 
organs involved via subsequent centrifugal virus spread were 
remarkably similar. Only in the cerebellum did fluorescent 
patterns vary; street virus was Purkinje-tropic whereas Lagos 
bat and Mokola viruses invaded all cerebellar layers.
A rabies-like illness preceded death when rhesus monkeys 
and dogs were inoculated intracerebrally with Lagos bat virus 
(Tignor et al., 1973). In the first of several cases of Lagos 
bat virus infections in the Republic of South Africa, the 
unidentified bat (probably an Epomophorus) was found sick 
with a rabies-like disease (Meredith and Standing, 1981; 
Crick et al., 1982). High temperature and drowsiness were 
features of two cases of Mokola virus infection of children, 
the second of whom died. At autopsy, cytoplasmic inclusion 
bodies seen in neurons were quite different in size and 
appearance from the Negri bodies of classical rabies virus 
infection (Familusi and Moore, 1972).
Common signs in the cats which died of Mokola virus 
infection in Zimbabwe (Foggin, 1985) were hypersensitivity to 
stimuli and muscle fasciculations, which led in some cases to
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initial diagnoses of insecticide poisoning or hypocalcaemic 
tetany. Incoordination followed by paralysis sometimes 
occurred. Histological examination of the brains revealed 
unusually extensive meningoencephalitis, and although a few 
doubtful intracytoplasmic inclusions were found in the 
thalamic region of some of the brains, in general no Negri 
bodies were seen. Two genets, a mongoose and a jackal were 
experimentally infected and all showed symptoms similar to 
those seen in naturally infected cats (Foggin, 1985). 
Although one of four shrews from which Mokola virus' was 
isolated was found dead near the laboratory at Ibadan (Kemp 
et al., 1972), the other three were apparently healthy.
Remarkably (for a lyssavirus), Mokola virus is said to 
be both neurotropic and viscerotropic. Wild shrews inoculated 
with Mokola virus and which showed signs of illness were able 
to transmit the disease to mice by biting; some shrews died 
of Mokola virus infection after eating infected mice. 
Clinical signs of disease in shrews included a tendency to 
save food instead of eating it, and some became restless, 
followed by flaccid paralysis. Others became aggressive but 
less effective in attack. There were marked histological 
changes in the brain, with lesions in the salivary glands, 
but neither intranuclear nor intracytoplasmic inclusion 
bodies were seen (Murphy et al., 1973a).
In the African case of human death from Duvenhage virus 
infection, clinical disease and post-mortem findings were
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consistent with a rabies virus infection (Meredith et al., 
1971). Electron microscopic studies of tissues from mice 
infected from this case revealed budding upon endoplasmic 
reticulum and plasma membranes of brain neurons, resembling 
laboratory or fixed virus rather than street virus infection 
(Meredith et al., 1971; Tignor et al., 1977). In 1985, a 
human death from bat rabies virus infection occurred in 
Finland (Lumio et al., 1986) and two deaths were reported 
from the U.S.S.R. (Selimov et al., 1986). Although Duvenhage 
virus infection can cause sickness and death in bats in 
Europe, it is not always possible to distinguish infected 
from healthy bats; one of seven apparently heathy bats which 
flew into a trap-net was infected (P. Grauhalle, pers. 
comm. ).
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1.9.5. Serological Relationships and 
Cross-protection Studies.
Most national laboratories now use immunofluorescent 
techniques for rabies diagnosis, but occassionally 
difficulties are encountered that may lead to a suspicion of 
strain differences. Even when a fluorescent polyclonal 
conjugate was used at twice its normal working strength on 
suckling mouse brain impressions, staining was poor with the 
rabies-related viruses although bright with classical viruses 
(Tignor et al., 1977). At my laboratory, following passage of 
the bat virus from Finland, mouse brain impressions were 
recorded as negative when a commercially prepared polyclonal 
conjugate was used but positive when a similarly prepared 
appropriate monoclonal conjugate was used. (King, unpub. 
data). Interestingly, in the original demonstration of this 
virus, antigen was detected in a brain smear by staining with 
a monoclonal conjugate (Lumio et al., 1986).
Indeed, polyclonal antisera, with which the earlier 
epidemiological surveys were made and the various 
interrelationships within the Lyssavirus group established, 
have now been largely replaced by the use of Mabs. These 
latter make it possible to show varying degrees of homology 
and heterogeniety, not only between serotypes but also 
between strains within serotypes.
In order to further investigate this heterogeneity, in
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1982 the WHO set up a working party on the application of 
Mabs in the characterization and differentiation of
laboratory and field strains of rabies virus. In the first 
four years the group concentrated on the development of a 
reduced panel for Mab-N grouping and identifying rabies and 
rabies-related viruses and from 1986 onwards the attention of 
the group was focussed on the virus isolates originating from 
European bats. The classification of the Lyssaviruses 
proposed by the working group is summarized in Table 1.3.
The concept of a truncated panel, however, contains one 
potentially serious flaw; the panel per se is designed to 
identify already known viruses. Theoretically, new isolates 
may react with some or all of these Mabs and fit into a 
recognized reaction pattern and yet on further examination be 
shown to be distinctive.
It has become obvious that the concept of a group 
antigen, the N protein of the nucleocapsid (Schneider et al., 
1973), was an oversimplification and indeed the diversity of 
the antigenic structure of the N proteins and the comparative 
ease with which differences can be determined by using Mab-Ns 
has meant that Mab-Gs are now seldom used.
It has been shown that while mice immunized with 
standard rabies vaccines are fully protected against 
homologous virus challenge and against street viruses that 
share several antigenic determinants, they are poorly 
protected against challenge with viruses of only a limited
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degree of antigenic homology with the vaccine virus 
(Koprowski et al., 1985). It is also worth remembering that 
the dog infected with Mokola virus in Zimbabwe had been 
immunized with a classical rabies vaccine (Foggin, 1982). The 
percentage of epitopes shared by the rabies virus used to 
prepare the human diploid cell vaccine (HDCV) at the Wistar 
Institute, Philadelphia, and a selection of street viruses 
from the Americas, western Europe, and southern Africa varied 
from 44% for some viruses of bat origin to 100% for viruses 
from European foxes and Argentinean dogs, and from 64% to 
100% for viruses from human cases in the U.S.A. (Wiktor, 
1985). That is to say, classical rabies vaccines could be 
expected to protect both animals and man from infection by 
these serotype 1 viruses. In marked contrast, Duvenhage virus 
shared only 34% of its antigenic determinants with the rabies 
vaccine virus, and there were no common determinants between 
the latter and Mokola or Lagos bat viruses. As first pointed 
out in 1971, there may be a case for producing polyvalent 
vaccines for use in certain parts of the world (Shope and 
Tignor, 1971).
Schneider, in experiments quoted by Lumio et al., (1986) 
showed that another classical rabies vaccine (suckling mouse 
brain) also gave poor protection in mice against the Hamburg 
and Stade viruses. Similar results were reported by Schneider 
and Meyer (1981 ). However, as Wunner has commented, this 
correlation of antigenicity between vaccine strains.
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challenge virus and the outcome of the infection may not hold 
in other species (Wunner, 1987).
In view of the fact that Duvenhage virus now appears to 
be endemic among bats of northern and western Europe, the 
question whether vaccines prepared against classical strains 
will protect against challenge with bat virus has been 
re-examined (Bitsch et al., 1986). These authors, in contrast 
to earlier workers, showed that both human and animal 
vaccines would protect mice against challenge with the Danish 
bat virus (DBV) and, most importantly, that human rabies 
immunoglobulin (HRIG) would also neutralize DBV. The latter 
observation has been confirmed by the examination of sera 
from immunized volunteers who had been given one of five high 
potency commercially available vaccines using the newly 
proposed abbreviated schedule for post-exposure treatment 
(Lafon et al., 1986). They also examined five preparations of 
HRIG currently available in Europe in the same type of 
neutralization test (Lennette et al., 1971; Smith et al.,
1973). All had high neutralizing antibody titres against both 
standard CVS and DBV. This satisfactory result led them to 
the conclusion that in cases of human contamination by an 
infected bat in Europe, post-exposure treatment with rabies 
vaccine and HRIG should be administered according to WHO 
recommendations as for contamination by rabid terrestrial 
animals.
But this is not the end of the story. In my laboratory
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we have found that HRIG, prepared in the United Kingdom from 
the sera of vaccinees who had received HDCV, neutralized 
serotypes 2-4 far less efficiently than serotype 1 (King, 
unpub. data). More recently it has been shown that in mice, 
HDCV gave only partial protection against challenge with 
human virus isolates from Finland and Saudi Arabia and gave 
no protection against challenge with Mokola virus and Lagos 
bat virus (Fekadu et al., 1988).
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Table 1.3. WHO Mab Grouping of Rabies-related
Viruses, 1989*.
Serotype Host Location
2 Lagos bat
(Three subtypes)
Lag 1 E. helvum Lagos Island
Lag 2 M. pusillus C.A.R.
Lag 2 cat Zimbabwe
Lag 3 ? cat R.S.A.
Lag 3 bat R.S.A.
? bat R.S.A.
? Fruit bat R.S.A.
Lag 3 E. helvum Senegal
? E. wahlbergi R.S.A.
Reference
Boulger and 
Porterfield, 1958 
Sureau et al., 1977 
Foggin, unpublished 
Schneider et al., 1983 
Schneider et al., 1983 
Schneider et al., 1983 
Meredith and Standing 1982 
Lafon, unpublished 
Saluzzo et al., 1983
3 Mokola
(One subtype)
Mok 1
cat
Human 
Human 
Shrew 
Rodent 
(x5), dog
Ibadan Familusi and Moore, 1972
Ibadan Familusi and Moore, 1972
Cameroun Le Gonidec et al., 1978
C.A.R. Saluzzo et al., 1982, 1983
Zimbabwe Foggin, 1982, 1983
4 Duvenhage
(Two subtypes)
Duv 1 Human
Insect, bat 
N. thebaica
Duv 2 bat
bat 
bat 
E. serotinus
R.S.A.
R.S.A.
Zimbabwe
Hamburg
Stade
Bremerhaven
Poland
Meredith et al., 1971 
van de Merwe, 1982 
Foggin, unpublished
Schneider, 1983 
Schneider, 1983 
Schneider, 1983 
1985
bat, xl00 Denmark, Germany
5 Finland
(One isolate) 
Human Finland Lumio et al., 1985
* Adapted from WHO/Rab.Res./89.33., the report of the fifth 
WHO Consultation on Monoclonal Antibodies in Rabies Diagnosis 
and Research, Geneva, 3rd. March, 1989.
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1.10. In Vitro Growth of Rabies Viruses.
This topic was recently reviewed (Crick and King, 1988).
1.10.1. History.
Noguchi and Levaditi were the first to successfully 
attempt to grow rabies virus in vitro and they independently 
reported the prolonged release of virus from cultured 
fragments of nervous tissue taken from infected animals 
(Noguchi, 1913; Levaditi, 1913, 1914). In Levaditi's
experiments the cells were kept alive in coagulated monkey 
plasma for up to two months but, interestingly, by that time 
the nerve cells had been supplanted by fibroblastic cells and 
the virus released would not infect nervous tissue cultures 
from uninfected animals. Stoel, however, in 1930 was able to 
passage the virus five times in embryonic chicken brains and 
hearts by explantation in rabbit plasma clots (Stoel, 1930).
The first successful cultivation of rabies virus 
without the use of plasma clots was reported by Kanazawa who 
used rabbit embryo brains suspended in Tyrode's solution 
(Kanazawa, 1936). Within a short period of time several 
others ('cited by Wiktor and Clark, 1975) had propagated fixed 
rabies virus strains in either mouse or rat embryo brain 
cells. Cultivations of rabies street viruses using material 
from the brain of a human patient and from that of a rabid
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dog were first made in 1942 (Plotz and Reagan, 1942). They 
were able to maintain these viruses for 11 and 9 days 
respectively. Later, it was found that rabies virus would 
replicate more efficiently in cell cultures derived from 
embryonic mouse brain than those from brains of new-born or 
adult mice (Parker and Hollander, 1945).
The susceptibility of primary mouse kidney cell 
cultures to rabies virus infection was reported in 1956 
(Vieuchange et al., 1956b). Two years later both street and 
fixed viruses were successfully serially passaged in primary 
hamster cells (Kissling, 1958), and by 1963 the potential 
use of virus grown in this way for the preparation of a 
vaccine had been demonstrated (Kissling and Reese, 1963). It 
has since been shown that large scale production of rabies 
virus is also possible in a variety of primary culture 
systems including pig kidney (Abelseth, 1964), chick embryo 
and duck embryo fibroblasts (Kondo, 1965), dog kidney 
(Hronovsky et al., 1966) and rhesus monkey (Lang et al., 
1969). In the meantime the propagation of rabies virus fixed 
strains in a wide variety of primary and serially passaged 
cell cultures had been reported (Aksenova et al., 1966).
Nowadays there are a number of cell lines and cell 
strains available for the regular production of large 
quantities of rabies virus. Baby hamster kidney cells 
(Macpherson and Stoker, 1962) are widely used because they 
are extremely susceptible to the virus, but Nil-2 (Diamond,
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1967), CER (Smith et al., 1977) and Vero (Montagnon, 1985) 
are also in common usage. Because of their heteroploid 
characteristics and oncogenic potential, however, none of the 
cell lines (with the exception of Vero cells) has been 
considered suitable for the production of human vaccines. In 
1964 the production of vaccine in a human diploid cell 
strain, WI-38, was described (Wilztor et al., 1964). Other 
diploid cell strains such as HEL (Hronovsky et al., 1973) and 
MRC-5 (Johnston et al., 1985) have been used for this purpose 
and a rhesus monkey diploid cell line vaccine has also beeen 
produced (Wallace et al., 1973; Burgoyne et al., 1985).
Rabies viruses will grow in a number of cells of 
poïkilothermie origin but not in cells of insect origin 
(Buckley, 1973). Other unusual cells, for example, chick 
embryo myotubes (Lentz et al., 1982) and a mouse macrophage 
cell line (King et al., 1984) have also been used for in 
vitro studies of rabies virus infection and pathogenesis. 
Less information is available on the ability of the
rabies-related viruses to grow in cell cultures. Lagos bat 
(Clark, 1979), Mokola (Clark, 1979) and Duvenhage (Tignor et 
al., 1977) viruses will grow in BHK-21, CER, Vero and C1300 
neuroblastoma cells (Clark, 1979; Smith et al., 1977; Tignor 
et al., 1977). Obodhiang and kotonkan viruses are
cytopathogenic for neuroblastoma cells (Clark, 1979) and
also grow in cells of Singh's Aedes albopictus mosquito cell
line, after which they can be passaged in BHK-21 and Vero
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cell lines (Buckley, 1973, 1975). Mokola differs from the
other two human pathogens (rabies virus and Duvenhage virus) 
in that it can replicate in both vertebrate and invertebrate 
cell cultures (Buckley, 1975).
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1.10.2. Virus Propagation.
Although a wide variety of cell types can be used to 
propagate rabies viruses, many systems require considerable 
periods of adaptation and prolonged passaging before 
substantial virus yields can be obtained (Wiktor, 1966;
Wiktor and Clark, 1975; Clark, 1979). In this respect, 
diploid cells are particularly difficult as exemplified by 
the original adaptation of the Pitman-Moore (PM) strain to 
WI-38 cells (Wiktor et al., 1964; Wiktor, 1966; Wiktor and 
Clark, 1975; Clark, 1979). Prolonged and regular serial 
passage of infected cells, initially with the addition of 
uninfected cells, was required before sufficient infectious 
virus was released into the culture supernatant fluid. Only 
at this stage could these fluids be held as virus stocks and 
used for subsequent re-infection of fresh uninfected cells. 
The yield in WI-38 cells, even with adapted virus, is only 
about one-tenth of that when cell lines such as BHK-21 or 
Vero are used - yet another reason for restricting the use of
diploid cells to the production of vaccine for humans.
However, regardless of the type of cell being used,
there are a number of factors which can have a profound 
effect on virus production. These include the pH of the 
culture medium, the presence or absence of growth supplements 
(such as serum or serum albumin) and temperature of 
incubation. Optimum conditions seem to vary between
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laboratories, the "sub-strain" of cells used and in the case 
of cell lines such as BHK-21, local differences in the 
composition of Eagle's MEM, the most commonly used medium. 
The quality of the cells at the time of initial infection is 
critical and in order to obtain maximum yield of virus it is 
vital to use cultures which are just confluent, having been 
passaged not more than 2-3 days previously. High input 
multiplicities of infection (MOI) may occassionally lead to 
autointerference (Yoshino et al., 1966a,b; Yoshino and 
Morishima, 1971), though this is not normally a problem.
Nevertheless, efforts to produce single cycle growth 
curves in rabies virus infected cells have, in general, been 
unsuccessful. This may be related to the fact that 
replication proceeds relatively slowly and that it is not 
always possible to produce synchronous cell populations 
(Wiktor and Clark, 1975; Clark, 1979).
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1.10.3. Cytopathology.
In general, no specific cytopathogenic effect (CPE) 
accompanies the production of rabies virus in cell culture. 
In infected BHK-21 monolayers, for example, the cells merely 
begin to "age" and detach more quickly from the supporting 
surface than uninfected control cells. However, in 1971, 
using chick embryo fibroblasts it was found that the 
viability of infected cells was sufficiently affected for 
plaques to develop (Yoshino et al., 1966a,b; Yoshino and 
Morishima, 1971). Similarly, plaques could be induced in 
infected agarose suspended BHK-21 cells (Sedwick and Wiktor, 
1967) and plaque-forming viruses could also be recovered from 
persistently infected cells of the same type (Kawai et al., 
1975). In neuroblastoma cells with rabies, Lagos bat, Mokola 
and Duvenhage viruses, infection is much more severe than in 
BHK-21 cells. Duvenhage virus actually induces the formation 
of syncytia and Obodhiang and kotonkan viruses will form 
plaques in these cells (Clark, 1980).
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1.10.4. Persistent Infection.
Since the first reported isolation of rabies DI 
particles (Crick and Brown, 1974), their production by many 
virus strains in many cell systems has beeen generally 
recognized (Clark, 1979; Kawai and Matsumoto, 1977; Wiktor et 
al., 1977). They are in fact extremely readily produced: for
example, detectable levels of Dis can be generated in the 
first undiluted passage of a cloned pool of HEP Flury virus 
(Kawai and Matsumoto, 1977). Purified rabies Dis, like those 
of other rhabdoviruses, interfere in culture with the 
production of homologous and closely related strains (Crick 
and Brown, 1974; Holland et al., 1976; Andzhaparidze et al., 
1981; King and Crick, 1988) and are probably involved in the 
establishment of persistent in vitro infections, a subject 
discussed in some depth (Holland et al., 1976, Holland, 
1987). Thus, without their initial introduction. Dis are 
produced during the establishment of persistently infected 
cultures, and alternating cyclical production of infectious 
virus is observed. An earlier conclusion that this pattern of 
virus production, which was accompanied by the production of 
interferon or an interferon-like substance (Wiktor and Clark, 
1972, 1975) is not necessarily contra-indicated by these more 
recent findings.
Serial propagation of viruses can also affect phenotype 
(Clark and Wiktor, 1974). As in the case of many other virus
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infections the host cell type persistently infected 
influenced the virus DI interactions and the virulence 
phenotype of the released virus (Andzhaparidze et al., 1981). 
However, when working with both virulent and avirulent 
viruses no correlation between DI production and virulence 
was found (Wunner and Clark, 1980).
Whatever mechanisms are involved in chronic or 
persistent infection, rabies virus has a clearly established 
endosymbiotic relationship with the host cells, which are 
able to continue growing and replicating as efficiently as 
control uninfected cells (Majer et al., 1977). Considerable 
effort to explain persistence in molecular terms has been 
made in many laboratories, and a comprehensive review of the 
topic has been published (Wunner, 1987).
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1.10.5. Virus in Infected cells.
In 1903 Negri and Bose independently described inclusion 
bodies associated with rabies infection of cells of the
brain, their presence or absence subsequently providing a 
practical method for establishing diagnosis (Perl, 1975). It 
was not until much later that "Negri bodies" were shown to 
contain viral antigen (Goldwasser and Kissling, 1958) and 
viral particles within the brain cell inclusions were 
demonstrated (Matsumoto, 1962, 1963). Using techniques
similar to those of Matsumoto, coupled with the use of
ferritin-labelled antiserum, it was shown that the similar 
inclusion bodies in BHK-21 cells, although containing virus 
particles, were largely composed of ribonucleoprotein
(Hummeler et al., 1967).
A number of other methods for detecting virus infection 
in vitro is now available. For convenience in diagnostic 
tests, conventional staining has been largely replaced by the 
fluorescent antibody (FA) technique. This technique has also 
become the method of choice for following the progress of
infection in cell culture. With fixed cells, the antigen
predominantly stained is the N- protein of the nucleocapsid, 
whereas staining of unfixed cells reveals mainly viral
glycoprotein located on plasma membrane (Clark, 1979).
Routinely, polyclonal hyperimmune antisera are still 
employed in the FA test, but in the past ten years or so
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Mab-Ns and Mab-Gs have become available. These provide more 
specific probes for distinguishing between cells infected 
with rabies virus or other members of the Lyssavirus group. 
Usually, the cells are treated with the appropriate 
unlabelled Mabs whose coupling with the viral antigen is then 
revealed by the addition of a labelled anti-mouse antiserum 
(Thomas, 1975).
Although the FA test is the most reliable and sensitive 
indicator of rabies virus infection, it does not necessarily 
provide a measure of infectious virus within the cells nor of 
their potential to release virus into the culture medium, a 
feature to be borne in mind when using the test to monitor 
virus production, for example, for vaccine manufacture.
Compared with FA, other tests for the detection and 
examination of infected cells are little used. However, some 
tests have particular value for particular circumstances. 
Complement-dependent immune lysis may be useful for detecting 
cells which are beginning to release virus or from which 
there is only a low level of virus release as in chronic 
infections (Wiktor et al., 1968), although reservations about 
the use of the method for this purpose have been expressed 
(Lodmell et al., 1981). Many workers have also used electron 
microscopy to examine the course of infection (e.g., Hummeler 
et al., 1967; Iwasaki et al., 1973).
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1.10.6. Application of Cell Culture Methods.
1.10.6.1. Rabies Virus Assay.
Somewhat surprisingly in view of the limited ability of 
the viruses to induce CPE, a number of plaque assay methods 
has been developed. Cell lines used for this purpose include 
BHK-21 (both the C13S sub-strain maintained in suspended 
culture (Wiktor, 1973) and BHK-21/C13 maintained in 
monolayers (Schneider, 1973), CER (Bussereau et al., 1982), 
the pig kidney cell line PK-2A (Strating et al., 1975) and 
Vero (Buckley and Tignor, 1975). Chick embryo fibroblasts 
(CEF) have also been employed (Yoshino et al., 1966a; Yoshino 
and Morishima, 1971; Sedwick and Wiktor, 1967). The most 
widely-used technique is based on agarose-suspended 
BHK-21/C13S cells in which most culture adapted fixed rabies 
viruses produce plaques after 5-7 days of incubation (Sedwick 
and Wiktor, 1967; Wiktor, 1973).
The plaques obtained in CEF (Yoshino et al., 1966a; 
Yoshino and Morishima, 1971) were regarded more as 
proliferative foci than the dead cells of which plaques are 
usually composed. More recently, an interference focus- 
forming technique in BHK-21 cells for the assay of DI 
particles has been developed (Kawai and Matsumoto, 1982). The 
same workers have also shown that virus development is 
influenced by the host cell (Matsumoto and Kawai, 1969).
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Lagos bat and Mokola viruses can also be assayed by 
plaguing in BHK-21/C13S cells (Clark, 1979), Mokola virus in 
a pig kidney cell line (David-West, 1974) and the entire 
Lyssavirus group in Vero cells (Clark, 1980). Obodhiang and 
kotonkan viruses can be titrated by the plaque method and by 
CPE in C1300 neuroblastoma cells (Clark, 1980).
Unfortunately, plaque assays do not always give 
consistent results even with well adapted fixed virus 
strains. For virus titration, they have been largely
superseded by fluorescent focus assays in which cells, for 
example, CEF or BHK-21 (Smith et al., 1973) are incubated 
with serial dilutions of virus, then fixed and treated with 
fluorescent antiserum or Mab-Ns 1-4 days later. Titration 
endpoints compare well with those obtained by intracerebral 
inoculation of mice (Smith et al., 1973). The test has proved 
suitable for fixed and street strains, not only of rabies
virus but also of Lagos bat, Mokola and Duvenhage viruses.
Virus neutralizing antibody can be titrated by either 
plaque reduction methods (Arko et al., 1973) or, more 
conveniently, by fluorescent focus inhibition tests (Campbell 
and Barton, 1988). Results with these tests also correlate 
well with those obtained by the mouse neutralization test. As 
an extension of the methods, both have been used in antibody 
binding tests whereby vaccine potencies may be determined
(Barth et al., 1981).
Infected culture fluids also include non-infectious
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particles and sub-viral components. Complement fixation tests 
can be used to measure total viral antigen (Kuwert, 1973a) 
and haemagglutination tests using goose erythrocytes to 
measure intact particles (Kuwert, 1973b). This method 
requires a concentration of at least 10  ^PFU/ml, and can only 
be used for virus assay in serum-free medium (Clark, 1979).
1.10.6.2. Virus Structure and Strategy for Replication.
Knowledge of rabies virus structure would be extremely 
limited without the ability to grow and radio-label virus in 
tissue culture prior to its purification and analysis by the 
techniques of molecular biology. In addition, cells in 
culture can be used to study the processes of virus 
infection, transcription and translation, replication, 
assembly and release. Also, many of the effects of virus on 
cellular metabolism can now be examined at the biochemical 
level; these have been comprehensively studied (Wagner, 1987; 
Tordo and Poch, 1988; Tsiang, 1988).
1.10.6.3. Pathogenesis.
Despite more than a century of continuous effort in 
laboratories throughout the world, the understanding of, and 
therefore ability to intervene in, the course of rabies 
infection remains extremely limited. Current concepts of
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rabies pathogenesis have been recently reviewed (Wunner, 
1987; Charlton, 1988). The following will be confined to the 
contribution cell culture techniques have made, and can make, 
in its elucidation.
Many of the earlier experiments employed thin section 
electron microscopy to visualize how infection occurs, the 
fate of the virus once it has entered the cell,
morphogenesis, and release of nascent virus. However, with 
the exception of Matsumoto and his colleagues ("cited by 
Wunner, 1987) where in vitro and in vivo studies were done in 
parallel, most of these experiments were made in BHK-21 or 
CER cells, despite the fact that in the intact animal
replication may be almost entirely restricted to nervous 
tissue. Results appear to vary with experimental conditions, 
that is, the strains of virus, MOI and type of cell employed 
(Matsumoto and Kawai, 1969; Brown and Crick, 1982). 
Observations with chronically infected C1300 neuroblastoma 
cells examined by the newer technique of scanning and freeze 
fracture electron microscopy may have more bearing on what 
happens in natural infection (Iwasaki and Minamoto, 1982).
Major developments in the study of pathogenesis have 
resulted from the availability of the plaque technique and 
thus the possibility of selecting "clones" and mutants. An
extension of this method whereby a strain of the virus is 
grown in the presence of suitable neutralizing Mab-Gs has 
made it possible to grow variants (Coulon et al., 1982;
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Lafon et al., 1983) with altered pathogenic (Coulon et al., 
1982) or protective (Wunner, 1987) potential whose antigenic 
changes can be subsequently mapped (Coulon et al., 1982; 
Lafon et al., 1983; Wunner and Dietzschold, 1987).
As an adjunct to these studies, at the Wistar Institute, 
Philadelphia, a comparison of cell-to-cell spread of 
pathogenic parental virus and apathogenic variants in vivo 
(in the brains of infected adult mice) and in vitro (in 
BHK-21 and neuroblastoma cells) has been made. Cultured 
neuroblastoma cells retained some characteristics of 
neurons, and correlation of differences in pathogenic 
behaviour between the two types of virus in both in vivo and 
in vitro systems was obtained (Dietzschold et al., 1985). No 
differences between pathogenic and apathogenic virus 
infections were observed in BHK-21 cells, a factor underlying 
the importance of selecting the appropriate model for each 
experimental situation.
Suitable virus receptors are necessary for successful 
infection and the host range of many viruses may therefore be 
determined initially by their presence or absence on the cell 
surface. A specific receptor for rabies virus has not yet 
been identified, if indeed one exists, although the 
involvement in infection of both muscle spindles and motor 
endplates in striated muscle has been implicated (Harrison 
and Murphy, 1978). Some experiments have been conducted in 
conventional cell systems such as CER and neuroblastoma
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cells, but a highly sophisticated compartmentalized technique 
for the culture of dorsal root ganglion cells has also been 
developed (Lycke and Tsiang, 1987). The system allows the 
infection and manipulation of neural extensions without 
exposing the neural soma to the infecting virus. Thus the 
high binding affinity of the virus to unmyelinated neurites 
and its transfer by the neurites to the neuronal soma has 
been shown, thereby supporting the view that sensory nerves 
can indeed be involved in the centripetal transfer of virus 
to the CNS.
In contrast, attempts have been made to substantiate the 
observation that motor endplates and hence motor nerves could 
be of prime importance in the transfer of virus to the CNS 
following its initial introduction to the body {Watson et 
al., 1981). A series of experiments involving first, isolated 
mouse diaphragm with attached phrenic nerves, and then 
cultured embryonic chick myotubes (both chosen for their high 
density acetylcholine receptors (AChR)), led them to the 
speculation that this receptor might be involved in rabies 
virus infections: at the motor nerve terminal region
post-synaptic AChRs are abundant (Lentz et al., 1982; Burrage 
et al., 1985). However, tests of this hypothesis in a number 
of cell culture systems including some lacking high density 
AChRs have led to the conclusions that AChRs are not 
necessary for rabies virus infection and that the 
susceptibility of different cell types does not depend on a
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single specific type of receptor (Reagan and Wunner, 1985; 
Wunner, 1987; Tsiang, 1985).
There is, however, increasing evidence that lipids 
(Superti et al., 1984) and carbohydrates (Conti et al., 1986) 
may be involved in the early interreactions between rabies 
virus and cell membranes. Again, the availability of suitable 
cultured cells is crucial in the investigations.
Comparatively little attention has been paid by most 
investigators to the possibility of an immunological 
involvement in at least some cases of rabies virus infection, 
for example, the "early death" phenomenon (Blancou et al., 
1980; Porterfield, 1981; Prahhakar and Nathanson, 1981). In 
a test using the P388D1 mouse macrophage cell line (Koren et 
al., 1975) it was shown that rabies antiserum diluted beyond 
the neutralization endpoint enhanced the ability of virus to 
infect these cells (King et al., 1984). A similar effect in 
the intact animal could go some way to explaining why certain 
animals or patients succumb to the disease despite 
vaccination and indeed die more rapidly than infected but 
unvaccinated individuals.
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1.10.6.4. Diagnosis.
Even in countries where rabies is not endemic, a 
diagnostic capability which includes virus isolation and 
identification is desirable, and for many years a replacement 
for the mouse test has been sought. CER and neuroblastoma 
cells were those first used to explore this potential (Smith 
et al., 1977; Smith et al., 1978). The system of cell culture 
has since been adopted in some laboratories (Webster, 1987; 
Rudd and Trimarchi, 1987; Umoh and Blenden, 1983), in many of 
which BHK-21 cells have not been regarded as sufficiently 
sensitive for use with field isolates. However at my 
laboratory we have found these cells satisfactory for 
diagnosis and for the preparation of virus stocks.
1.10.6.5. Vaccines.
Effective vaccination policies are so much part of the 
prevention and control of rabies that probably the most 
important use of cell culture is in the production of 
vaccines. Cultured vaccines are free from many of the side 
effects of nerve tissue and of avian tissue vaccines, store 
well, and are highly antigenic. They can be prepared in 
primary cell cultures, in cell lines and in cell strains, and 
may consist of modified live (attenuated) or inactivated 
vaccines. An idea of the variety of vaccines manufactured can
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be gained from Table 1.4. Cells such as BHK-21 and Nil-2 are 
particularly good sources of antigen and can be grown in bulk 
in suspension cultures (Chapman et al., 1973) or as
monolayers on microcarriers (Whiteside and Spier, 1977).
With the increasing availability of highly potent
inactivated vaccines, the use of live virus vaccines for 
domestic animals is being discouraged, especially where 
rabies has been eliminated or is under control (Anon.,
WH0/Rab.Res./85.21., 1985). They are, however, being
distributed in bait for the control of wildlife (fox) rabies 
in Europe and Canada (Schneider et al., 1987; Wandeler, 1988; 
Maclnnes, 1988).
Live virus vaccines are not used for humans, and for 
medical use the choice of cell substrate has until recently 
been confined to primary cell cultures (Barth et al., 1984) 
or human cell lines such as WI-38 (Wiktor et al., 1964), or 
MRC-5 (Johnston et al., 1985). Because of technical 
difficulties and the consequent high costs of these products, 
alternatives have been sought and vaccines have been produced 
in a rhesus monkey diploid cell line (Wallace et al., 1973; 
Burgoyne et al., 1985). It now appears that Vero cells are 
also acceptable as a substrate for human vaccine manufacture. 
These cells have the advantage of being readily adapted to 
growth on microcarriers (Montagnon et al., 1985; El- 
Karamany, 1987).
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Table 1.4. A Selection of Rabies Vaccines
Currently Under Manufacture*.
Modified Application 
Substrate Inactivated Live Human Animal
Primary Cells
Hamster kidney + + + +
Dog kidney + +
Pig kidney + +
Foetal calf kidney + +
Chick embryo
fibroblasts + + + +
Diploid cell strains
Human lung - WI-38 + +
Human lung - MRC-5 + +
Rhesus monkey lung
FRhL-2 + +
Heteroploid cell lines 
Monkey kidney -
Vero + + +
Hamster kidney -
BHK-21 + + +
Hamster kidney -
Nil-2 + +
Dog kidney + +
Pig kidney + + +
* Adapted from Crick and King, 1988.
92
There are, however, certain disadvantages in maintaining 
infected cells for vaccine production in large scale 
propagators, not least of which is the need to supplement the 
medium with serum or serum substitutes (El-Karamany, 1987; 
Whiteside and Spier, 1977). This does not apply if roller 
bottles are used, and a very low medium volume;cell ratio can 
be maintained. The method, though more labour intensive than 
with tanks, is simpler, the equipment easier to instal and 
maintain and, in the event of contamination of one roller, 
the entire batch need not be discarded. These are factors 
which should not be ignored when considering the feasibility 
of transferring vaccine production to developing countries.
Killed vaccines are often concentrated and, for human 
use, purified before inactivation (El-Karamany, 1987; Barth 
et al., 1984; Kuwert et al., 1985). Their potency can then be 
monitored by antibody binding tests (Barth et al., 1984) 
which can be conducted in the same type of cell as is used 
for production purposes. Blind passages of the product in 
uninfected cells are often made to confirm the efficacy of 
virus inactivation (Netter and Perkins, 1973).
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1. 11. Aims of this Thesis :
The primary objective of this study was to examine the 
antigenic relationships between rabies and rabies-related 
viruses from geographical regions where these viruses are 
known to co-exist. This objective required the development of 
a cell culture technique which would present the virus 
isolates for monoclonal antibody (Mab) assay in the minimum 
number of passages from original brain material; the 
development of a brain-smear technique which could be used 
for this work in countries where cell culture techniques were 
either not available and/or feasible and the generation of a 
panel of Mabs directed against the internal proteins of the 
rabies-related viruses. By use of the prototype strains of 
these viruses as immunogens it was hoped to provide further 
insight into the antigenic relationships of the viruses 
present in European bat species.
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Chapter 2. General Materials and Methods.
2.1. Materials.
The following materials were used in this work;
Acetone. GPR grade. 80% acetone = 80% in de-ionized water.
Aminopterin. Purchased from .Sigma Chemical Co, Poole, 
Dorset. 3.82mg of aminopterin was dissolved in 2ml of 0.1M 
NaOH and made up to 200ml with de-ionized water. The solution 
was filtered through an 0.22um Milipore membrane and stored 
in 6ml aliquots at -20®C.
ATV (Antibiotics, trypsin and versene). Each 50ml of 10x 
concentrate contained trypsin at 0.05%, versene at 0.02%, 
Penicillin at 100 units/ml and streptomycin at 100ug/ml. The 
concentrate was filtered through an 0.22um Millipore filter 
and then Mycostatin to 25 units/ml and 0.35ml of 7.5% sodium 
bicarbonate solution were added. The concentrate was stored 
at -20®C and for use a 50ml aliquot was thawed and added to 
450ml of distilled water.
Balb/c mice. Purchased from Interfauna Ltd. Cambridge.
Barium Chloride. Used at 5% in PBS.
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Beta-propiolactone. Purchased from Sigma Chemical Co.
Dorset. Used at 1/2000.
BHK-21 cells. Baby hamster kidney BHK-21 cells
(Macpherson and Stoker, 1962) were purchased from Gibco Ltd, 
Irvine, Scotland. Fresh stocks were prepared in growth medium 
and aliquots were laid down in liquid nitrogen.
Centocor. FITC-anti-rabies globulin (termed Centocor) was 
purchased from Centocor Inc., Malvern, Pa. USA. and used at 
1/20 in PBS.
Counting Chamber. Improved Neubauer.
CVS virus. The Challenge Virus Standard CVS-24 was purchased 
from The American Type Culture Collection, Rockville, USA.
DEAE-dextran. Purchased from Sigma Chemical Co., Poole.
Di-methyl sulphoxide (DMSO, scintillation grade), purchased 
from Koch-Light Ltd. was used at 15% in growth medium.
Goat Anti-mouse Immunoglobulins (IgA+IgG+IgM) conjugated to 
fluorescein iso-thiocyanate (FITC). Purchased from Cappel, 
Organon Teknika Corporation, West Chester, U.S.A.
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Growth medium. To 700ml sterile distilled water was added 
100ml of 10X Glasgow modification MEM (Gibco), 100ml tryptose 
phosphate broth, 10ml 200mM L-glutamine, 20ml 7.5% sodium 
bicarbonate and 5ml antibiotic solution containing Penicillin 
(100 units/ml) Streptomycin (100ug/ml) and Mycostatin (25 
units/ml). Before use 100ml of ox serum was added.
HAT medium. Growth medium with 1% aminopterin and 1% HT.
Hypoxanthine and Thymidine (HT). Purchased from BDH. 272mg 
of hypoxanthine was dissolved in 70ml 0.1M NaOH and made up 
to 150ml with de-ionized water. 77.6mg of thymidine was 
dissolved in 20ml de-ionized water and added to the 
hypoxanthine solution. The volume was made up to 200ml with 
de-ionized water, filtered through an 0.22um Millipore 
membrane and stored in 6ml aliquots at -20®C.
Leighton tubes. Purchased from Murray & Co., Woking, England.
Microscope. Fluorescent = Leitz Fluovert fitted with an XBO 
75W xenon high pressure lamp and ultra-violet filter set. 
Magnification (approximately xl50) was achieved with a 25xLL 
(long reach for 96-well plates) or 25xFluotar (normal focal 
length for 84-well plates and Teflon slides) objective and 
6.3X/18 eyepiece.
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Microscope. Incandescent = Leitz Diavert (inverted). 
Magnification (approximately xl00) was achieved with a
10/0.26 Phaco objective and Periplan 10x eyepiece.
Mouse Monoclonal Typing Kits. Purchased from Serotec, Oxford.
PBS (Phosphate buffered saline) pH 7.2. 40ml of solution A 
(5.4g Na2HP04 + 1.574g NaH2PO4.2H20 was added to 60ml of
solution B (8.5g NaCl in 60ml H2O) and the volume made up to
1 litre with 900ml H2O. The pH was adjusted to 7.2.
Street virus. Fox brain 58605 was one of a batch of 20 rabies 
infected brains kindly donated in 1985 by Dr. Jean Blancou, 
C.N.E.V.A., Malzeville, France.
Teflon slides. Teflon (polytetrafluoroethane) coated 75mm x 
25mm glass slides with 12 9mm wells were purchased from C. 
A. Hendley, Essex, Ltd., England.
84-well plates. Greiner Labortechnik, were purchased from 
Dynatech Laboratories, England.
96-well plates. 96-well tissue culture clusters with flat 
bottom wells, 0.32cmz growth area, were purchased from 
Costar, Cambridge, Mass. USA.
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2.2. Methods.
2.2.1. Lynphokine Preparation.
The spleen was aseptically removed from an uninoculated 
mouse killed by neck dislocation and after washing in several 
changes of serum - free medium to remove blood etc., the 
cells were dispersed with ATV and the volume made up to 100ml 
with growth medium. The cell suspension was divided between 
two 80cm2 bottles and incubated at 37®C for 5 days. Following 
centrifugation at 1000g for 10min, the supernatant was 
filtered through an 0.22um membrane filter, split into 5ml 
aliquots and stored at -70®C until required.
2.2.2. Storage of Cells in Liquid Nitrogen.
For freezing, suspended cells were centrifuged at 350g 
for 10min and the supernatant removed without disturbing the 
cell pack. Just sufficient medium to re - suspend cells was 
added and the volume made up with DMSO-free medium to half 
that required, i.e., 2ml for 80cmz, 1ml for 25cmz bottles. 
After the addition of an equal volume of 15% DMSO medium the 
cells were dispensed into labelled vials, placed in a 
polystyrene box in the gas phase of the liquid nitrogen and 
the following day transferred to the racking system.
For further growth, a vial of cells was removed from the
99
racking system, rapidly thawed at 37®C and the cells added to 
9ml BHK-21 growth medium. After centrifugation at 350g for 
10min the supernatant was discarded, the cells were 
re-suspended in 10ml of growth medium, transferred to a 
25cm2 bottle and incubated at 37°C overnight.
2.2.3. Antibody Screening Test.
In order to detect Mab secretion from hybridoma cells 
the indirect fluorescent antibody (IFA) staining technique 
used for microplates was adapted to 96-well plates. 
Homologous virus adapted to BHK-21 cells was used to infect 
an 80cm2 bottle and four Leighton tubes each containing a 
glass coverslip. When coverslip cultures stained with 
Centocor indicated that the cells in the bottle were 80-100% 
infected, the bottle cells were suspended in ATV, added to 
growth medium and mixed with an equivalent volume of 
uninfected BHK-21 cells. After appropriate dilution the cells 
were then seeded into 96-well plates which were incubated at 
35®C overnight then fixed in 80% acetone, air - dried and 
stored at -20®C.
In one plate several wells were stained with Centocor 
and the percentage of infected cells was recorded. The 
remainder of the plate was used in a chequer-board titration 
to establish the working dilution of Cappel FITC-conjugated 
anti-mouse IgG using a previously prepared mouse anti-rabies
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antiserum. Throughout this work different batches of Cappel 
were titrated before use but the working dilution was 
invariably found to be 1/150.
2.2.4. Immunogens.
Five rabies-related viruses from serotypes 2 - 5  
{(Table 2.1.) Lagos bat, Mokola, Duvenhage, Denmark bat and 
Finman (an isolate made from the brain of a man who died in 
Finland of rabies believed to be of bat origin)} were used as 
immunogens.
Due to the constraints put upon work with rabies virus 
in the United Kingdom, it was not possible to attempt to 
concentrate or to purify viruses or to for example prepare 
purified viral proteins. Therefore, the immunizing agent in 
each case was the cell-free supernatant fluid from virus 
grown in BHK-21 cell culture.
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Table 2.1. Origin of Immunogens Used for the Generation of
Monoclonal Antibodies.
Lagos Bat Virus. 
(RVl)
(Serotype 2)
Passage history; suckling mouse brain 
passage number 19 Lot 1. Purchased
from the 
Collection,
American Type 
ref. ATCC VR-720.
four times in BHK-21
fifth day 
immunogen.
harvest
cells
(P4D5)
Culture 
Passaged 
and the 
used as
Mokola Virus. 
(RV4)
(Serotype 3)
Passage history; suckling mouse brain 
passage number 8 Lot 1. Purchased from 
the American Type Culture
Collection, ref. ATCC VR-376. Passaged 
four times in BHK-21 cells and the 
fourth day harvest (P4D4) used as 
immunogen.
Duvenhage Virus. 
(RV6)
(Serotype 4)
Passsage history; suckling mouse brain 
passage number 2 kindly supplied as 
freeze-dried material by the NIV 
Sandringham, R.S.A. Passaged once in 
BHK-21 cells and the fourth day 
harvest (P1D4) used as immunogen.
Denmark Bat Virus. 
(RV7)
(Serotype 4)
Passage history; Second mouse brain 
passage of Ra 12 kindly supplied by 
Dr. Jan Westergaard, Copenhagen. 
Passaged four times in BHK-21 cells 
and the fourth day harvest (P4D4) used 
as immunogen.
Finman Virus. 
(RV8)
(Serotype 5)
Passage history: Second mouse brain
passage of patient brain kindly 
supplied by Dr. Erkki Neuvonen of 
Helsinki. Passaged six times in 
BHK-21 cells and the fifth day 
harvest (P6D5) used as immunogen.
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2.2.5. Immunization Procedures.
Each virus from which Mabs were to be prepared was 
adapted to growth in BHK-21 cells by passage of infected 
cells as described in Chapter 3. From an 11ml virus stock 
prepared for mouse immunization 1ml was removed and titrated 
in BHK-21 cells as described. To the remainder was added 
beta-propiolactone (to a final concentration of 1/2000) and 
the mixture was held at +4®C overnight. It was then heated at 
37°C in a water bath for 60min, adjusted to pH 7.2 with NaOH, 
a sample removed for inocuity tests in mice and the remainder 
stored at -70®C until inocuity test results were known.
For each immunogen shown to be free of viable virus, 1ml 
was inoculated intraperitoneally into each of three 
approximately six-week-old Balb/c mice. Four weeks later the 
inoculation was repeated and after a further four days one 
mouse was sacrificed for spleen fusion.
2.2.6. Inocuity Tests.
For inocuity tests on each immunogen, six 21-day-old 
mice were inoculated intracerebrally with 0.03ml of the 
beta-propiolactone treated virus and were observed daily for 
signs of rabies virus infection. After 21 days without 
causing clinical signs or death in mice, the immunogens were 
assumed to be inocuous and the mice were sacrificed.
103
Chapter 3. Preparation of Cell Cultures and Brain 
Impressions for the Analysis of Mabs 
Reaction Patterns
3.1. Introduction.
The culture of rabies viruses in vitro has recently 
been reviewed (Crick and King, 1988). Central to the method 
of adaptation of these viruses to growth in BHK-21 cells is 
the maintenance of stock cultures and as in the case of virus 
production for other purposes, including vaccines, the 
quality of the cells used is an all-important factor. 
Monolayer stock bottles should be passaged every three or 
four days using a 1:4 split ratio and cells for infection 
should not be used at more than three days of age. BHK-21 
cells maintained in this fashion are hardy, require a 
relatively simple growth medium supplemented by inexpensive 
ox serum and since they require no additional CO2 to support 
growth they have a possible safety advantage over open 
culture systems.
Culture bottles surplus to immediate requirements may be 
stored at ambient temperature or at +4®C, and passage levels 
kept low by returning to these cells up to 2-3 weeks later, 
when after one or two passages they regain their rapid growth 
characteristics. Cells in exponential growth phase are far 
more sensitive to rabies virus infection than those in lag or
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decline phase and the addition of DEAE-dextran to a final 
concentration of 100ug/ml (Zalan et ai., 1979) to suspended 
cells shortly before infection further increases their 
sensitivity.
This chapter describes methods of growth of laboratory 
(vaccine) strains in BHK-21 cells and their subsequent 
titration. In addition, the adaptation of street viruses to 
growth in these cells followed by the preparation of infected 
cells for the determination of Mabs profiles is described.
Cell culture techniques, however, are costly and time 
consuming and the development of an alternative technique for 
antigenic reaction pattern determination which employs brain 
smear preparations on Teflon coated multispot slides is also 
described. In this work brain smear techniques were used to 
identify the majority of viruses but they were replaced by 
cultural techniques when problems were encountered.
3.2. Titration of Stock Viruses (e.g.CVS).
For each virus titration, a series of 10-fold dilutions 
was made by the addition of 0.5ml of virus to 4.5ml of growth 
medium, using a clean sterile pipette for each virus 
transfer. A replicate of 50ul of each virus dilution was then 
added to each of 10 wells of a 96-well Costar microtitration 
plate to which had been previously added 50ul of growth 
medium in all wells.
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The monolayer of an SOcm^ bottle of BHK-21 cells was 
washed by tipping the medium into disinfectant and rinsing 
the cells with two changes of approximately 25ml of ATV. The 
cells were then incubated with approximately 10ml of ATV. 
When the cells began to detach from the plastic surface 
(usually after a few minutes) the cell monolayer was 
disrupted by rapid pipetting until a suspension of individual 
cells was obtained. These were then added to 90ml of growth 
medium containing DEAE-dextran to a final concentration of 
100ug/ml. Using a multi-channel pipette, 50ul of cell 
suspension was then added to each well of the virus titration 
plate, starting with the row which contained the highest 
virus dilution. The lid of the plate was fitted then sealed 
to the plate with Lassotape to avoid loss of gases during 
incubation. The plates were incubated at 35®C for 4 days. The 
plate contents were then tipped into disinfectant and the 
plates dumped into a bath containing 80% acetone for 10mins, 
air-dried and then stained with Centocor.
Plate reading was carried out on the Fluovert 
microscope. Each well of the plate was examined for the 
presence of fluorescent rabies-specific intracytoplasmic 
inclusions and scored as positive or negative (+ or -). At 
the end of the reading the virus titre was calculated.
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3.3. Adaptation of Street Viruses to Growth in BHK-21 Cells.
Rabies viruses will grow in a variety of mammalian cells 
but their adaptation is sometimes prolonged and difficult. 
In this work, adaptation was readily achieved by the passage 
of infected cells, rather than by passage of supernatant 
fluid to fresh monolayers (Fig. 3.1.). To determine 
parameters for the virus isolation method, 1ml of a 10% 
suspension of a rabies infected fox brain (ref.58605) was 
mixed with 80ml DEAE-dextran treated suspended BHK-21 cells. 
From this mixture six 25cmz plastic bottles and twelve 
Leighton tubes containing glass coverslips were seeded. The 
coverslip cultures were used to monitor the growth of virus 
in bottle cultures. On the same day, each of six 21-day-old 
mice were inoculated intracerebrally with 0.03ml of the 10% 
suspension of fox brain.
The following day, the supernatant fluid of one Leighton 
tube was aseptically removed and stored at -70'C. The 
coverslip was removed, the cells were fixed for 10mins in 
cold acetone, stained with an FITC-conjugated rabies 
antiserum (Centocor) and examined under the fluorescence 
microscope. An estimate of the percentage of infected cells 
was made. The cells in the bottle were suspended with ATV and 
a proportion (usually 25% but greater if the brain material 
had had a deliterious effect on the growth rate) was 
passaged. Other samples were similarly treated on day 2, or
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on days 3, 4, 5 or 6. When the cells in the Leighton tube
indicated that more than 80% of the cells in the bottle were 
likely to be infected, these cells were suspended with ATV 
and seeded into an 80cm^ bottle which was incubated for six 
days during which time it was sampled daily. At the end of 
the experiment, all samples were titrated in one test using 
four replicates for each virus dilution. After 4 days 
incubation plates were fixed in 80% acetone, stained with 
Centocor and the titres recorded (Fig. 3.5.).
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Fig. 3.1. Adaptation of Street Viruses to Growth in 
BHK-21 Cells.
A piece of the brain is homogenised in a TenBroek 
grinder and the mixture transferred to a bijou bottle. The 
coarse particles are allowed to settle and 0.2 - 0.3ml of the 
supernatant fluid is used to infect 11ml of DEAE-dextran 
treated BHK-21 cells in suspension. From this mixture each of 
two Leighton tubes containing a coverslip are seeded with 
1.5ml and the bottle and tubes are incubated at 35 ®C 
overnight, during which time monolayers form. The Leighton 
tubes are used to monitor progress in adaptation. When 
coverslip cultures indicate that bottle culture cells are 80% 
infected, plates for Mabs reaction pattern analysis may be 
prepared.
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3.4. Preparation of Microplates for Mabs Reaction 
Pattern Determination.
To a 25cm2 bottle containing 11ml of suspended BHK-21 
cells was added 0.2ml of a 1/10 virus stock solution. After 
thorough mixing, 1.5ml of the suspension was added to each of 
two Leighton tubes containing coverslips and these and the 
bottle were incubated at 35®C for two days. One of the 
coverslips was then examined to estimate the percentage of 
infected cells. This was usually found to be 80-100% but if 
lower the second coverslip was examined the following day. 
The cells of the bottle were then suspended in ATV, taken up 
into 2ml growth medium then added to 4ml of uninfected BHK-21 
cells at four times the normal seeding rate.
By means of a multi-channel micropipette designed for 
the purpose (Fig. 3.2.), 10ul of the cell mixture was added 
to each well. The plates were then sealed in a moist chamber 
and incubated overnight. After fixation in 80% acetone for 
10min the plates were air-dried and stored at -70®C. One 
plate was examined with Centocor and an estimate of the 
percentage of infected cells recorded.
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Fig. 3.2. Multichannel Hicropipette Apparatus Designed 
for the Distribution of Infected BHK-21 
Cells to Microplates.
The apparatus consisted of a standard 12-channel 
variable volume (5 - 50ul) Titertek micropipette purchased 
from Flow Laboratories, Irvine, to which was added a set of 
microtubes held in position by an aluminium plate. This was 
manufactured by the Central Veterinary Laboratory workshop. 
The plastic tips were six tips/band Terasaki pipette tips 
purchased from Flow Laboratories and to enable application of 
the tip bands to the apparatus one side of the band rings was 
cut with scissors.
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3.5. Preparation of Teflon Slides for Mabs Reaction
Pattern Determination.
Approximately 0.03ml of either cell cultured isolate or 
10% suspensions of original or mouse-brain passaged material 
was inoculated intracerebrally into each of two 3-week-old 
mice, which were then observed daily. When in extremis one 
mouse of each pair was euthanased with Halothane and the 
brain removed. By means of rolling the brain along the 
surface of a wooden tongue-depressor excess moisture (blood 
etc.) was removed and the lower brain surface became adhered 
to the wood. The upper surface of the cerebral hemispheres 
was removed with scissors to expose the antigen-laden white 
matter and the brain was trimmed such that serial impressions 
could be made on twenty pencil-labelled Teflon slides (Fig.
3.3.). Care was taken to avoid contact between Teflon and 
brain.
Slides were then air-dried for at least one hour at 
room temperature, fixed in acetone at -20®C for one hour then 
thoroughly air-dried. One slide was stained with Centocor and 
the degree of positivity recorded. Slides were stored at 
-20®C where they remained satisfactory for many months. The 
brain of the second infected mouse was removed and stored at 
-70*C.
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Fig. 3.3. Preparation of Teflon-coated 
Multispot Slides for the 
Determination of Mabs Reaction Patterns.
The mouse brain is removed and rolled along the wooden 
tongue depressor to remove excess moisture (blood etc.). The 
cerebral hemispheres are removed and serial impression smears 
made, avoiding contact between brain and the Teflon coating.
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3.6. Results.
Most of the laboratory (vaccine) strains including 
CVS-24 used in this work were purchased from the American 
Type Culture Collection as cell-adapted strains and they 
readily grew in BHK-21 cells without prior adaptation. In the 
example cited in this Chapter (Fig. 3.4.), CVS virus grew to 
a titre of 107.3 TCIDse/ml.
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Fig. 3.4. Titrations were carried out in Costar 96-well 
plates which were incubated at 35®C for four days. Readings 
were made using the Fluovert microscope to give a 
magnification of approximately xl50.
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Result; Titre = 107*3 TCIDse/ml.
Fig. 3.4. Titration of CVS virus in BHK-21 cells.
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Passage of infected cells led to rapid adaptation of the 
virus from a French fox to BHK-21 cells. Highest titres were 
obtained when cells were passaged either daily or at two day 
intervals, and by 9-12 days virus stocks suitable for use in 
Mabs studies were obtained (Fig. 3.5.).
By comparison with virus adaptation to cell culture, of 
the six 21-day old mice inoculated intracerebrally with the 
10% fox brain suspension, the first mouse died of rabies 
virus infection on the 13th day and the remainder had died by 
the 17th day after infection (results not shown).
Experiments with both microplate cultures and Teflon 
slides confirmed the usefulness of each technique for the 
analysis of viruses with Mabs (results not shown).
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Fig. 3.5. Titration of supernatant fluids from BHK-21 
cell cultures infected with rabies virus from 
fox 58605 and passaged at 1, 2, 3, 4, 5 and 
6 day intervals.
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3.7. Discussion.
The method of virus titration proved to be accurate and 
reproducible. Indeed, the method is regularly used to titrate 
the virus used in the measurement of antibody levels in sera 
of human vaccinees. On the occasions where there was a need 
to titrate viruses in both BHK-21 cells and mice, the titres 
were comparable (data not shown). Results in BHK-21 cells 
were available after four days whereas mice did not usually 
die until at least ten days after inoculation. Although for 
virus titrations four days incubation was selected as the 
optimum because almost all of the cells in a well containing 
virus were infected and therefore each well was easy to read, 
plates could be read at two or at three days when virus
infection appeared as small plaques of fluorescent cells.
BHK-21 cells proved to be an ideal vehicle for the 
adaptation of rabies street viruses to growth in cell 
cultures. Other cells, for example, mouse neuroblastoma (MNA 
C1300, clone NA), have been shown to be 200 times more
sensitive to rabies viruses (Umoh and Blenden, 1983) but they 
require a 5% CO2 atmosphere (not available during the course 
of this work) and they replicate far more slowly than BHK-21
cells. As is clearly indicated (Figs. 3.5.), transfer of
cells to an 80cm^ bottle (equivalent to a 1:4 split) delayed 
the production of virus to maximum titre and in subsequent 
passage work this step was omitted. More than one hundred
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rabies viruses were adapted in this manner and in no case 
where these viruses were simultaneously inoculated into mice 
did the virus kill the mice but fail to become adapted to 
growth in BHK-21 cell cultures (data not shown).
Although daily transfer of cells was shown to be the 
quickest method, in practice passage at two day intervals was 
adopted as the standard method since on occassions daily 
passages resulted in cell monolayers of poorer quality. It 
was also found to be unneccessary to passage the cells to 
larger bottles and virus stocks were prepared by the passage 
in a 25cm2 bottle of cells surplus to use for microtitration 
plates. After 5 days this bottle was placed at -70°C. and the 
virus stock harvested when required.
When prepared in the manner described, microplates were 
invariably shown to have sufficient numbers of infected cells 
to allow confidence in results. By employing a heavy seeding 
rate monolayers formed overnight but without a cycle of virus 
replication taking place. Thus when used for Mabs studies, 
positive cells were seen against a background of negative 
cells.
The adaptation method has been successfully used for the 
isolation of rabies and rabies-related viruses from animal 
brains of many species from different parts of the world. It 
was also used for the isolation of rabies virus from six of 
seven saliva samples taken on consecutive days from a patient 
who later died of rabies contracted abroad (data not shown).
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The costs of Mabs production and usage are a limiting 
factor and the desirability of microtechniques are 
self-evident. By the use of Greiner microplates, tests could 
be carried out in duplicate yet still be less than one half 
the cost of tests in 96-well plates.
Part of this work involved co-operation with colleagues 
in countries where cell culture techniques are not always
available. However, in order to study the epidemiology of
rabies it is neccessary to be able to identify virus 
variants, and the Teflon slide technique was developed in
response to that need. It became apparent that the
technicalities of adaptation of viruses to cell cultures 
could be avoided and for much of this work Teflon slides 
alone were used to determine Mabs profiles. As a safeguard 
against the possibility of a "negative" smear from an 
infected brain, only slides containing rabies-specific 
inclusions in more than 50% of the impression area were 
considered suitable for antigenic reaction pattern 
determination.
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Chapter 4. Generation of Monoclonal Antibodies.
4.1. Introduction.
In the industrialized parts of the world the risk to 
humans of dying from rabies is now very small, due mainly to 
the success of control programmes involving domestic canine 
vaccination coupled with human pre-exposure and post-exposure 
prophylaxis. With the advent of new vaccines and oral 
vaccination technologies it may soon be possible also to 
control the disease in certain wildlife animal reservoirs, 
thus lessening the scope for transfer of the disease to 
domestic animals and thence to man. However, in many parts of 
the world the disease is not confined to a single wildlife 
host species, rather the broad adaptability of the virus to a 
wide variety of warm-blooded hosts has resulted in a complex, 
interactive, multiple-host zoonosis which will be very 
difficult to control (Smith et ai., 1990); whilst even one 
wildlife enzootic exists, the threat of re-introduction of 
the disease to domestic animals and humans remains.
Thus, in order to control and then perhaps eradicate 
rabies it is important to know how the virus moves in and 
among reservoir hosts, and the ability to identify and 
characterize antigenic variants of the virus is an essential 
part of this knowledge.
The rabies virion can be divided into two structural
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and functional units, the envelope and the nucleocapsid core 
(Tordo and Poch, 1988). The envelope contains glycoprotein 
(G) which has specific regions involved not only in the 
attachment of virus to the host cells but also in humoral and 
cellular responses. This specificity has, by neutralization 
and cross - protection studies, allowed the recognition of 
several "serotypes" (cited by King and Crick, 1988). During 
infection core proteins are abundantly produced and they can 
be easily detected by indirect tests on fixed material.
Since the first description of rabies-specific Mabs 
(Wiktor and Koprowski, 1978) much has been learned of the 
ecology and epizootiology of rabies virus and of the epitopic 
variation which occurs amongst the various members of the 
Lyssavirus genus. Most of the information with regard to 
epitopic variation has been gathered from the use of Mabs 
prepared from classical rabies viruses - those viruses which 
in time have been adapted to growth in cell cultures for the 
purpose of, for examples, vaccine production or studies of 
virus pathogenicity. It is possible to distinguish two rabies 
viruses by the use of a single Mab (presence or absence of a 
particular epitope) but in general, large panels of Mabs are 
required to discriminate viruses that are closely related and 
distinguishable by relatively few antigenic differences. This 
chapter describes the production of a number of Mabs from 
prototypes of the rabies-related viruses with which a 
detailed antigenic reaction pattern analysis of street rabies
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and rabies-related viruses will be made.
Clones of antibody forming cells can be grown in vitro 
by the fusion of an antibody secreting B-cell with a myeloma 
cell to produce a hybrid cell - a "hybridoma". Myeloma cells 
which are non-antibody secretory (NS) and lack the enzyme 
hypoxanthine phosphoribosyl transferase are selected for 
fusion because, since they lack this enzyme, they will not 
grow in the presence of hypoxanthine, aminopterin and 
thymidine (HAT). Spleen cells cannot grow because they are 
not of a continuous cell line. The hybridoma cells will grow 
because they have the transferase enzyme activity derived 
from the spleen cells and the ability of the myeloma cells to 
grow in continuous culture. Thus, following fusion of the two 
cell types, the hybrid cells in the cell pool are grown in 
HAT medium until all the non-fused cells have died. The 
hybrid cells then are "weaned" on to normal growth medium 
first by the removal of aminopterin and then by the removal 
of hypoxanthine and thymidine from the medium.
T-lymphocytes produce a variety of mediators 
(lymphokines) that can activate macrophage and other 
lymphocytes. The addition of a lymphokine preparation to 
growth medium during the cloning of hybridoma cells enhances 
the ability of these cells to replicate.
Although there are five classes of immunoglobulin, the 
three most commonly occurring classes of mouse immunoglobulin 
are IgG, IgM and IgA. The major immunoglobulin component of
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serum is IgG and it has a molecular weight of approximately 
150,000 Daltons. Four subclasses of IgG (IgGl, IgG2a, IgG2b 
and IgG3) have been found based on differences in amino - 
acid sequences in the heavy chains. IgM has a molecular 
weight of about 900,000 Daltons and each molecule consists of 
five identical subunits in the shape of a circular pentamer 
joined by disulphide bonds and held together by a joining (J) 
chain. IgA is usually monomeric with a molecular weight of 
about 150,000 Daltons but may also occur as a dimer held 
together by a J chain.
The ability of an antibody molecule to combine with an 
antigen depends upon the region of the molecule known as the 
antibody binding site, in which a particular sequence of 
amino-acids provides a configuration complementary to that of 
an antigen. These antibody configurations can also act as 
antigenic determinants, thus permitting antisera to be 
prepared against them which can be used to determine the 
class and sub-class of fusion products.
When generating a monoclonal antibody panel it is 
advisable to know the type and class of each Mab since, for 
example, IgM pentamer molecules may be broken down by 
freezing, leading to inconsistency of test results. IgM Mabs 
are for this reason rarely included in Mabs panels. Class and 
subclass specificity may be simply determined by a 
modification of an immunodiffusion technique (Ouchterlony, 
1948) whereby the supernatant fluid of a hybridoma culture is
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diffused against class and subclass specific antisera to form 
precipitin bands.
Once the Mab type and class specificities have been 
established their ability to neutralize the homologous virus 
should be determined. Mabs produced from mice immunized with 
purified nucleocapsid will, as expected, react with 
nucleocapsid proteins only, but those produced from mice 
immunized with whole virus may be directed towards the 
surface glycoprotein (G) or one of the two main structural 
proteins N and NS.
Most but not all of the glycoprotein - specific Mabs are 
capable of virus neutralization (Flamand et ai., 1980) and 
although they may bind to rabies virus - infected unfixed 
cells and lyse them in the presence of complement, when they 
are reacted against the membranes of such cells in the 
absence of complement the indirect fluorescent antibody 
staining pattern observed is one of intense but diffuse 
fluorescence (Wiktor and Koprowski, 1978). The above is in 
marked contrast to that observed when Mabs directed against 
the nucleocapsid antigens bind to intracytoplasmic inclusions 
of acetone-fixed virus-infected cells or impression smears, 
when a rather uneven spread of distinct foci is observed.
It thus becomes apparent that before incorporation into 
a Mab panel the neutralizing ability of each Mab should be 
determined. In this work all of the Mabs were tested for 
neutralizing ability against their homologous virus.
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4.2. Somatic Cell Hybridization (Fusion).
4.2.1. Fusion Technique.
After the immunized mouse was killed by neck 
dislocation, the skin on the left side was removed, the 
peritoneal cavity was opened aseptically and the spleen 
removed. Using sterile scissors and forceps the spleen was 
cut into a number of small pieces which were placed in a 
TenBroek grinder containing 5ml of serum - free medium and 
gently disrupted.
The mixture was allowed to stand for 5min. so that 
coarse particles settled, then the supernatant was removed 
and added to 20ml of serum - free medium and centrifuged at 
350g for 6min. At the same time two 25cmz bottles of NSl 
cells were similarly centrifuged.
Each type of cell was re-suspended in 20ml serum - free 
medium and the cells were then counted in an Improved 
Neubauer chamber. The counts of four corners of the chamber 
were recorded and the mean taken as the value from which the 
total count/ml was calculated. All of the spleen cells were 
added to sufficient NS-1 cells to give a ratio of spleen : 
NS-1 = 5:1. The mixture was centrifuged as before for 8min. 
All but approximately 50ul of supernatant was discarded.
The cells were re - suspended by tapping the side of 
the centrifuge tube and 1ml of warm 50% polyethylene glycol
131
(PEG) was then added slowly, stirring gently with a pipette, 
allowing cell fusion to take place. The mixture was then 
diluted 1:2 every minute by the addition of serum - free 
medium to give a final volume of 25ml. Throughout the fusion 
process the cells were treated very gently since fused cells 
are fragile and may be easily ruptured.
The fusion mixture was centrifuged as before and the 
supernatant removed. Cells were then re - suspended in HAT 
medium containing 20% ox serum to give a final cell 
concentration of 3.5 x 10  ^ cells/ml. They were then 
distributed into 96-well Costar plates at 200ul/well. 
Usually there was sufficient cell volume to fill ten plates, 
which were then incubated at 37®C for seven days. For the 
Mokola and Duvenhage fusions (see below) the facility for 
incubation in an atmosphere enriched to 5% CO2 was not 
available, but for later fusions such an incubator was used.
Plates were examined under the Diavert microscope and 
the presence of hybridomas recorded. Using a fresh pipette 
tip for each well, 100ul of medium was carefully removed and 
was replaced with 100ul of HAT medium. The plates were 
re-sealed and returned to the incubator for a further four 
days.
Following a further reading of the plates, a 50ul sample 
was removed from each well containing a hybridoma and was 
tested by IFA for the presence of antibody. The volume was 
replaced in the well by the addition of 50ul of HT medium.
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Sampling was repeated until all hybridomas had been tested 
twice. On some occasions the hybridomas were not tested 
until after they had been transferred to 24 - well plates.
When each hybridoma was clearly established and 
replicating freely (usually determined by the ability of 
cells to generate an acid pH to the medium) the cells of 
antibody secreting hybridomas were gently suspended in the 
supernatant fluid and transferred to 1ml of HT medium in a 
well of a 24-well plate. The original well was re-filled 
with 200ul of HT medium to maintain a reserve culture.
Cultures in 24-well plates were examined daily and fresh 
HT medium was added as required. Tests for antibody secretion 
were continued and when necessary the cultures were 
expanded, first 1:2 in HT medium, then to a 25cmz bottle and 
finally to two 25cm2 bottles containing 10ml of HT - free 
growth medium.
When cells at this stage were in exponential growth 
phase the supernatant fluid was removed for further testing 
and the cells were prepared for storage in liquid nitrogen.
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4.2.2. Hybridoma Cloning Technique
Each vial of hybridoma cells to be cloned was removed 
from the liquid nitrogen store and rapidly thawed by
immersion in a 37®C water bath. The vial contents were
removed and added to 10ml of growth medium and the cells
were then centrifuged at 350g for Smin. The supernatant, 
which contained residual DMSO from the freezing process, was 
removed with a pipette and discarded. The cells were taken up 
in 10ml of growth medium and seeded into a 25cmz bottle which
was then incubated at 37®C for three days or until copious
growth of cells had taken place.
A sample was removed, diluted 1/10 and the cells counted 
in an Improved Neubauer chamber as before. From the 25cmz 
bottle a fresh sample was taken and diluted to give a
concentration of 50 cells/ml. From this suspension dilutions 
of 1/5 (10 cells/ml) and 1/10 (5 cells /ml) were made.
To each well of two 96-well Costar plates was added
100ul of growth medium containing 5% lymphokine. The cell
dilutions were added such that 48 wells of one plate were
seeded with 5 cells/100ul, 48 wells with 1 cell/100ul and all
96 wells of the second plate with 0.5 cells/100ul
theoretically equivalent to 5 cells/well, 1 cell/well and 1 
cell in alternate wells respectively.
The plates were sealed and incubated as before and
examined for clones eight days later. At this time 100ul of
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medium was carefully removed from each well which contained a 
clone, replaced with an equivalent volume of growth medium, 
and the plates were re-sealed then returned to the incubator.
Once the clones were of sufficient size they were 
sampled and tested for antibody secretion. The best secreting 
clone as judged by speed of growth and healthy appearance was 
expanded to the 25cmz bottle stage and the cells were then 
stored in liquid nitrogen. Each clone was then re-cloned 
using the technique as described above.
Once the second cloning had been completed an adequate 
cell sample (usually the cells from two 25cmz bottles) was 
stored in liquid nitrogen.
4.2.3. Production of Concentrated Mab.
Cells were expanded to give 200ml of supernatant fluid. 
After centrifugation at 350g to remove cells, antibody was 
precipitated by the slow addition at +4®C of an equal volume 
of saturated ammonium sulphate to the supernatant fluid on a 
magnetic stirrer, followed by stirring at +4®C overnight. The 
precipitate was then centrifuged at 1000g for 15min. at +4°C, 
the deposit taken up in a minimum volume of PBS, placed in a 
dialysis sac, dialysed against several changes of PBS for two 
days and the volume adjusted to 10ml (equivalent to a x20 
concentration) with PBS. The concentrated Mab was then split 
into 1ml aliquots and stored at -20®C until required.
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4.2.4. Production of Ascitic Fluid.
An aliquot of cells from each cloned Mab was grown to 
produce one 25cmz bottle of actively replicating hybridoma 
cells. The cells were centrifuged at 300g for 5min at room 
temperature and after removal of supernatant fluid the cells 
were suspended in 2ml of growth medium. Two Balb/c mice were 
each inoculated i.p. with 1ml of the suspension, and were 
then observed daily for signs of swelling. When the mice were 
adjudged to be of sufficient size to warrant collection of 
ascitic fluid they were euthanased with Halothane and the 
ascitic fluid carefully harvested by pipette through the 
abdominal wall. The fluids from each of the pair of mice were 
centrifuged in a microcentrifuge at 13000g for 2min at room 
temperature and then pooled and stored at -70®C. Occasionaly 
mice did not respond or solid tumours were produced. In these 
instances two further mice were inoculated.
4.3. Immunoglobulin Iso-typing Technique.
Before use, typing plate kits which had been stored at 
+4®C were opened and allowed to air-dry at room temperature. 
Approximately 75ul of each Mab-containing tissue culture 
fluid to be tested was then pipetted into the large central 
well of one of the rosettes. Using a clean tip for each of 
the test antisera, 10ul of each of IgGl, IgG2a, IgG2b, IgG3,
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IgA and IgM were pipetted, in a documented fashion, into each 
of the outer six wells of the same rosette. The plates were 
sealed and stored overnight at room temperature. The 
following morning they were examined over a reflected light 
and the position of precipitin lines recorded. A second plate 
examination was made the following day and any changes in 
line formation or addition were added to the record.
4.4. Neutralization Test Technique.
The test method used to determine the neutralizing 
capacity of the Mabs was an adaptation of that used to 
determine antibody levels in sera of human vaccinees. A 
series of six 50ul three-fold dilutions was made in 
duplicate of each concentrated Mab in a 96-well Costar plate. 
The dilution range was 1/10 to 1/2430. The virus homologous 
for each Mab, which had been previously titrated and diluted 
to contain an estimated 100 TCID5e/50ul, was added to each 
well at 50ul/well. The plates were incubated at 35®C for one 
hour and then a suspension of BHK-21 cells was added. They 
were then sealed and incubated at 35®C for four days. After 
disposal of plate fluids the cells were fixed in 80% acetone, 
air dried, stained with Centocor and read on the Fluovert 
microscope. Specific fluorescence in cells of a well 
indicated absence of antibody in the concentrated Mab.
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4.5. Results
The fusion method of minimum virus treatment (i.e., no 
concentration or purification) and short course of 
immunization, together with the distribution of spleen cells 
into approximately 1000 aliquots (plate wells) minimized the 
risk of multiple hybridoma production in wells, with 
consequent difficulty of clone separation. In practice, 
during the first reading of the plates of a fusion more than 
one hybridoma in a well was rarely seen. Nevertheless, the 
cells of each specific antibody secreting hybridoma were 
cloned twice.
4.5.1. Mokola Fusion.
At the first plate reading after fusion, sixty seven 
hybridomas were recorded and by the second reading this 
number had increased to eighty four hybridomas. Since in many 
instances results of IFA tests at this stage were equivocal 
all of the hybridomas were transferred to 24-well plates.
From examination of 24-well plate cultures, eleven 
clones were shown to be secreting antibody but six of these 
secreted antibody against BHK-21 cells only and were 
discarded at this stage. Five antibodies (designated M2, M5,
M6, M7 and Mil) were selected for the re-cloning process 
described above.
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4.5.2. Duvenhage Fusion.
At the first plate reading thirty five hybridomas were 
recorded and after the second reading forty two hybridomas 
were transferred to 24-well plates. At this time 
contamination of the medium with a fungal infection occurred 
and only ten hybidomas were saved for transfer to the 25cm^ 
stage. These hybridomas were labelled D1 - D10, but
subsequent testing revealed that four of these secreted 
antibody to BHK-21 cells only and these were discarded. Six 
hybridomas (designated 01, 02, 03, 08, 09 and 010) were
selected for re - cloning. Mab 08 was later shown to be 
directed against the virus glycoprotein.
4.5.3. Oenmark Bat Fusion.
At the first plate reading 324 clones were observed and 
at the second reading 348 clones were recorded. A total of 
104 clones were transferred to 24-well plates but fifty of 
these failed to grow and at this stage ten were shown to be 
secreting anti-BHK-21 cell antibodies only and were 
discarded. Upon transfer to 25cmz bottles, only fifteen 
hybridomas survived or were shown to be secreting antibody 
and of these a further six were shown to be secreting 
anti-BHK-21 cell antibodies only and were discarded. Thus, 
nine hybridomas (designated DBl, DB2, DB3, DB4, DB6, DB9,
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DB10, DBll and DB14) were selected for re-cloning.
4.5.4. Lagos Bat Fusion.
At the first plate reading after fusion 122 hybridomas 
were observed and at the second reading 147 hybridomas were 
recorded. Only sixty seven of these developed into hybridomas 
of sufficient size to transfer to 24-well plates and of these 
twenty eight were shown to secrete antibody. Five secreted 
anti-BHK-21 cell antibody only and the remaining twenty three 
(designated LI, L2, L3, L4, L6, L8, L10, Lll, L12, L13, L14,
L15, L16, L17, L18, L19, L20, L22, L23, L25, L26, L27 and
L28) were selected for re-cloning.
4.5.5. Finman Fusion.
Only thirty eight hybridomas were observed at the first 
plate reading and no further hybridomas were recorded when 
the plates were read for a second time. Once again fungal 
contamination proved to be a problem and only twenty four 
hybridomas survived transfer to 24-well plates. From these, 
no antibody secretion was detected in sixteen, anti-BHK-21 
cell antibody was detected in three and specific antibody was 
detected in five. The latter, (designated FI, F2, F3, F4 and 
F5) were selected for re-cloning.
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4.5.6. Mab Iso-Typing.
Of forty eight Mabs prepared, cloned and concentrated as 
described, forty seven were tested against anti-IgGl, IgG2a, 
IgG2b, IgG3, IgM and IgGA. The results are summarized in 
Table 4.1.
Seven Mabs (D2, D10, DB2, DB6, L6, L14 and L22) were of
IgM type; eighteen Mabs (M5, M6, DBl, DBS, L2, L4, L13, L16,
L18, L20, L23, L25, L26, L28, F2, F3, F4 and F5) were of IgGl 
type; fourteen Mabs (M7, Dl, D3, DB3, DB4, DB14, LI, L3, Lll, 
L12, L15, L17, L27 and FI) were of IgG2a type; five Mabs
(Mil, DB10, L8, L10 and L19) were of IgG2b type; two Mabs (M2 
and D9) were of IgG3 type and one Mab (DBll) was of IgA type.
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Table 4.1. Results of Immunoglobulin Iso-typing
of 47 Cloned Mabs.
Clone Type/ Clone Type/ Clone Type/
Class Class Class
M2 IgG3 DB10 IgG2b L17 IgG2a
M5 IgGl DBll IgA L18 IgGl
M6 IgGl DB14 IgG2a L19 IgG2b
M7 IgG2a LI IgG2a L20 IgGl
Mil IgG2b L2 IgGl L22 IgM
Dl IgG2a L3 IgG2a L23 IgGl
D2 IgM L4 IgGl L25 IgGl
D3 IgG2a L6 IgM L26 IgGl
D9 IgG3 L8 IgG2b L27 IgG2a
D10 IgM L10 IgG2b L28 IgGl
DBl IgGl Lll IgG2a FI IgG2a
DB2 IgM L12 IgG2a F2 IgGl
DB3 IgG2a L13 IgGl F3 IgGl
DB4 IgG2a L14 IgM F4 IgGl
DB6 IgM L15 IgG2a F5 IgGl
DB9 IgGl L16 IgGl
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4.5.7. Neutralization Tests.
4.5.7.1. Mokola Mabs.
Five Mabs (M2, M5, M6, M7 and Mil) were titrated against 
20 TCID50 of the immunogen. None of the Mabs elicited 
neutralizing ability against Mokola virus.
4.5.7.2. Duvenhage Mabs.
Six Mabs (D1,D2, D3, 08, 09 and 010) were titrated
against 40 TCID50 of the immunogen. Mab 08 neutralized the 
virus to a titre >1/2430. None of the other Mabs elicited 
neutralizing ability against Duvenhage virus.
4.5.7.3. Denmark bat Mabs.
Nine Mabs (DBl, DB2, DB3, DB4, DB6, DB9, OB10, DBll and 
DB14) and Mab 08 (see above) were titrated against 125 
TCID50 of the immunogen. None of the Mabs elicited 
neutralizing ability against Denmark bat virus.
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4.5.7.4. Lagos bat Mabs.
Twenty-three Mabs (LI, L2, L3, L4, L6, L8, L10, Lll,
L12, L13, L14, L15, L16, L17, L18, L19, L20, L22, L23, L25,
L26, L27 and L28) were titrated against 50 TCID50 of the
imumnogen. None of the Mabs elicited neutralizing ability 
against Lagos bat virus.
4.5.7.5. Finman Mabs.
Five Mabs (FI, F2, F3, F4 and F5) were titrated against 
90 TCID50 of the immunogen. None of the Mabs elicited 
neutralizing ability against Finman virus.
As a result of the cloning, iso-typing and determination 
of neutralization characteristics of these Mabs, together 
with preliminary testing which revealed that some of them 
reacted only with their homologous virus (data not shown), 
thirty six Mabs were incorporated into a panel (Table 4.2.) 
with which rabies viruses from terrestrial animals and 
rabies-related viruses from other species (Chapters 6 and 7 
respectively) were examined. The reaction patterns obtained 
when these Mabs were tested against the prototype viruses of 
Serotypes 1 - 5  are shown in Table 4.3.
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Table 4.2. References of 36 Mabs Incorporated into a Panel
for the Examination of 
Rabies and Rabies-related Viruses.
Immunogen Mabs
Mokola (5):
M2, M5, M6, M7, Mil.
Duvenhage (3):
Dl, 03, 09.
Denmark-bat (7):
DBl, DB3, DB4, DB9,. DB10, DBll, DB14.
Lagos bat (16):
LI, L2, L3, L4, L8, Lll, L15, L17, LIB,
L19, L20, L23, L25, L26, L27, L28.
Finman (5):
FI, F2, F3, F4, F5.
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4.6. Discussion.
The original panel of rabies Mabs prepared at the Wistar 
Institute (Wiktor and Koprowski, 1978) used the ERA vaccine 
virus as immunogen and this same virus was also used to 
prepare a Mabs panel at the CDC Atlanta (J. S. Smith, pers. 
comm.). From the beginning of this work it was decided to use 
each of the rabies-related prototype viruses as an immunogen, 
leading to the generation of a panel of Mabs from a variety 
of immunogens rather than from a single immunogen which may 
have produced a more narrow spectrum of activity.
This decision influenced the course of the immunization 
procedure adopted; whilst a hyperimmunization schedule could 
be expected to produce many more Mabs from a fusion, the 
attendant work of cloning and sorting would have been beyond 
the available resources. The adoption of a simple 
immunization schedule led to the generation of a useful, 
manageable panel of Mabs. From the five fusions, forty eight 
hybridomas were expanded, cloned and concentrated for stocks.
The lack of a CO2 incubator during the Mokola and 
Duvenhage fusion processes contributed to the loss of some 
hybridomas. Despite sealing the fusion plates with Lassotape 
slow growing hybridomas were unable to maintain pH on the 
acid side of neutrality and they did not survive.
Following the cloning procedures of Mokola, Duvenhage 
and Denmark bat hybridomas, ascitic fluid containig Mabs were
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prepared, but in the ensuing climate against animal 
inoculation, Lagos bat and Finman clones were expanded to 
give supernatant fluid concentrates and ascitic fluids were 
not prepared. There were advantages in this method. Ascitic 
fluids were sometimes difficult to prepare because the cloned 
cells produced solid tumours or failed to replicate in the 
mouse abdominal cavity. In order to standardize the products, 
all of the clones were expanded to give concentrated Mabs.
Use of the simple immunodifffusion technique allowed an 
accurate determination of Mab type and class and led to the 
removal of seven IgM candidate Mabs from the panel. That such 
a large proportion (15%) should be of IgM class may have been 
a reflection of the relatively short period (32 days) between 
primary stimulation of the mice and spleen removal for 
fusion. An available technique for the dissociation of the 
pentamer IgM molecules into monomer molecules was not used 
because preliminary tests had shown that it was unlikely that 
these Mabs would further contribute to virus differentiation, 
but the hybridoma cells were stored in liquid nitrogen.
Mabs M2 and D9 were classed as IgG3 and it is rare to 
produce this antibody class from fusion techniques. This 
again may have been a reflection of the immunization method 
since, for example, none of nearly 100 Mabs produced by the 
Wistar Institute and the CDC Atlanta, following extensive 
immunization procedures, were of this class (T.J. Wiktor and 
J.S.Smith, pars, comms.).
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Although a broad spectrum of Mabs is required to 
characterize closely related rabies viruses, only those which 
are stable and recognize different epitopes should be used. 
The seven IgM Mabs (D2, D10, DB2, DB6, L6, L14 and L22) and
four other Mabs (L10, L12, L13 and L16) which were later
shown to react only with Lagos bat viruses therefore were not 
incorporated into the panel.
Only one Mab (D8) of the forty eight Mabs tested against 
their homologous viruses showed neutralization activity and 
by inference recognized the virus G protein. There is no 
doubt that this low number was due to the screening method 
(IFA tests on acetone-fixed cell cultures) used to detect Mab 
secretion of hybridoma cells. This particular method of 
detection was selected since the objective was to generate a 
manageable panel of anti-N Mabs prepared from a variety of 
immunogens which could be used on either acetone-fixed 
infected cell cultures or brain smears. The use of anti-G 
Mabs in this mode is contra-indicated since when using brain 
smears the fluorescence picture is difficult to interpret and 
can lead to inconsistent results.
Mab D8 neutralized its homologous virus (Duvenhage) but 
did not neutralize Denmark bat virus - evidence that 
Duvenhage virus of Africa, although similar to the viruses 
of European bats, is not identical to them.
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Chapter 5. Protein Specificities of Selected Mabs.
5.1. Introduction.
The protein specificities of polyvalent antibodies or 
Mabs may be quantified by the use of a liquid precipitation 
assay. The method involves the use of internally labelled 
antigen, prepared by the incorporation of 3SS - methionine 
into the antigen during cell or virus growth. This labelled 
preparation is then solubilized by a mixture of nonionic 
detergents and SDS, then added to the antiserum or Mab of 
choice. The immune complexes which form can be precipitated 
by the addition of Staphylococcus protein A bound to a 
carrier resin or to the organism itself. Following removal of 
the protein A by centrifugation the complexes are ready for 
gel electrophoresis and their mobility can be determined by 
the development of a photographic film.
5.2. Materials and Methods.
Note: Acrylamide and bisacrylamide are neurotoxins and must
be handled with extreme care:
Acrylamide gel (30%). 90gm of acrylamide was added to 150ml 
of distilled water and stirred to dissolve. The volume was 
made up to 300ml with distilled water and the solution was
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filtered through an 0.45um Nalgene filter then stored at +4®C 
in a brown reagent bottle.
Acrylamide gel (12.5%) for discontinuous SDS separating gel: 
18.75ml .of 30% acrylamide was added to 4.65ml of 1% 
bisacrylamide, 11.25ml of 1.5M Tris-HCl pH 8.8, 9.5ml of
distilled water, 0.15ml of 10% APS, 0.45ml of 10% SDS and 
0.015ml of TEMED (Tetramethylethylenediamine). The solution 
was de-gassed before the addition of SDS and TEMED, since the 
presence of oxygen reduces the efficiency of gel 
polymerization.
Bisacrylamide gel (1%). 2.0gm of bisacrylamide was added to
175ml of distilled water and stirred until dissolved. The 
volume was made up to 200ml with distilled water and the 
solution was filtered and stored as above.
Ammonium persulphate (10%). 0.3gm of ammonium persulphate was 
dissolved in 3.0ml of distilled water. This reagent was 
prepared freshly for use each time required.
Aprotinin. Purchased from Sigma Chemical Co. Poole, Dorset.
Bovine serum albumin (BSA). Fraction V. Purchased from Sigma 
Chemical Co., Dorset.
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Electrode buffer. A 10x concentrated buffer was prepared by 
the addition to distilled water of 60.6gm of Tris, 288gm of 
glycine and 20gm of SDS to give a final volume of 2L. The 
buffer did not require adjustment of pH and was used at pH 
8.2 - 8.4. The Protean II Gel Apparatus required about 2.5L 
for electrophoresis and before use the concentrated buffer 
was diluted 1/10 with distilled water.
"Enhance." Purchased from Du Pont, Stevenage, Herts.
Laemmli saoule buffer. 12.5ml of 0.5M Tris-HCl pH 6.8 was 
added to 2.3gm SDS, 5.0ml 2-mercapto-ethanol and 20ml 50% 
glycerol. The volume was made up to 100ml with distilled 
water and stored in 5ml aliquots at -20°C. Before use lul of 
0.1% bromphenol blue was added to each 100ul of sample for 
electrophoresis.
LKB Multiphor II. Purchased from Pharmacia, Milton Keynes.
Phenylmethyl sulfonylfluoride {FHSE). 200mM in isopropanol.
RIPA (radio-immunoprecipitation assay) Buffer. To 30ml of 
5.0M NaCl was added 10.0gm sodium deoxycholate, 10.0gm of 
Triton X-100, 10ml of 10% sodium dodecylsulphate (SDS) and 
10ml of 1.0M Tris, pH 7.4. The volume was then made up to IL 
with distilled water.
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stacking Gel {6%); 2ml of 30% acrylamide was added to 2ml of 
1% bisacrylamide, 5ml of 0.5M Tris-HCl pH 6.8, 10.75ml of
distilled water, 0.1ml of 10% APS, 0.2ml of 10% SDS and 0.1ml 
of TEMED. (TEMED with APS was used to catalyse acrylamide 
polymerization and de-gassing of this solution was not 
required).
Staphylococcal Protein A. Cowan 1 strain of Staphylococcus 
aureus was purchased as a prepackaged reagent from Miles
Yeda, USA. After reconstitution of the vial contents with
10ml of distilled water containing 0.1% sodium azide the 10% 
suspension was ready for use and the surplus was stored in 
0.5ml aliquots at -20*C until required.
Working Buffer. 100ml RIPA buffer was made 2mM with respect 
to PMSF. To the 200mM stock solution of PMSF in
isopropanol was added Aprotinin to a final concentration of 
10K units/ml (K units of the inhibitor were indicated on the 
bottle). The working solution was made 0.2% with respect to 
BSA. (BSA was added as a carrier in the precipitation
reactions to provide an alternative to the labelled antigens 
for protease activity).
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5.2.1. 3sg-Hethionine Labelling.
For in vitro labelling of virus in cell culture, cell 
infection was carried out at an MOI of 1.0 or at a rate which 
ensured 100% infectivity and yielded the highest possible 
titre of virus in the supernatant fluid. At this time culture 
fluid was removed and replaced with methionine-free growth 
medium supplemented with 1.0% BSA. ^ss-methionine was added 
to a final concentration of 50 microcuries in 10ml (usually 
each 150cm2 bottle contained approximately 0.5mCi/3-5 x 10® 
cells) and was incubated with the cells for 5-6 hours.
At the end of the labelling period the cells were rinsed 
two or three times with ice cold PBS, the bottle was drained 
and 5.0ml of RIPA buffer with protease inhibitors was added. 
This treatment lead to the virtual solubilization of the 
monolayer and the remaining cells were scraped from the 
surface with a rubber policeman and the bottle contents 
transferred to a 50ml polypropylene tube. The viscous fluid, 
in which nucleic acids had been liberated from the cell 
nuclei, was taken into the barrel of a 20ml syringe through 
an 18 gauge needle and repeatedly pipetted up and down until 
the viscosity was considerably reduced. The fluid was then 
diluted with an equal volume of RIPA buffer and clarified by 
centrifugation at 35K in an SW41 rotor for 90min at +4®C. The 
supernatant fluid was removed, divided into 1ml aliquots and 
stored at -70®C until required. The deposit and tube were 
discarded to a radioactive-waste container.
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5.2.2. Immunoprécipitation Reaction.
Caution. Surgical gloves were worn for the following;
To a 1.5ml Eppendorf tube was added 0.4ml of RIPA buffer 
containing BSA with protease inhibitors and 0.1ml of the 
labelled antigen preparation. After mixing on a vortex mixer, 
10ul of the antiserum to be tested was added and further 
constantly agitated at room temperature for two hours. When a 
rotating platform was not available for this purpose, manual 
agitation or vortex mixing every 15min was substituted. 0.1ml 
of a 10% suspension of the protein A organisms was added and 
incubated with agitation for an additional hour. Mixing at 
this time was critical because the protein A suspension had a 
tendency to settle.
The samples were centrifuged at 13000g for Imin in an 
Eppendorf Micro centrifuge. The supernatants were poured into 
a radioactive-waste container. The pelleted material was then 
re-suspended in 1.0ml of RIPA buffer containing BSA and 
protein inhibitors. The washing step was repeated two 
additional times and a third time with RIPA buffer with 
protein inhibitors but no BSA. This last step was to remove 
BSA which would otherwise have interfered with the tracking 
of proteins on the SDS-Page gels. After the last wash, 0.1ml 
of Laemmli sample buffer containing SDS and
2-mercapto-ethanol was added and the re-suspended sample
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boiled for 3min. Finally, the suspension was centrifuged and 
as much of the supernatant fluid as possible (without 
disturbing the pellet) transferred to a fresh tube. 
Bromphenol blue as a dye marker was added and gel 
electrophoresis carried out.
5.2.3. Electrophoresis Parameters:
Test samples were loaded on to a 6% stacking gel above a 
12.5% separating gel in the Protean II gel apparatus. Current 
was connected to the anode of the lower chamber and to the 
cathode of the upper chamber. Constant current was used to 
give an initial P.O. of 100V until migrating proteins reached 
the separating gel, then was changed to 30mAmps/slab gel for
3 - 4  hours, dependent upon rate of migration. The gel was 
washed in fixative (10% acetic acid, 30% methanol) with 
agitation overnight. For fluorographic amplification, the 
gel was washed in "Enhance" for 60 to 90min then dried in a 
gel dryer at 80®C under vacuum for one hour by laying the gel 
on dampened filter paper and overlayering with saran-wrap 
(clingfilm). The dried gel was then carefully placed in 
contact with film in a cassette and stored at -70*C overnight 
or for longer as required and then developed.
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5.3. Virus and Antisera for RIPA.
5.3.1. Viruses.
Mokola virus (Mok 1) and Duvenhage virus (Duv 1).
Each virus was passaged in neuroblastoma (MNA) cells at 
an MOI of 0.015 and the 2-day supernatant fluid was used to 
inoculate a confluent monolayer of MNA cells, ^ss-methionine 
was added 24 hours post-infection and the cells were 
harvested 4 hours later.
5.3.2. Polyclonal Antisera and Mabs.
5.3.2.1. Mokola RIPA (Fig. 5.1.):
Nine Mabs which had been shown by IFA techniques to 
react with Mokola virus were selected for analysis of their 
protein specificity. A further two Mabs which did not react 
with this virus were included as control negatives.
5.3.2.2. First anti-Duv 1 RIPA (Fig. 5.2):
Eight Mabs, six of which had been shown by IFA 
techniques to react with Duvenhage virus, were selected for 
analysis of their protein specificity and two Mabs which did
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not react with this virus were used as control negatives. 
Five polyclonal antisera (kindly provided by Dr. J. S. Smith 
of the CDC Atlanta) were added for comparison. In addition, 
a mouse anti-Duv 1 hyperimmune serum was included. This had 
been prepared as follows; mice were given one i.p. injection 
of 1x106 TCID50 of Duv 1 (MNA pld2 supernatant fluid) 
followed by one foot pad (f.p.) injection of the same 
inoculum 2 months later. After a further 3 weeks the mice 
were exsanguinated and their sera pooled, split into aliquots 
and stored frozen.
5.3.2.3. Second anti-Duv 1 RIPA (Fig. 5.3.):
In order to further investigate reactions obtained from 
the first anti-Duvenhage RIPA, a second test was prepared. 
Mabs D1 and D3 were pooled and re-tested. The only Mab (D8) 
which earlier had proved to neutralize Duvenhage virus was 
included, as were two commercially prepared FITC-conjugated 
diagnostic reagents. The first of these was a polyclonal 
antiserum but the second was a pool of two Mabs, both of 
which had been prepared against purified nucleocapsid 
antigen. Three Mabs from the first test, two of which had 
migrated to the N protein level and one of which did not 
react, were included as controls.
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5.4. Results.
Of the eleven Mabs (M5, M6, M7, DBll, LI, D2, DIG, DB3, 
DB4, DB14 and FI, lanes 1 - 11 respectively) selected for 
examination against Mokola virus, nine gave a precipitation 
band with a protein of comparable mobility to the N protein 
as determined by comparison with an anti-Duvenhage polyclonal 
serum (Fig. 5.1.). Mabs DBll and LI (lanes 4 and 5 
respectively) were included as negative controls and did not 
precipitate any viral proteins.
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Fig. 5.1. Mokola Virus (Mok 1) RIPA with Eleven 
Selected Mabs.
Lane 1, M5; lane 2, M6; lane 3, M7; lane 4, DBll; lane 5, LI; 
lane 6, D2; lane 1, D10; lane 8, DB3; lane 9, DB4; lane 10, 
DB 14 and lane 11, FI.
Lane 12 was the polyclonal anti-Duv 1 serum.
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Similarly, Mabs L16 and L3 (lanes 1 and 2) migrated to 
the N level when tested with Duvenhage virus (Fig. 5.2.). 
These two Mabs were selected for this assay because although
they were prepared against an heterologous virus they had
been shown in IFA tests to react with Duvenhage virus. In
contrast, no precipitation bands were given by Mabs DB10 and 
DB9 (lanes 3 and 4) which in previous IFA tests had been
shown to be negative when reacted with Duvenhage virus.
Although of somewhat uneven migration, with Mabs DBl, 
D9, D3 and D1 (lanes 5 - 8  respectively) precipitation was at 
the N level when compared with the anti-Duv 1 hyperimmune 
serum (lane 14). In addition there was a trace of NS 
precipitation, particularly with Mab D9 (lane 6).
No band was observed in lane 9 (the RSB pre-vaccination 
serum) and in lanes 10 and 11 (RSB 601.U. and Pasteur 2I.U.), 
bands were observed at the N protein level only. In lane 12 
(anti-Pasteur ascitic fluid) by far the heaviest 
precipitation was at the N protein level, with some evidence 
of anti-G and anti-NS proteins. In lane 13 the ERA virus 
antiserum migrated to the G and N protein level only. Lane 
14, which contained the homologous Duvenhage hyperimmune 
serum, revealed strong bands at the G, N and NS protein 
levels.
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Fig. 5.2. Duvenhage virus (Duv 1) RIPA with Eight 
Selected Mabs.
Lane 1, L16; lane 2, L3; lane 3, DB10; lane 4, DBS;
lane 5, DBl; lane 6, D9; lane?, D3 and lane 8, Dl.
Lanes 9 - 13 were polyclonal sera of the following origin: 
Lane 9, Rabies Serum Bank (RSB) human, pre-vaccination; lane
10, RSB 60 I.U.; lane 11, RSB 2 I.U.; lane 12, anti-Pasteur
virus ascitic fluid and lane 13, anti-ERA virus antiserum.
Lane 14 was the homologous anti-Duv 1 serum.
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In the second assay against Duv 1 virus (Fig. 5.3.), 
lane 2 contained Mab D8 which was known to neutralize 
Duvenhage virus; this Mab brought down a protein that was not 
precipitated by any other of the assayed Mabs, at a mobility 
consistent with the G protein of the anti-Duv 1 antiserum 
(lane 1). In lane 3 (RSB 601.U.) results were equivalent to 
those previously obtained (Fig. 5.2., lane 10) but with the 
1/10 dilution of this serum (lane 4) although precipitation 
at the N level was still present, no NS precipitation 
occurred. Of the four RSB sera of unknown potency (lanes 5 - 
8), N precipitation was given in lanes 5 and 8 but there was 
no precipitation in lanes 6 and 7. Lane 9 (BBL) showed bands 
against G, N and NS whereas in lane 10 (Centocor, the Mab 
pool) as expected the band was directed mainly against the N 
protein, but a trace at NS mobility was also visible.
As in the first assay, Mab D3 (lane 11) recognized a 
viral protein that migrated slightly further than expected 
but a mixture of Mabs Dl and D3 (lane 12) produced a band at 
the N level together with some evidence of NS, as did Mab D9 
in lane 13. Mab DB9, included in this assay (lane 14) in 
order to confirm previous IFA test results of positive 
reaction with Denmark bat virus but no reaction with 
Duvenhage virus, failed to produce a precipitation band. In 
no instance did Mabs used in these three assays precipitate 
more than a trace of protein at the NS level when compared 
with the NS protein precipitated by Duvenhage antiserum.
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Fig. 5.3. Duvenhage Virus (Duv 1) RIPA with Six 
Selected Mabs.
Lane 1, polyclonal anti-Duv 1 serum; lane 2, D8; lane 3, RSB 
60 I.U.; lane 4, RSB 60 I.U. diluted 1/10; lanes 5 - 8 ,  RSB 
sera of unknown potency; lane 9, a commercially prepared 
(BBL) FITC-conjugated antiserum; lanel0, the commercially 
prepared (Centocor) FITC-conjugated Mabs used throughout this 
work; lane 11, D3; lane 12, Dl with D3; lane 13, D9 and lane 
14, DB9.
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5.5. Discussion.
Although in ideal circumstances the protein specificity 
of all Mabs should be determined, in practice this was not 
possible. A selection was made of those Mabs which at the 
time had been shown to have the ability to distinguish one 
virus from another. All of the nine precipitating Mabs 
assayed against Mokola virus bound to a protein that had a 
gel migration similar to that of the virus nucleocapsid. One 
of these Mabs was IgM Mab D10 (Fig. 5.1., lane 7) which was 
known to react with Mokola virus and which was included in 
the assay to observe the precipitation reaction of an IgM 
Mab. The precipitation band was far weaker than the bands 
produced by the other eight Mabs, the most probable 
explanation for this weakness being the low affinity of 
Staphylococcal protein A for murine IgM.
Mab FI was included in this assay (lane 11) since in IFA 
tests it had been shown to react with Mokola virus. This 
latter reaction was unexpected since the F Mabs, prepared 
against the virus isolated from a biologist in Finland who 
died of rabies believed to be of bat origin, did not react 
with any of the 100 or so other viruses against which they 
had been tested. The precipitation band for Mab FI confirmed 
the relationship between Mokola and the Finland virus and 
further investigation of the relationship of these two 
viruses is warranted.
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An unexpected and somewhat inexplicable result was 
obtained with the first Duvenhage assay (Fig. 5.2.). In lanes 
5 and 7 (Mabs DBl and D3) migration appeared to have been 
slightly faster than that in lanes 6 and 8 (Mabs D9 and Dl). 
Mab D9 and to a lesser extent the other three Mabs of this 
group appeared to have some NS protein activity, despite the 
cloning regime undertaken for their purity. It is unlikely 
that the N protein is a precursor for the NS protein and thus 
an alternative explanation may be that the viral proteins 
were not fully dissociated during treatment with the 
detergent buffer. Some support for this hypothesis is given 
by the similar reaction of Centocor (Fig. 5.3., lane 10). 
This is a pool of two Mabs which were prepared by immunizing 
mice with purified N protein, yet in this assay a trace of 
precipitation at the NS level was also given. A repeat test 
would be desirable, since, when a "fast" Mab (D3) was mixed 
with a "slow" Mab (Dl) and assayed under the same conditions, 
bands at an identical migration rate (lane 12) to those of 
Mab D9 alone (lane 13) were produced (Fig. 5.3.).
The precipitation band given by one Mab (D8) was at a 
different migration to that of all other Mabs assayed and was 
equivalent to that of the G protein of the control 
anti-Duvenhage antiserum. Since this Mab also neutralized the 
homologous (Duvenhage) virus it is most probable that it is 
directed against the surface glycoprotein.
The fact that no precipitation was detected by Mabs DB10
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and DB9 (Fig. 5.2., lanes 3 and 4) provides further evidence 
of the differences between the Duvenhage virus of Africa and 
the Duvenhage-like viruses of European bats.
Perhaps with the exception of the anomalous readings of 
migration levels of Mabs DBl and D3 and with the certain 
exception of Mab D8, all of the precipitating Mabs migrated 
at the same rate as Centocor. This Mab pool brings down only 
one protein in a rabies preparation and also brings down the 
baculovirus - rabies recombinant N protein (J.S.Smith, pers, 
comm.). Thus it is most probable that the protein 
precipitated by the Mabs in these assays, with the above 
exceptions, is N protein.
From the results recorded in Chapters 3 and 4 of this 
work and for the reasons therein, a panel of thirty six 
Mab-Ns was generated from cell culture concentrates and was 
used to determine the antigenic reaction patterns of the 
viruses designated in Chapters 6 and 7.
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Chapter 6. Identification of Rabies Viruses 
of Terrestricd Animals.
6.1. Introduction.
In the years since the first description of 
rabies-specific Mabs (Wiktor and Koprowski, 1978), the 
ability to identify and characterize antigenic variants of 
rabies virus has become an essential part of almost all 
rabies investigations. The broad adaptability of the virus to 
a variety of warm-blooded hosts has resulted in a complex, 
interactive multiple-host zoonosis. Much has been learned of 
the antigenic variation within the viruses in and among 
terrestrial animal reservoir hosts of Europe and America, but 
less is known of the variation present in the natural hosts 
of the disease in southern Africa and the Soviet Union.
To date, there is no complete record of the antigenic 
variation present in the rabies-related viruses. The purpose 
of this work was to examine those viruses isolated in Africa 
and which were still available, together with a substantial 
number of isolates from European bats, with Mabs generated by 
using the rabies-related group prototypes as immunogens.
In this Chapter, for comparison with these 
rabies-related viruses, terrestrial animal isolates were 
selected from countries of southern Africa, the Soviet Union 
and Germany, where both classical rabies and rabies-related
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viruses are known to co-exist. The origins of the viruses are 
prefaced by a brief history of rabies in the country from 
which they were taken and where possible the geographical 
locations were plotted (Figs. 6.1. and 6.2.).
Brain smears were used in preference to cell-cultured 
virus. On some occassions, however, non-specific staining 
occurred in all smears. An attempt was made to overcome this 
problem either by pre-treatment of a second set of smears 
with a preparation of goat anti-mouse IgG conjugated to 
horseradish peroxidase or by resorting to culture techniques.
6.2. Materials and Methods.
6.2.1. Preparation of Brain Smears.
In the majority of instances, a 10% suspension of 
infected brain was inoculated intracerebrally into two 3-week 
old mice which were then observed daily. When the mice were 
seen to be sick they were euthanased to relieve further 
suffering but, on occassions, mice were found dead without 
apparent previous sickness. The brain of one mouse was used 
to prepare smears on multispot slides and the brain of the 
second mouse was harvested as a source of stock virus. Since 
brain smears lack homogeneity they were used only when at 
least 50% of the smear could be expected to contain rabies 
antigen (determined by a prior test with Centocor antibody).
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6.2.2. Mab Tests on Brain Smears.
Slides of smears which had previously been fixed in 
acetone and stored at -20®C were removed from the freezer and 
air-dried. Mabs (40ul) were added to the smears in a 
documented fashion and the slides were incubated at +37®C for 
30mins. After washing in PBS for 10mins followed by 
air-drying, 50ul of FITC-conjugated goat anti-mouse antiserum 
at appropriate dilution was added to each smear and the 
slides returned to the incubator for a further 30mins. After 
washing in PBS for 10mins. they were air-dried and read on 
the Fluovert microscope.
Ten samples (RV 284, 287, 323, 331, 386, 391, 400, 425,
427 and 430) which gave non-specific staining reactions were 
re-tested. In these tests, a second set of slides was 
similarly treated except that before the addition of Mabs, 
40ul of the peroxidase conjugate diluted to 1/25 (six times 
the working dilution used in other work) was added to each 
smear and the slides were incubated at +37®C for 30mins. They 
were then washed in PBS for 10mins., air-dried, then used as 
above.
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6.3. Mab Analysis of Terrestrial Animal Viruses 
from southern Africa.
6.3.1. Zimbabwe.
Although there is anecdotal evidence that rabies was 
present in parts of Zimbabwe prior to European settlement in 
1890, the first detailed account was provided by Edmonds, 
(cited by Sinclair, 1922). An outbreak of rabies in dogs in 
1902 was controlled largely by their destruction and the 
disease was eradicated by 1913, only to become established 
again in 1950. During 1952 the first serious outbreaks in 
wildlife, especially jackals, were confirmed and the 
following year an incident in which 47 sheep died of rabies 
after being attacked by a honey badger was reported 
(Darbyshire, 1953). Since 1954 disease occurrence and 
distribution has fluctuated considerably (Foggin, 1986). 
Canine rabies predominates in the heavily populated communal 
(tribal) lands and jackal rabies in the less densely 
populated commercial farming areas, though the disease is 
also found here in mongooses, civets and ratals (honey 
badgers) (J. Bingham, pars. comm.). In addition the three 
rabies-related viruses Lagos bat, Mokola and Duvenhage have 
all been isolated in Zimbabwe.
The origins of brain samples from 20 animals of nine 
species collected during the years 1986-1991, together with 
mouse inoculation details, are recorded in Fig. 6.1. and in 
Table 6.1.
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Table 6.1.
Terrestrial Animal Specimens from Zimbabwe.
Lab. Ref. Year Senders' Mouse Death
(RV) Reported Ref. Species * (Days)
120 1986 16300 Human D9, D9
121 1986 16383 Human D9, D10
124 1986 14034 Cat D12, D12
125 1986 14056 Cat D7, D9
129 1986 15867 Dog D6, D7
130 1986 11926 Mongoose D8, D8
132 1986 2/2/86 Rodent? Dll, Dll
284 1990 18765 Bovine D14, K14
285 1990 18769 Human K13
286 1990 18774 Jackal Kll, K13
287 1990 18775 Dog K8, K8
322 1991 18623 Jackal K12
323 1991 18650 Jackal K12
325 1991 18659 Cat K10, K10
328 1991 18914 Jackal D9, Dll
329 1991 18917 Jackal K7, K7
330 1991 18922 Jackal K7, K7
331 1991 18945 Jackal D9, D9
332 1991 18959 Civet K10, D14
333 1991 19049 Ratel K10, Kll
* D = Died; K = Killed in extremis.
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6.3.2. Botswana.
In Botswana the incidence of rabies in the fauna is 
largely unknown and although the main vectors are dogs, 
cattle and jackals are often affected (Maganu and Staugard, 
1985). During the decade 1973-1982 a total of 662 positive 
diagnoses of animal rabies was made - a mean of 66 cases per 
annum - of which 49% were in dogs. Towards the end of the 
1980s, however, the incidence of rabies in the north-east of 
the country began to increase. Farm animals, bitten by 
jackals, were the chief source of victims and the number of 
jackals appeared to increase despite attempts to control 
their population size by strychnine poisoning.
In 1990, of the 254 animals found to be rabid, 186 (73%) 
were of bovine and caprine species, and only 24 (9.5%) were 
canines. A further 34 cases (13%) were of wildlife species 
including 24 jackals (G. Wibberley, pers. comm.). Twelve 
brain samples from seven species were collected during the 
years 1988-1991; the details of species origin and mouse 
inoculation are summarized in Fig. 6.1. and in Table 6.2.
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Table 6.2.
Terrestrial Animal Specimens from Botswana.
Lab.Ref. Year Senders' Mouse Death
(RV) Reported Ref. Species * (Days)
386 1990 R39/7/90 Bovine K10, D13
388 1991 R3/1/91 Bovine K7
389 1990 R16/12/90 Jackal K10
390 1990 Rll/12/90 Canine K10, Kll
391 1991 R8/1/91 Bovine K8, K9
392 1988 R8/11/88 Caprine K8, K9
393 1989 Rll/2/89 Canine D13
400 1988 R7/12/88 Caprine K10, K15
387 1991 R2/2/91 Mongoose K7, K7
396 1990 R13/12/90 Dorn. Cat K8
397 1988 R16/8/88 Bovine D7, K7
398 1989 Rl/3/89 Genet K10, Kll
* D = Died; K = Killed in extremis.
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6.3.3. Namibia.
Rabies is known to have occurred in dogs and livestock 
in Namibia in 1887 (Schneider, 1985) and it subsequently 
spread throughout most of the country. In 1977 an epizootic 
in kudu (Tragelaphus strepsiceros) was first observed and up 
to 50,000 of the animals were estimated to have died by 1982, 
when the outbreak spontaneously regressed. It was shown 
experimentally that kudu would succumb to the disease 
following the instillation of infected saliva into the buccal 
and nasal cavities and that infected kudu could secrete virus 
of very high titre {circa 10® MLDso/ml) in the saliva 
(Barnard et al., 1982). From these experimental results it 
was concluded that kudu are highly susceptible to oral 
infection and that by this means non-bite kudu to kudu 
transmission took place. Samples from two kudu and one jackal 
were obtained from Namibia in 1980 and their origins and 
mouse inoculation details are summarized in Fig. 6.1. and in 
Table 6.3.
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Table 6.3.
Terrestrial Animal Specimens from Namibia
Lab. Ref. Year Senders' Mouse Death
(RV) Reported Ref. Species * (Days)
135
136 
138
1980
1980
1980
947/80
968/80
1070/80
Kudu
Kudu
Jackal
K20
D14
D16, D19
* D = Died; K = Killed in extremis.
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6.3.4. Republic of South Africa.
Cluver in 1927 noted that Thunberg made reference to 
rabies in South Africa in 1772 and further outbreaks were 
reported to have occurred in 1828, 1857 and 1861. In 1932 a 
fatal disease resembling rabies in man followed bites by 
genets (Neitz and Marais, 1932). Today, as in Zimbabwe, 
although it is probable that the dog was solely responsible 
for the epizootic that originated in the mid-1940s, both the 
dog and the black-backed jackal are important reservoirs of 
the disease (Meredith, 1982). However, less threatening to 
human life but still of major importance, rabies is enzootic 
in small carnivora, particularly the yellow mongoose Cynictis 
penicillata. Disease occurrence in the Felidae is widespread 
but of low incidence, suggesting contact with reservoir 
species such as Genetta and Cynictus rather than the 
maintenance of disease within the Felidae. In addition, the 
three rabies-related viruses Lagos bat, Mokola and Duvenhage 
have all been isolated in the Republic of South Africa.
Five samples were obtained in 1980 and a further twenty 
nine samples from eight species were obtained in 1990; their 
origins and passage histories are recorded in Fig. 6.1. and 
in Table 6.4.
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Table 6.4.
Terrestrial Animal Specimens from 
Republic of South Africa
Lab. Ref. 
(RV)
Year
Reported
Senders'
Ref. Species
Mouse Death 
* (Days)
189 1980 1067/80 Dog D14, D17
425 1990 ND 352 Dog K14, K14
426 1990 ND 292 Dog K14, K17
427 1990 ND 378 Dog K13, K14
428 1990 ND 51 Dog D13, K17
429 1990 ND 56 Dog K12, K13
430 1990 ND 57 Dog Kll, Kll
431 1990 ND 72 Dog K10, K10
432 1990 ND 77 Dog D4, K9
433 1990 ND 89 Dog K10, Kll
402 1990 20/90 B.E.Fox K13, K17
405 1990 101/90 B.B.Jackal K6, K10
415 1990 598/90 B.B.Jackal K15, K16
416 1990 623/90 W.Mongoose K6, K12
404 1990 61/90 Y.Mongoose K10, K12
421 1990 670/90 Y.Mongoose K10, K12
423 1990 710/90 Y.Mongoose K8, K9
403 1990 57/90 Y.Mongoose K10
407 1990 257/90 Y.Mongoose D8, K8
412 1990 466/90 Y.Mongoose K10, K10
413 1990 480/90 Y.Mongoose K8, K8
420 1990 669/90 Y.Mongoose K9
422 1990 692/90 Y.Mongoose D9, K10
137 1980 990/80 Mongoose D8, D10
225 1980 1051/80 Mongoose K8
140 1980 1716/80 Wildcat D14, D14
141 1980 1927/80 Wildcat D6, D8
409 1990 298/90 C.Wildcat D8, Kll
419 1990 637/90 G.Squirrel K9, K9
414 1990 544/90 B.B.Jackal K12
410 1990 332/90 Y.Mongoose K8, K9
411 1990 416/90 Y.Mongoose K10, K10
417 1990 634/90 Y.Mongoose K12, K13
418 1990 636/90 G.Mongoose K12, K13
* D = Died; K = Killed in extremis
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6.3.5. Results.
In the majority of the Mab reactivity tests the brain 
smear technique proved to be a useful vehicle for the 
analysis of virus profiles. On ten occassions, however, the 
pattern of reactivity was obscured by the presence of 
non-specific fluorescent "Negri body" sized inclusions in all 
of the smears, although some differentiation between positive 
and negative smears could still be made by examination for 
the presence or absence of "star-dust" and nerve fibres, (the 
typical picture of rabies fluorescence). Pre-treatment with 
peroxidase conjugate on repeat smears led to some 
clarification of the picture but the Negri-body sized 
inclusions continued to appear as faintly stained granules 
and for accuracy, when non-specific staining was encountered 
the alternative cell culture test was used.
No differences in the reaction pattern of twenty brain 
specimens from nine species of Zimbabwe were observed (Table
6.5.). Of the thirty six Mabs used in the tests, only twelve 
(M2, DBl, DB3, DB4, DBll, DB14, L3, L4, L23, L25, L26 and
L28) gave positive reactions. Thus, the epitopes against 
which the remaining twenty four Mabs were prepared were not 
present in these viruses. Indeed, none of the eight Mabs 
prepared against Duvenhage and Finman viruses reacted with 
these viruses.
Four specimens (RV 284, 287, 323 and 331) which gave
non-specific staining were cultured in BHK-21 cells and, at
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the third or fourth passage, cells were seeded into 84-well 
plates then re-tested with the Mabs panel. The reaction 
patterns obtained were identical to those obtained with the 
other sixteen specimens.
From the twelve samples tested from seven species of 
Botswana, two distinctive reaction patttems were observed 
(Table 6.5.). Whilst eight samples gave a reaction pattern 
identical to that of specimens from Zimbabwe (i.e., twelve 
Mabs, M2, DBl, DB3, DB4, DBll, DB14, L3, L4, L23, L25, L26
and L28 positive with all samples and no reactivity with Mabs 
prepared against Duvenhage and Finman viruses), four samples 
(RV 387, 396, 397 and 398 from a mongoose, a domestic cat, a 
bovine and a genet respectively) appeared to have a further 
six epitopes missing (recognized by Mabs DBll, DB14, L4, L23, 
L25 and L28). As with the samples from Zimbabwe, three tested 
by brain smear analysis (RV 386, 391 and 400) gave
non-specific results but all gave a reaction pattern 
identical to the Zimbabwean isolates when adapted to BHK-21 
cell cultures.
Each of the three samples (two kudu and a jackal) from 
Namibia gave a reaction patttem which was identical to that 
obtained from samples of Zimbabwe (i.e., twelve Mabs, M2, 
DBl, DB3, DB4, DBll, DB14, L3, L4, L23, L25, L26 and L28
positive with all samples and no reactivity with Mabs 
prepared against Duvenhage and Finman viruses) (Table 6.5.).
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Table 6.5.
Reaction Patterns of 36* Mabs with Samples 
from Zimbabwe, Botswana and Namibia.
RV M2 DBl DB3 DB4 DBll DB14 L3 L4 L23 L25 L26 L28
Zimbabwe
120,121,124, + + + + + + + + + + + +
125,129,130, + + + + + + + + + + + +
132,284,285, + + + + + + + + + + + +
286,287,322, + + + + + + + + + + + +
323,325,328, + + + + + + + + + + + +
329,330,331, + + + + + + + + + + + +
332,333. + + + + + + + + + + + +
Botswana
386,388,389, + + + + + ' + + + + + + +
390,391,392, + + . + + + + + + + + + +
393,400. + + + + + + + + + + + +
387,396,397, + + + + + +
398. + + + + + +
Namibia
135,136,138. + + + + + + + + + + + +
* 24 Mabs (M5, M6, M7, Mil, Dl, D3, D9, DB9, DB10, FI, 
F2, F3, F4, F5, LI, L2, L8, Lll, L15, L17, L18, L19, L20 and
L27) were negative with all samples.
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Two distinctive reaction patterns were also observed 
when brains from thirty four animals of the Republic of South 
Africa were examined (Table 6.6.). As previously, one 
reaction pattern was defined by twelve of the thirty six Mabs 
used (M2, DBl, DB3, DB4, DBll, DB14, L3, L4, L23, L25, L26
and L28). No distinction could be made between the viruses of 
ten canines, a bat-eared fox, two black-backed jackals and a 
water mongoose (RV 402, 405, 415 and 416 respectively).
Some antigenic variation, however, was observed in the 
reactivity patterns of the remaining twenty samples. The 
basic pattern was defined by reaction with only eight (M2, 
DBl, DB3, DB4, DBll, DB14, L3 and L26) of the thirty six 
Mabs. In the reaction pattern given by three yellow mongooses 
(RV 404, 421 and 423) Mab DBll was positive and Mab DB14 was
negative. The reaction pattern given by a further six yellow 
mongooses (RV 403, 407, 412, 413, 420 and 422), two
unidentified mongooses (RV 137, 225), two unidentified
wildcats (RV 140, 141), a Cape wildcat (RV 409), a ground
squirrel (RV 419) and a black-backed jackal (RV 414) differed 
from this pattern in that DBll was negative and DB14 was 
positive. Mab DB14 gave only a weak reaction with smears 
from a further three yellow mongooses (RV 410, 411 and 417)
and a Cape grey mongoose (RV 418). The weak reactions were 
consistent and reproducible and took the form of a reduced 
amount of "star-dust" with the larger granules being less 
intensely stained.
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Three canine samples (RV 425, 427 and 430) which gave 
non-specific staining and the four samples (RV 410, 411, 417
and 418) which gave weak reactions with Mab DB14 were 
re-examined after adaptation to BHK-21 cells. The canine 
samples gave an identical reaction pattern to the canine 
samples tested by brain smear technique. The weak reactions 
of Mab DB14 took the form of an apparent reduction in the 
number of infected cells and reduced amount of fluorescence 
within these cells.
None of the Mabs prepared against Duvenhage and Finman 
viruses reacted with the viruses from South Africa.
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Footnote to Table 6.6.
In many instances throughout this work the expertise 
needed to accurately identify animal species was not 
available. This was not the case in the Republic of South 
Africa in 1990 however, and the following abbreviations have 
been used in the Table:
B.B. Fox = Bat - eared fox, (Otocyon megalotis)
B.B. Jackal = Black-backed jackal, (Canis mesomelas)
W. Mongoose = Water mongoose, (Atilax paludinosus)
C.G. Mongoose = Cape grey mongoose (Galerella pulverelentus) 
Y. Mongoose = Yellow mongoose, (Cynictis penicillata) 
Mongoose = unidentified mongoose
Wildcat = unidentified wildcat 
C. Wildcat = Cape wildcat, (Felis libyca)
G. Squirrel = Ground squirrel, (Xerus erythropus)
186
Table 6.6.
Reaction Patterns of 36* Mabs with Samples 
from Republic of South Africa.
Species/ RV M2 DBl DB3 DB4 DBll DB14 L3 L4 L23 L25 L26 L28
Canine
189,425,426, + + + + + + + + + + + +
427,428,429, + + + + + + + + + + + +
430,431,432, + + + + + + + + + + + +
433. + + + + + + + + + + + +
B.E.Fox
402. + + + + + + + + + + + +
B.B.Jackal
405,415. + + + + + + + + + + + +
W. Mongoose
416. + + + + + + + + + + + +
Y.Mongoose
404,421,423. + + + + + + +
403,407,412, + + + + + + +
413,420,422. + + + + + + +
Mongoose
137,225. + + + + + + +
Wildcat
140,141. + + + + + + +
Cape Wildcat
409. + + + + + + +
G.Squirrel
419. + + + + + + +
B.B.Jackal
414. + + + + + + +
Y.Mongoose
410,411,417. + + + + 0 + +
C.G.Mongoose
418. + + + + 0 + +
0 = weak positive
* 24 Mabs were negative with all samples. These were: 
M5, M6, M7, Mil, Dl, D3, D9, DB9, DB10, FI, F2, F3, F4, 
F5, LI, L2, L8, Lll, L15, L17, L18, L19, L20 and L27.
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Fig 6.1. Terrestrial Animal Specimens*from Southern Africa
The precise origin of RV 120, 124, 125, 130,132, and 325 are unknown.
6.4. Mab Analysis of Terrestrial Animal Viruses 
from the Soviet Union and Germany.
6.4.1. The Soviet Union
The latter-day epidemiology of rabies in the Soviet 
Union has been described (Isakov, 1949 and. Selimov et al., 
1980). Briefly, the disease spread to most parts of the Union 
from a focus of fox rabies in the 1940s in the Astrakhan 
region of the Volga delta, where there was a dense population 
of raccoon-dogs, foxes and wolves. Now, rabies is endemic in 
much the same areas and species. In addition it has spread to 
include polar foxes in the arctic region, foxes throughout 
the whole of the southern border areas as far east as the 
Sea of Okhotsk and dogs and wolves in regions bordering Iran, 
Afghanistan and the People's Republic of China. Rabies in 
bats has been reported from Kiev, Voroshilovograd, Belgorod, 
Omsk and Novosibirsk (cited by Selimov et al., 1988) and the 
incidents at Voroshilovograd and Belgorod each resulted in a 
human fatality. Some but not all of the virus isolates made 
from bats in the Soviet Union resembled the rabies-related 
Duvenhage virus of Africa (Selimov et al., 1988).
Betweeen the years 1986 to 1990, thirty nine specimens 
from twelve species collected from the Soviet Union were 
examined. Their origins are recorded in Table 6.7. Because 
of the vastness of the geographical area covered, the samples
189
were grouped into seven regions (Baltic, Tula, Kraznodar, 
Asia, Yakutska, Murmansk and Tuva) (Fig. 6.2.). In addition, 
because a number of these samples came from the polar region 
a Mab (P41), which was believed to recognize rabies viruses 
of arctic origin only, was included in the tests. (This Mab 
was kindly donated by Dr. L.G. Schneider of the WHO Rabies 
Collaborating Centre, Tubingen, Federal Republic of Germany).
Mouse passages of the viruses were made in Moscow and no 
record of the days to death were kept. However, all other 
aspects of the techniques employed were the same except that 
in the fluorescence microscope, which was taken to Moscow for 
the purpose, the xenon burner was substituted by a mercury 
vapour lamp.
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Table 6.7.
Origin of 39 Terrestrial Animal Specimens 
from the Soviet Union.
Region
Tula
Kraznodar
Asia
Murmansk
Baltic
Yakutska
Tuva
Area Lah1. Ref. Species
Tula 138, 576, 7213 Fox
13, 276, Dog
KOR Human
Tula 392, 1173 Fox
1172 Bovine
M-K Human
Tula 223 Fox
Voronezh 378, 395 Fox
Tula 1113, 7011 Fox
Tula SKR Human
Kraznodar 1304 Cat
Kraznodar 1305, 1306 Fox
Omsk 412 Badger
Tuwa 965 Wolf
Uzbekistan KOB, ESN Human
Omsk 308 Fox
Chita 209 Fox
Chita 943 Cossac Fox
Murmansk lA Polar Fox
Murmansk ? Dog
Estonia 143 Wolf
Estonia 144 Raccoon-dog
Pscov SHE Human
Yakutska 969, 994, 995 Polar Fox
Yakutska 759, 761 Polar Fox
Yakutska 962, 988 Reindeer
Tuva 10 Suslik
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Fig 6.2. Specimen Collection Areas of the Soviet Union
6.4.2. Germany.
Although rabies has been recognized in Europe for 
centuries, for unknown reasons it disappeared from Central 
Europe at the beginning of this century, only to re-emerge in 
the form of an epizootic in foxes during the second World War 
(Wandeler, 1988). Rabid foxes moved from Poland to East 
Germany in 1948 and travelled across the north German plain 
until, by 1950, the disease was present in West Germany 
(Kaplan et al., 1986). The frontal wave of disease spread at 
about 40Km annually, reaching France in 1978. Fox population 
control in Germany and France resulted in a reduction in the 
number of infections of domestic animals and humans but was 
not successful in the eradication of rabies (Blancou, 1988).
In contrast, oral vaccination, practised in Germany 
since 1983 and in France since 1986, has had more definitive 
results. Nevertheless in the re-unified Germany of 1990 
there were still 5572 rabies cases of which 1082 (19%) were 
in domestic animals and in France, 2984 cases of which 463 
(15%) were in domestic animals (Rab. Bull. Europe 4/90).
Towards the end of 1990 it was reported that foxes in 
the Potsdam area, where oral vaccination was in progress, 
were dying of vaccine-induced rabies. Four foxes from West 
Germany and six foxes from the former East Germany were 
received and their passage histories are recorded in Table 
6.8.
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Table 6.8.
Origin of 10 Terrestrial Animal Specimens from 
Re-unified Germany.
Lab. Ref. Senders' Mouse Death
(RV) Ref. Area Species * (Days)
311 1293 Naven Fox K9, K9
312 1408 Naven Fox K7, D10
317 1529 Naven Fox K9, K9
313 1455 Brandenburg Fox D7, K7
310 1246 Potsdam Fox K8, K10
314 1465 Potsdam Fox K7, K8
315 1493 Potsdam Fox K6
316 1510 Potsdam Fox Kll, K12
318 1532 Belzig Fox K9, 010
319 Vi 317 Zehlendorf Fox K10, K10
D = Died; K = Killed in extremis.
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6.4.3. Results.
Seventeen of the thirty seven Mabs (M2, D3, D9, DBl,
DB3, DB4, DB9, DBll, DB14, L3, L4, L18, L23, L25, L26, L28
and P41) were positive with some or all of the thirty nine 
viruses from terrestrial animals of the Soviet Union. Two 
basic reactivity patterns were demonstrated and within these 
two patterns minor variations were observed which enabled
eight patterns to be recognized. The first of these patterns
(PI, Table 6.9.) was demonstrated by tests on six viruses 
from the Tula region (RV 138, 576, 7213, 13, 276 and KOR from 
three foxes, two dogs and a human). With the exception of Mab 
P41, all of the seventeen Mabs were positive with all of 
these viruses.
The second reaction pattern (P2, Table 6.9.) was defined 
by four viruses (RV 392, 1173, 1172 and M-K from two foxes, a 
dog and a human), also from the Tula region. This pattern 
differed from the first pattern by the absence of reactivity 
of Mabs D3 and DB9.
A third reaction pattern (P3, Table 6.9.) in this 
geographical region was demonstrated by six viruses (RV 223, 
378, 395, 1113, 7011 and SKR from five foxes and a human).
This pattern differed markedly from the previous two patterns 
of viruses from that region in that only eight Mabs (M2, DBl, 
DB3, DB4, DBll, DB14, L3 and L26) gave positive reactions. 
The third reaction pattern was also demonstrated by four 
isolates (RV 412, 965, KOB and ESN from a badger, a wolf and
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two humans) from the Tuwa/Uzbekistan/Omsk area of the Asian 
region (see Table 6.7.).
The fourth reaction pattern was demonstrated by three 
viruses (RV 1304, 1305 and 1306 from a cat and two foxes)
from the Kraznodar region (P4, Table 6.9.). This pattern 
differed from the third pattern only in that Mab D9 also gave 
a positive reaction.
A fifth reaction pattern (P5, Table 6.9.) was 
demonstrated by two groups of viruses (RV 308, 209 and 943
from two foxes and a cossac fox from the Omsk/Chita area of 
the Asian region and from RV lA and ? from a Polar fox and a 
dog in Murmansk). This reaction pattern was identical to 
pattern P3 except that the viruses also reacted with Mab P41.
Similarly a sixth reaction pattern was shared by two 
groups of viruses, RV 143, 144 and SHE from a wolf, a
raccoon-dog and a human from the Baltic region and RV 969, 
994 and 995 from three Polar foxes of the Yakutska region 
(P6, Table 6.9.). This pattern was characterized by
reactivity with twelve Mabs (M2, DBl, DB3, DB4, DBll, DB14,
L3, L23, L25, L26, L28 and P41).
A second group of viruses from the Yakutska region 
formed the seventh reaction pattern (P7, Table 6.9.). The
group consisted of four viruses (RV 759, 761, 962 and 988
from two Polar foxes and two reindeer) and the pattern 
differed from the sixth pattern by the absence of reactivity 
with Mabs DBll and DB14.
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A unique isolate (RV 10 from Tuva) represented the 
eighth reaction pattern (P8, Table 6.9.). This virus from a 
suslik was reactive with ten Mabs (M2, DBl, DBll, DB14, L3,
L4, L23, L25, L26 and L28).
None of the Mabs prepared against the Finman virus 
reacted positively with the viruses from the Soviet Union.
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Two distinctive reaction patterns were demonstrated in 
ten fox specimens from Germany (Table 6.10.). Thirteen of the 
thirty six Mabs (M2, DBl, DB3, DB4, DBll, DB14, L3, L4, L18,
L23, L25, L26 and L28) reacted with four or more of the virus 
isolates. Four specimens (RV 311, 312, 317 and 313) from the 
former West German territory reacted with Mab M2 but not with 
Mabs L4, L18, L23, L25 and L28. Six specimens (RV 310, 314,
315, 316, 318 and 319) from the former East German territory
did not react with Mab M2 but were positive with Mabs L4, 
L18, L23, L25 and L28. None of the Duvenhage or Finman Mabs 
reacted with these viruses.
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Table 6.10.
Reaction Patterns of 36* Mabs with 10 Fox 
Sandies from Re-unified Germany.
RV M2 DBl DBS DB4 DBll DB14 L3 L4 LIB L23 L25 L26 L28
311 + + + + + + + +
312 + + + + + + + +
317 + + + + + + + +
313 + + + + + + + +
310 + + + + + + + + + + + +
314 + + + + + + + + + + + +
315 + + + + + + + + + + + +
316 + + + + + + + + + + + +
318 + + + + + + + + + + + +
319 + + + + + + + + + + + +
* 23 Mabs (M5, M6, M7, Mil, Dl, D3, D9, DB9, DB10, FI, 
F2, F3, F4, F5, LI, L2, L8, Lll, L15, L17, 
L19, L20 and L27) were negative with all
samples.
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6.5. Discussion.
The brain-smear technique on multispot slides was 
developed not only as a convenient and rapid method of 
antigenic analysis but more specifically for use in countries 
where cell culture techniques were not readily available. 
However, the unexpected occurrence of non-specific results 
impaired the test accuracy. One or two brain samples which 
had given this type of result were re-inoculated into mice 
but an identical picture was obtained when their brains were 
harvested and tested (data not shown).
Since the fluorescence picture of these samples was 
generally confined to one of fluorescent particles of Negri 
body size in smears which were expected to be negative and 
with a reduction or absence of the "star - dust" and nerve 
fibre normally associated with fluorescence of brain smears, 
an attempt to block the effect by prior addition of 
peroxidase - conjugated goat anti-mouse serum was made. The 
partially successful result suggested that the effect was 
caused by the formation of an antigen-antibody complex, 
either within the mouse brain before death or at the time of 
smear preparation. The latter explanation is more likely to 
be correct since there are no published reports of rabies 
virus infection leading to a breakdown of the blood-brain 
barrier. It is well known however that sero-conversion 
shortly before death, leading to high levels of antibody in
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the blood, frequently occurs (Hattwick and Gregg, 1975).
Interestingly, this non-specific reaction was observed 
only in the samples from southern Africa. The effect did not 
appear to be related to species origin since the ten samples 
came from dogs (4), cattle (3), jackals (2) and a goat. 
Recently, the effect has also been observed in tests of a 
similar nature carried out in the Republic of South Africa 
(R. Swanepoel, pars. comm. ).
In the few cases where results could not be obtained by 
brain smear techniques, the viruses were adapted to BHK-21 
cells then tested in microplates. Whilst it may be predicted 
that the adaptation process may lead to changes in the virus 
antigenic profile, such changes were not observed to have 
taken place in these analyses since the pattern of reactivity 
was shown to be identical to that of other viruses of the 
same region and when four samples were adapted to BHK-21 
cells for the purpose of investigating the weak reactions of 
brain smears obtained with Mab DB14 an identical result was 
also obtained. This is not to say that the adaptation process 
does not lead to such changes - any that may have occcurred 
may have taken place in other regions of the virus genome.
To date there are no substantive reports of antigenic 
variation amongst the viruses of terrestrial animals of 
mainland southern Africa although in the limited number of 
jackal and dog cases examined from Zimbabwe all isolates were 
shown to be identical (J.S. Smith, pers.comm. ). Thus is was
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interesting to find differences in the Mabs patterns of 
reactivity with the isolates of four animals - two 
mongooses and two wildcats - from South Africa when these 
animals were examined alongside the Zimbabwean viruses (Table 
6.6.). Variation in the reactivity patterns of rabies viruses 
is to be expected; even in Pasteur's time it was known that 
the biological characteristics of the virus could be changed 
by its repeated passage in animals and more recently Mab-Ns 
have been successfully used to investigate reactivity 
patterns of wildlife rabies in the USA (Smith et al., 1984).
The finding led to the examination of other rabies cases 
from Botswana, Namibia and the Republic of South Africa, 
revealing the widespread distribution of both major patterns 
of reactivity with the Mabs together with additional minor 
patterns present amongst the "mongoose" type rabies viruses.
In his paper Wildlife Rabies: Past and Present in South 
Africa (Meredith, 1982) the author points to the fact that 
historically the oldest and largest rabies area "comprises 
that region in which the main wildlife reservoir of the virus 
is to be found in the small carnivore members of the 
sub-family Viveridae, plus, to a lesser extent, certain wild 
Canidae, Felidae and Mustelidae. The other area is that in 
which the jackal and/or the semi-feral domestic dog are the 
principal disseminators".
The findings in this work support these epidemiological 
observations. Moreover, although no differences were observed
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amonst the "canine" viruses, subtle differences were noted 
amongst those of "mongoose" origin. When the origins of the 
virus isolates were plotted on a map they occurred as 
clusters of viruses in different geographical locations 
(Table 6.6. and Fig. 6.1.), pointing to the potential 
usefulness of the Mabs panel as an epidemiological tool. 
Indeed, none of the clusters of patterns of reactivity which 
was noted in the South African viruses were identical to the 
pattern found in viruses from Botswana.
As is the case in the United States where it has been 
observed that accidental "spill-over" of disease may occur 
from the major vector to other species within a defined 
geographical region (Smith and Baer, 1988), so too were these 
observations made in South African animals. For example, in 
the south-west of the country a "mongoose" virus type was 
found in a black-backed jackal (RV 414), whereas all other 
jackals tested in this work died of a "canine" virus type.
Similarly, virus from a ground squirrel (RV 419) was 
identified as a "mongoose" virus type and the virus of a 
water mongoose (RV 416) was identified as a "canine" virus 
type. The finding of a "mongoose" virus type in a bovine of 
Botswana (RV 397) was of particular interest. Local opinion 
is that the domestic animal cases arise from contact with 
infected dogs or jackals (G. Wibberley, pers. comm.) but on 
the basis of the results with Mabs this finding would suggest 
that that may not always be the case.
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The group of rabies viruses from southern Africa 
examined in this work is perhaps too small in number to allow 
major conclusions to be drawn, particularly when the size of 
the geographical area covered is taken into consideration. It 
is clear, however, that considerable variation exists.
Whereas in the United States an active surveillance 
programme with close co-operation between medical and 
veterinary workers has been in position for almost fifty 
years, no such surveillance nor co-operation has existed in 
the Soviet Union. Hence this work represents a first attempt 
to investigate variation within the rabies viruses of the 
Soviet Union at the present time and it lacks the back-up of 
historical surveillance which is an essential element from 
which meaningful epidemiological conclusions can be drawn.
The results of testing thirty nine specimens from the 
Soviet Union revealed the presence of eight patterns of 
reactivity with the Mabs. This large number of patterns is 
perhaps less surprising when the vast geographical area (Fig.
6.2.) and the variety of species from which the specimens 
were drawn is taken into account.
The over-all picture which emerged from the results is 
one of two basic patterns with minor variations within each 
of these patterns. Specimens from the Tula region exhibited 
both of the basic patterns. In one major pattern there were 
two minor patterns both of which closely resembled the virus 
of East German foxes, examplified by its reaction with Mab
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LIS. This Mab does not react in any other virus pattern from 
the Soviet Union, nor in those from Africa.
The second basic pattern was examplified by the absence 
of reactivity with Mabs L4, L23, L25 and L28. It was present 
in specimens from the southern parts of the Soviet Union from 
Chita (north of Mongolia) in the east across the Asian parts 
of the Union through Uzbekistan, westward to Kraznodar and 
northward to Murmansk. Variation within this pattern was 
minimal - three specimens from Kraznodar region additionally 
reacted with Mab D9.
One extraordinary result was obtained from a ground 
squirrel (Sciuridae spermophilopsis) or suslik from the Tuwa 
region, on the border with Mongolia. The reaction pattern 
differed from all other patterns described in this work and 
the virus could not be matched with any other virus when it 
was tested against the anti-N Mabs panels of thirty six Mabs 
of the Wistar Institute and twenty two Mabs of the CDC 
Atlanta, USA (results not shown).
Since the Tula region is the only region where both 
basic patterns were demonstrated, one might speculate on the 
origins of these two virus types. The first basic pattern 
described, defined by reactivity wih Mabs L4, L23, L25 and
L28, is present in the European parts of the Soviet Union 
whereas the second basic pattern is mainly confined to the 
Asian parts. It may be that the Tula region is where these 
two types of viruses, and possibly historical enzootics, meet
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and coalesce.
Because of its' ability to recognize viruses of polar 
origin, Mab P41 was included in the analysis of these viruses 
and as expected it reacted positively with viruses from the 
Baltic, Murmansk and Yukutska regions. Interestingly, it also 
reacted positively with viruses from the Omsk/Chita area of 
the Asian region, (about 55®N), far south of the arctic 
circle. There is a parallel in this migration of viruses of 
arctic origin, however; rabies in white foxes spread from the 
arctic region southwards through the eastern and central 
provinces of Canada and on into the United States where it 
has reached New York State (Bisseru, 1972). Viruses from 
foxes in this area (about 40®N) also react with Mab P41 (data 
not shown). It may not be wise to ascribe a particular 
function to a particular Mab, however. Recently it was 
reported that Mab P41 reacted with one of twenty isolates of 
canine origin from Nigeria (Umoh et al., 1990).
Following the political re-unification of East and West 
Germany in 1990, the opening of East German borders allowed 
access to the wildlife of new territories and an opportunity 
to extend the oral vaccination programme to the whole of 
Germany. A suggestion that foxes were dying of 
vaccine-induced rabies led to the examination of the German 
foxes described in this work. The cause of the problem was 
shown to be not due to the vaccine but to the use of Centocor 
(an FITC-conjugated pool of two anti-N Mabs) in which one of
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the Mabs was below strength and the second Mab-epitope was 
not present in the virus (data not shown). The reaction 
pattern obtained with the (former) East German foxes suggests 
that eastern Europe may become a rewarding area for future 
research.
Twenty Mabs (M5, M6, M7, Mil, Dl, DB10, LI, L2, L8, Lll, 
L15, L17, L19, L20, L27, FI, F2, F3, F4 and F5) failed to
react with any of the 118 viruses of terrestrial animal 
origin tested in this work. Three Mabs, however, (DBl, L3 and 
L26) reacted with all of these viruses and a further two Mabs 
(DB3 and DB4) reacted positively with all viruses except that 
from the Tuva suslik (RV 10). Thus these five Mabs form a 
group of broad spectrum Mabs for the recognition of 
terrestrial animal rabies viruses. In addition, seven Mabs 
(M2, DBll, DB14, L4, L23, L25 and L28) reacted with viruses 
from both continents and were useful in the determination of 
different patterns of reactivity amongst these viruses. 
Interestingly, none of the Duvenhage Mabs reacted with 
viruses of terrestrial animal origin from Africa and none of 
the Mabs prepared from the Finman isolate reacted with 
viruses of terrestrial animal origin from either continent. 
The latter points will be discussed in Chapter 8.
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Chapter 7. Identification of Rabies-related Viruses.
7.1. Introduction.
The history of the rabies-related viruses has been 
recently reviewed (King and Crick, 1988) and an up-date of 
the review was recorded earlier in this work {Chapter 1). 
Briefly, no isolations of rabies-related viruses have been 
made in Africa since 1986 but in Europe positive cases in 
bats continue to be reported; between the years 1977 - 1990, 
417 cases were confirmed and bat rabies was reported for the 
first time in France in 1989 (Anon., Rab. Bull. Eur. 4/89). 
Over 95% of the cases have been reported since 1985, chiefly 
in Denmark, northern Germany and the Netherlands (Anon., Rab. 
Bull. Eur. 4/90).
In this Chapter, sixty four rabies-related viruses were 
tested either as mouse brain smears or as BHK-21 cell adapted 
cultures in 84-well microplates against the panel of thirty 
six Mabs. The choice of substrate was governed by expediency. 
Since the seeding of plates was preceded by mixing 
suspensions of infected with non-infected BHK-21 cells, an 
arbitary minimum level of 20% infected cells was taken as 
satisfactory for test purposes. When this minimum figure was 
not achieved, a further passage of infected cells was 
undertaken. All tests were carried out in duplicate and weak 
reactions were re-tested, also in duplicate. In addition, the
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brains of over one thousand British bats of at least fourteen 
species were examined for the presence of rabies antigen.
7.2. Origin of 64 Rabies-related viruses.
Because of the vastness of the geographical area from 
which the rabies-related viruses were collected, their 
origins are shown in Table form only (Table 7.1.). For 
convenience, in the Table the samples are arranged in "virus 
groupings" as defined by the rabies serotypes (cited by King 
and Crick, 1988), that is, the Lagos bat viruses (serotype 
2), the Mokola viruses (serotype 3) and the Duvenhage viruses 
of Africa and Duvenhage-like viruses of European bats 
(serotype 4). Finman virus, isolated from a biologist who 
died of rabies, is provisionally classified as serotype 5.
Included in the forty one bat samples from Europe are 
representatives from each of the six European countries 
(Denmark, France, Germany, Holland, Poland and Spain) which 
currently report bat rabies cases. Most of the bats were 
serotines but three samples from Germany were from bats of 
unidentified species and two samples from the Ukraine were of 
Vespertilio murinus and Nyctalus noctula species. In addition 
three Myotis dasycneme bats from Holland were tested.
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Table 7.1. 
Origins of 64 Rabies - related Viruses.
Lab. Ref. Geographical Year Species No. Senders’
(RV) Location Isolated Tested Ref.
Serotype 2, Lagos bat viruses:
1 Nigeria 1956 Ehe/vum 1 Boulger
3 R.S.A. 1983 Bat 1 Pinetown
134 R.S.A, 1982 Cat 1 839/82
190 R.S.A. 1980 Ep.wah!bergi 1 687/80
133 Zimbabwe 1986 Cat 1 16302
43 CAR. 1974 M.pusHus 1 Sureau
41 Senegal 1985 Enetvum 1 Dakar bat
Serotype 3, Mokola viruses:
4 Nigeria 1968 Crooidumsp. 1 Shope
5 R.S.A. 1970 Cat 1 Umhlanga
39 Cameroun 1971 Crocfdam sp. 1 Le Gonidec
40 C.A.R. 1981 Ls/kapasf 1 Saluzzo
174-177 Zimbabwe 1981 Cats 4 Foggin
Serotype 4, African viruses:
1© R.S.A. 1970 Human 1 Meredith
131 Zimbabwe 1986 Bat 1 RS16
139 R.S.A. 1981 Bat 1 1486/81
Serotype 4, European viruses:
154 USSR 1985 Human 1 Yuli
Various Europe 1968-1989 Bat 41 Various
Serotype 5?, Finman viruses:
8 i Finland 1985 Human 1 Lumio
29 I Holland 1987 M.dasycneme 1 47072
30 i Holland 1987 M.dasyoneme 1 47129
228 Holland 1989 M.dasycneme 1 92666
* Most of these bats Eptesfcus serot/nus (serotine) bats from Denmark, France, Germany, 
Holland, Poland and Spain, but three bats were of unidentified species from Germany and two 
(UB1 and UB2) were Vespertilio murinus (particolored) and Nyc^us noctuiaipoQM^ ) bats 
from the Ukraine.
7.3. British Bats Examined for Rabies-related viruses.
During the years 1986-1990 smears from the brains of 
1059 bats found sick or dead were examined with Centocor 
antibody for the presence of rabies antigen. Included in this 
total were eight bats from a species (Pipistrellus nathusi) 
not indigenous to Britain and these bats were found grounded 
on oil-rigs. The species and numbers of bats examined are 
recorded in Table 7.2.
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Table 7.2. Species Origin of British Bats Examined for 
the Presence of Rabies Antigen.
No.
Species Common Name Size Rarity Tested
Barbastellus barbastellus Barbastelle M Very rare 1
Eptesicus serotinus Serotine L 29
Myotis bechsteini Bechstein's M Very rare 1
Myotis brandti Brandt's S 2
Myotis daubentoni Daubenton's S 17
Myotis mystacinus Whiskered S 29
Myotis nattereri Natterer's M 31
Nyctalus leis1eri Leisler's M Very rare 2
Nyctalus noctula Noctule L 21
Pipistrellus nathusi * Nathusi's Pip. S 8
Pipistrellus pipistrellus Pipistrelle S Common 673
Plecotus auritus Brown Long-eared M Common 172
Plecotus austriacus Grey Long-eared M Very rare 3
Rhinolophus ferrumequinum Greater Horseshoe L Rare 2
Rhinolophus hipposideros Lesser Horseshoe S 1
Unidentified 67
* = European Species; S = Small; 
M = Medium; L — Large.
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7.4. Results.
7.4.1. Lagos bat Viruses.
The results of the examination of seven Lagos bat 
viruses are summarized in Table 7.3. Twenty-five Mabs (L2, 
L3, L4, L8, Lll, L15, L19, L20, L23, L25, L26, L27, L28, M2,
M5, M6, DB3, DB4, LI, L17, L18, DBl, Dl, Mil and M7) reacted
with some or all of these viruses and the remaining Mabs did 
not react with any of them.
Analysis of the seven viruses with the Mabs revealed the 
presence of five patterns of reactivity. Three viruses (RV 3, 
134 and 190, from an unidentified bat, a cat and an 
Epomophorus wahlbergi bat) from the Republic of South Africa 
gave an identical pattern but could be distinguished from the 
prototype virus (RV 1 from an Eidolon helvum bat from 
Nigeria) by their absence of reaction with Mab M7 and their 
positive reactivity with Mab Dl.
The remaining three viruses (RV 133, 42 and 41 from a
cat, a Micropterus pusilis bat and an Eidolon helvum bat) 
were individual isolates from Zimbabwe, Central African 
Republic and Senegal respectively. They were distinguishable 
by their reactivity with Mabs LI, L17 and L18. In addition, 
one of these viruses (RV 133 from Zimbabwe) reacted with Mab 
Mil and gave weak positive reactions with Mabs DBl and Dl. 
These weak reactions were consistent and reproducible. Virus
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RV 43 (from a Micropterus pusilus bat of the Central African 
Republic) did not react with Mabs L18, DBl, Dl and Mil. Virus 
RV 41 from an Eidolon helvum bat of Senegal also failed to 
react with these four Mabs and in addition was negative with 
Mabs LI and L17.
None of the Finman Mabs (FI - F5) reacted with the Lagos 
bat viruses.
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7.4.2. Mokola Viruses.
Examination of eight Mokola viruses (Table 7.4.) 
revealed that nineteen of the thirty six Mabs (M2, M5, M6,
M7, Mil, DB3, DB4, L2, Lll, L20, L23, L25, L26, L28, FI, F2, 
F5, L15 and F4) reacted with some or all of these viruses.
All of the anti-Mokola Mabs (M2, M5, M6, M7 and Mil) reacted 
with all of the Mokola viruses.
From the results obtained with the Mabs, the viruses 
could be separated into three reactivity patterns on the 
basis of reactions with four Mabs (F2, F5, L15 and F4). The
prototype virus (RV 4) from a Nigerian shrew was
distinguishable from the other viruses by its positive 
reaction with all four of these Mabs. Two viruses, RV 5 from
a South African cat and RV 39 from a shrew of Cameroun
respectively, were positive with Mabs F2 and F5, and gave a 
weak reaction with Mab L15 but were negative with Mab F4. 
Five viruses (RV 40 from a rodent of the Central African 
Republic and RV 174-177 from four cats of Zimbabwe) gave
positive reactions with Mab F2 but were negative with the 
remaining three Mabs. None of the Duvenhage (Africa) Mabs 
(Dl, D3 and D9) reacted with the Mokola viruses.
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7.4.3. Duvenhage (Africa) Viruses.
Of the thirty six Mabs of the panel, fifteen (M2, Dl, 
D3, D9, DBl, DB3, DB4, DBll, DB14, L2, L3, L17, L20, L26 and
L27) were positive with all three of the Duvenhage (Africa) 
group of viruses. The results are summarized in Table 7.5. No 
differences were observed between the reaction patterns of 
the prototype strain (RV 6) from a human in South Africa and 
of the viruses from a bat (RV 131) from the same country and 
another bat (RV 139) from Zimbabwe. None of the Finman Mabs 
reacted with the Duvenhage (Africa) viruses.
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7.4.4. Duvenhage-like Viruses (Europe).
Twenty (D3, D9, DBl, DB3, DB4, DBll, DB9, DB10, DB14,
L20, M2, M7, Mil, L3, L25, FI, F2, F3, F4 and F5) of the
thirty six Mabs reacted with some or all of the 
Duvenhage-like viruses of Europe (Table 7.6.). Two basic 
reaction patterns were determined, with minor variation in 
one of these patterns.
The first pattern was defined by the reactivity of 
twelve Mabs (D3, D9, DBl, DB3, DB4, DBll, DB9, DB10, DB14,
L20, M2 and M7) with virus RV 154, from a child in the USSR
who died of rabies following the bite of an insectivorous bat 
and the majority (39) of the samples which were from serotine 
or unidentified bats. Within this pattern, however, Mab M7 
did not react with virus RV 154 and gave weak positive 
reactions with a substantial proportion of serotine bat 
samples, the remainder of which were negative. This same Mab 
(M7) defined a minor antigenic variation within this basic 
pattern in that it reacted positively with two viruses of 
this group, UBl from a Vespertilio murinus bat and UB2 from a 
Nyctalus noctula bat. Both of these bats came from the 
Ukraine. All of the Finman Mabs were negative with all of the 
forty two viruses of this group.
The second basic pattern, in which fourteen Mabs (D3, 
D9, DBl, DB3, DB4, DBll, Mil, L3, L25, FI, F2, F3, F4 and F5) 
were positive, was observed in the human sample RV 8, (the
221
prototype virus used as immunogen for the Finman Mabs) and 
three samples (RV 29, 30 and 228) from Myotis dasycneme bats 
from Holland. All of the Finman Mabs were positive with the 
four viruses of this group.
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7.4.5. Examination of British Bats.
None of 1051 brains from British bats and eight brains 
from European bats found on oil-rigs and examined for the 
presence of rabies or rabies-related virus was positive with 
Centocor antibody. They were therefore not submitted for 
examination with the Mabs panel.
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7.5. Discussion.
The original distinctions between the rabies-related 
viruses of Africa, recognized by specific hyperimmune sera, 
were maintained in the Mab analyses; Lagos bat viruses were 
clearly distinguishable from Mokola and Duvenhage viruses 
(Table 7.7.). In addition the Mab panel recognized multiple 
variants within two of these virus groups. For example, 
although isolates of Lagos bat virus were clearly more 
closely related to each other than they were to isolates of 
Mokola virus and vice versa, five reaction patterns in the N 
protein of these viruses were recognized by differential 
reactivity with Mabs M7, Dl, Mil, L18, LI and L17. 
Similarly, three reaction patterns of Mokola virus were 
observed by use of Mabs L15, F2, F5 and F4. There are too few 
isolates from these two virus groups, however, to permit the 
association of a particular reaction pattern with a 
particular species or geographical region.
In comparison, the three Duvenhage viruses examined were 
defined by a single reaction pattern with fifteen Mabs. Thus 
the virus from the index case (RV 6) from a human who died of 
rabies following a bat bite could not be distinguished from 
those of an unidentified but probably insectivorous bat (RV 
139) from Louis Trichardt (about 250Km north of the index 
case) and an insectivorous bat (RV 131) from Bulawayo, 
approximately 250Km further north. These are the only three
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isolates of Duvenhage virus, collected over a comparatively 
small geographical area but separated by a time span of some 
16 years.
Although the virus most frequently found in European 
(serotine) bats is referred to as Duvenhage-like, on the 
basis of these analyses there are a substantial number of 
differences (Table 7.7.). For example, one (Dl) of only three 
Mabs of the panel prepared against the prototype Duvenhage 
(Africa) virus recognized an epitope in all three of the 
Duvenhage (Africa) viruses but did not recognize an epitope 
in any of the European bat viruses tested. Indeed, the only 
anti-G Mab (D8) generated in this work, which was also 
prepared against the Duvenhage (Africa) virus, not only 
failed to neutralize the prototype Denmark bat virus but also 
failed to react with this virus in IFA tests, indicating the 
absence of this epitope in the Denmark bat virus. Conversely, 
Mabs DB9 and DB10, prepared against the Denmark bat virus, 
recognized epitopes in all of the "serotine" virus isolates 
from Europe but failed to recognize an epitope in the three 
Duvenhage (Africa) viruses.
These two virus groups can be further distinguished by 
their differential reactivity with Mabs L17, L3, L27, L2 and 
L26. All of these Mabs recognized epitopes in the Duvenhage 
(Africa) viruses, but none of them recognized an epitope in 
the "serotine" viruses of Europe. In view of the similarity 
between the reaction patterns of viruses from serotine bats
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of Europe and the different but single reaction pattern of 
the Duvenhage viruses of Africa, the results suggest that the 
relationship of these two groups of viruses is somewhat more 
distant than was hitherto believed.
Five Mabs (FT, F2, F3, F4 and F5), generated from the
virus isolated from the Swiss bat biologist who died of 
rabies in Finland, all recognized epitopes in the three 
viruses (RV 29, RV 30 and RV 228) isolated from Myotis 
dasycneme bats of Holland. This result supports 
circumstantial evidence (the victim was reported to have been 
bitten by a bat fifty one days before death) that the Finnish 
virus is of bat origin. The Mabs did not recognize epitopes 
in the viruses isolated from the other (41) "serotine" bats 
of Europe and therefore there must be at least two rabies 
virus bio-types present in European bat species.
The reaction patterns of these two bio-types were 
clearly distinguishable (Table 7.7.). None of five Mabs (L20, 
M2, DB14, DB9 and DB10) which reacted with virus isolates of
the "serotine" bio-type recognized epitopes in virus isolates
of the other bio-type (for convenience in this work, referred 
to as the "Finman" bio-type). Conversely, eight Mabs (L3, 
L25, Mil, FI, F2, F5, F4 and F3) which recognized epitopes in 
the "Finman" viruses did not recognize epitopes in the
"serotine" viruses.
Just as the "Finman" viruses could be distinguished
easily from the "serotine" or Duvenhage-like viruses of
227
European bats, so too could they be distinguished from the 
Duvenhage viruses of Africa. Seven Mabs (L25, Mil, FI, F2, 
F5, F4 and F3) which recognized epitopes in the "Finman" 
viruses did not recognize epitopes in the Duvenhage (Africa) 
viruses (Table 7.7.). Conversely, six Mabs (L17, L27, L2,
L26, L20 and DB14) which recognized epitopes in the Duvenhage 
(Africa) viruses did not recognize epitopes in the "Finman" 
viruses.
One Mab only (L20) of the sixteen Mabs prepared against 
Lagos bat virus recognized an epitope in viruses of 
"serotine" origin whilst two other Mabs (L3 and L25) 
recognized epitopes in viruses of "Finman" origin. This is in 
contrast with the six Mabs (L17, L27, L2, L26, L20 and DB14)
which recognized epitopes in Duvenhage (Africa) viruses as 
stated above. Only three Mabs were prepared against the 
Duvenhage virus, one of which (Dl) recognized an epitope in 
two of the Lagos bat virus groups but none in the viruses of 
European origin; the other two Mabs (D3 and D9) did not 
recognize epitopes in the Lagos bat viruses but gave positive 
reactions with all European bat viruses tested. None of the 
Finman Mabs (FI - F5) reacted with any virus of bat origin 
except the viruses from Myotis dasycneme bats of Holland. 
These latter points illustrate the great diversity that 
exists amongst the viruses of frugivofous and insectivorous 
bats examined in this work.
Eight Mabs (L25, Mil, DB3, DB4, FI, F2, F5 and F4) which
228
recognized epitopes in the prototype Finman virus (RV 8) also 
recognized epitopes in the prototype Mokola virus (RV 4) 
(Table 1.1.). Indeed, four of the Mabs (FI, F2, F5 and F4) 
defined three reaction patterns within the Mokola virus 
serotype. The reservoir species of Mokola virus, assuming 
that there is one, has not been determined. The virus has not 
been isolated from a bat but the results in this work show 
that there is a relationship between the rabies viruses 
isolated from a man who died of the disease in Finland 
following a bat bite, bats in Holland and shrews, cats and a 
rodent in Africa.
229
î
a.
I
g
ce
>
g
8 i
§ I il> ^  o xS::z
N
N
_0)
JD
H
0
O)
3
"O
0
%
0
i
!û
0
ce
3
C
O
n
0
CD
co
sz
%
H
'S
2:'
0
E
E
3
CO
I
<0
U) 
CM 
U_ 1 -
CO
O
0>
m :
O
0>
<0
N
(O
in
CM
%
CM
R
S3
S3
in
O)
co
co
N
+ + + + 
+ + + +
+ + O
o
co
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+•
+
+
+
+
+
+
+
+
+
+
+
+
+
+
Hh
+
4*
+
+
+
+
+
+
+
+
+
4"
4»
4-
4^
4*
+
+
4*
+
4-
+
+
4
4
4
4
4
Q
4
4
4
4
4
4
4
4
4
4
> 4
4 + 
4 4
4
4
4
4
4
4
4
4
4
4
4
1
B
I
B
II
ti <D
Î1I  I  
1
4 >
S 8 ?
CO
8 it
lO
S
co
<0
I»
o =>
> m
s "
N
8
8
CO
Chapter 8. General Discussion and Conclusions.
Rabies has been known in Britain since mediaeval times 
but as there is no record or evidence of a wildlife 
reservoir, the disease has probably never been truly endemic. 
It is remarkable that foxes and other wildlife did not become 
infected with rabies, bearing in mind the extensive fox
population that existed in the nineteenth century (Meldrum, 
1988). With the exception of two isolated cases, one in 1969 
and the other in 1970 in dogs recently released from
quarantine, the country has been free of rabies since 1922. 
Since that year however, rabies has been confirmed in 29 
cases in animals undergoing quarantine and this factor, 
together with the realization that infected animals might be 
released from quarantine, albeit rarely, lead to the adoption 
of vaccination of quarantined animals, beginning in 1971. 
Only one case of death from rabies in quarantine has been 
reported since that time (King et al., 1985).
Stringent rules governing the handling of dangerous 
pathogens were drawn up by the Health and Safety Executive 
and although because of the relatively low contagiousness of 
rabies virus it was placed in hazard group 3, because of the
possible serious outcome of release of this virus to our
wildlife the Ministry of Agriculture, Fisheries and Food 
insisted upon containment hazard group 4 for its keeping and 
handling. Such facilities are expensive to build and maintain
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and, not surprisingly, few Institutions and Laboratories 
could justify such expenditure. Today, only two Institutions 
(the Central Veterinary Laboratory and the National Institute 
of Biological Standards and Control) and one vaccine 
manufacturer in the U.K. are licenced to hold and to work 
with rabies viruses.
Within the past few years the disease picture in Europe 
has dramatically changed; wildlife rabies has been reported 
in the centre of Paris and has reached the Channel ports, 
oral vaccines either of modified live virus or recombinant 
virus origin have been laid in bait in millions of doses and 
rabies in bats has been shown to be present in many European 
countries including our nearest neighbour, France. With 
modern day travel the threat of accidental or illegal 
importation of an infected animal is also increased and the 
need to be able to detect and correctly identify rabies 
viruses has become paramount, since the response to the virus 
would be governed by its type. For example, if the virus was 
shown to be of bat origin, the contingency plans for wildlife 
destruction may be restricted or not brought into play at all 
since, although bat viruses can spill over into terrestrial 
animals, there is no evidence to suggest that a cycle of 
infection within these animals can become established (Smith 
and Baer, 1988).
The need to safeguard our wildlife and the stringent 
safety requirements have led to the current situation whereby
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very few physicians or veterinarians in this country have 
experience of working with rabies virus. Yet a nucleus of
such experience is essential if the disease, should it enter 
our wildlife, is to be recognized, controlled and then 
eradicated. To maintain and to broaden this nucleus of 
experience international co-operation in the rabies field was 
necessary and this thesis describes part of an international 
programme to examine antigenic variation in rabies viruses 
from regions of the world where rabies was frequently 
reported but where such work had not previously been 
undertaken.
Despite the neurotropic character of rabies viruses in 
vivo they show a remarkable ability to replicate in a wide 
variety of mammalian cells in vitro. Unfortunately, with the 
exception of cells of neuroblastoma origin, they adapt to 
growth within these cells only slowly when passaged by
traditional methods (Wiktor, 1966). Neuroblastoma cells, 
however, require an atmosphere of additional CO2 for growth 
(not available in the early part of this work) and they are 
less hardy and resistant to the toxicity sometimes 
encountered in brain material. The method devised in this 
work resulted in the rapid adaptation of a wide variety of
rabies viruses to growth in BHK-21 cells, a cell line which
is used in many rabies laboratories of the world. In most 
instances virus stocks and/or plates to be used to determine 
the reaction patterns of the viruses with Mabs could be
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prepared well ahead of the time taken to kill mice for the 
preparation of brain smears for similar purposes.
Nevertheless, since part of this work involved 
collaboration with rabies laboratories overseas where cell 
culture methods are neither available nor feasible, the 
brain smear technique on Teflon-coated multispot slides 
herein described was developed. The method had advantages not 
only for these laboratories but because of the 
labour-intensive nature of culture techniques it became the 
method of choice in this work. One disadvantage of the brain 
smear method was that in a low percentage of cases 
non-specific staining was encountered. The effect could be 
partially blocked by pre-treatment with anti-mouse IgG 
antibody conjugated with horseradish peroxidase, but in this 
work results were obtained by resorting to cell culture.
Production of hybridomas secreting Mabs is also an 
extremely labour-intensive occupation and the choice of a 
simple immunization procedure with a variety of immunogens 
which resulted in a manageable number of hybridomas from each 
fusion allowed the production of a panel of Mabs giving a 
broad spectrum of reactivity. Had a regimen of 
hyperimmunization of mice with a single strain of virus from 
terrestrial animal origin been selected as the protocol it 
may have resulted in a larger number of Mabs but it is 
extremely unlikely that the relationship between Myotis 
dasycneme bat virus and Mokola viruses (Table 7.7.), for
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example, would have been recognized.
To more fully characterize viruses they should be 
examined with both anti-N and anti-G Mabs but the latter 
characterization requires neutralization test procedures 
which are technically more difficult, time-consuming and 
costly. One would have expected to produce more anti-G Mabs 
than were demonstrated in this work and indeed more may have 
been produced but were not recognized by the screening method 
which was adopted. The one anti-G Mab (D8) which was 
recognized and characterized, however, did not appear to be 
different from the others when viewed in reaction with 
acetone-fixed virus in cell cultures under the fluorescent 
microscope. It was nevertheless a useful Mab in that it 
distinguished the virus from which it was prepared (Duvenhage 
from Africa) from Denmark bat virus, thus confirming the 
differences between these two viruses shown by anti-N Mabs.
To date, the complete amino acid sequences of the 
N-protein of only two rabies viruses have been published - PV 
virus, derived from Pasteur's virus (Tordo et al., 1986) and 
SAD B19 (the modified live virus oral vaccine derived from 
ERA virus which is currently being distributed in bait in 
Europe) (Conzelmann et al., 1990). Two other viruses, CVS 
11, derived from Pasteur's virus and ERA, derived from an 
American canine isolate (Street Alabama Dufferin - SAD), 
have been similarly sequenced but the complete sequences have 
not been published (Wunner et al., 1988). However, the amino
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acid sequences deduced from the N-protein gene of each of 
three viruses (PV, ERA and CVS 11) were 450 residues long and 
when these deduced sequences were compared, a high degree of 
homology was shown; the N-protein of the ERA and CVS-11 
viruses differed by nine amino acids (98% homology) and the 
N-protein of the ERA virus differed from that of PV virus by 
five amino acid residues (99% homology) (Wunner et al., 
1988). From the published seqences of PV and SAD B19 viruses 
the same high degree of homology was observed - only four of 
the 450 amino acid residues were different (Table 8.1.)
This compares with the homology of the ectodomain 
sequences between the glycoproteins of ERA and CVS viruses 
(94.3%) and the 92% homology between matrix proteins of the 
same two viruses (Wunner et al., 1988). Thus the high degree 
of homology of the N-proteins compared with that of other 
proteins of these viruses suggests that differences in the 
N-protein which can be shown by Mabs reaction patterns may be 
meaningful in epidemiological studies.
In total, in this work the reaction patterns of one 
hundred and eighty three viruses were determined with thirty 
six Mabs. The viruses, of which sixty four were 
rabies-related (serotypes 2-5) and one hundred and nineteen 
were "classical" rabies (serotype 1), included the prototype 
viruses of each of the serotypes. The reaction pattern of the 
prototype virus of serotype 1 (CVS-24, Table 4.3.) was
identical to that of "canine" viruses of Zimbabwe.
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Table 8.1. N-protein Amino acid Differences Between 
PV and SAD B19 Rabies Viruses.
aa Position 
in Sequence
Virus
PV
Virus 
SAD B19
59
66
157
410
Cysteine 
Aspartic acid 
Serine 
Isoleucine
Glycine
Asparagine
Asparagine
Methionone
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In order to examine the relationships of these viruses, 
twenty nine reaction patterns, some of which were identical 
but were determined in viruses from different geographical 
regions, were submitted for analysis by the "Clustan" 
computer analysis programme (Wishart, 1987). The results are 
shown in Figure 8.1. The analysis revealed eight reaction 
pattern groupings (in the figure, displayed by coloured 
blocks and for convenience lettered A to H with the number of 
viruses in each pattern group in parenthesis). There was a 
clear division of the pattern groups into two major groups, 
the first of which was subdivided into groups A and B, the 
Mokola and the Lagos bat viruses. These viruses are clearly 
related to each other but are more distantly related to the 
remaining viruses, as would be expected since they can be 
distinguished from them by serological tests using homologous 
polyclonal antisera. . The analysis confirmed the findings of 
others that Mokola virus and CVS virus represent the two most 
antigenically-distant serotypes of medical importance within 
the Lyssavirus genus (Bourhy et al., 1990).
The remaining reaction patterns could also be divided 
into two groups (C to F and G with H, Fig.8.1.). Rather 
surprisingly, the Finman reaction pattern (group C) and the 
Duvenhage viruses of Africa and "serotine" viruses of 
European bats reaction patterns (group D) of these groups, 
although distinct, were more closely related to the serotype 
1 viruses of group E (the "mongoose" viruses of Africa and
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group F (the wildlife viruses of Asia) than they were to the 
reaction patterns of the Mokola and Lagos bat viruses. The 
serotype 1 reaction patterns of this group were more closely 
related to each other than to the reaction patterns of the 
remaining serotype 1 viruses (groups G and H).
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Fig. 8.1. "Clustan" computer programme analysis of the 
relationships of 64 rabies-related and 119 
classical rabies viruses * as determined by 
reactivity patterns with 36 Mabs.
Each vertical line represents the coefficient of 
relatedness (expressed in figures of the right hand column) 
of one group of virus reaction patterns compared with the 
reaction patterns of 28 other groups of viruses. The lettered 
coloured blocks represent groups of viruses of close 
relationship as follows;
A (26, 25 and 24) are the eight Mokola viruses.
B (23, 22, 21, 20 and 19) are the seven Lagos bat viruses.
C (29) is the four Finman viruses.
D (28 and 27) are the three Duvenhage (Africa) and forty two
"serotine" viruses of European bats.
E (18, 17, 16 and 13) are the twenty four viruses from
sixteen mongooses, three wildcats, a cat, a jackal, a
genet, a ground squirrel and a bovine, all from South 
Africa and Botswanwa.
F (4, 10, 5 and 3) are the twenty two viruses from fifteen 
foxes, three humans, a dog, a cat, a badger and a wolf from 
West Germany and Kraznodar, Asia and Murmansk regions of 
the Soviet Union.
G (7, 8, 15, 14, 12, 11 and 6) are the fifty six viruses from 
fourteen dogs, eleven jackals, four humans, two goats, four 
bovines, two kudu, three cats, two mongooses, a bat-eared 
fox, a civet, a ratel, a rodent, a suslik, a wolf, a 
raccoon-dog, two reindeer and five Polar foxes from 
Zimbabwe, Botswana, Namibia, South Africa and the 
Yakutska, Tuva and Baltic regions of the Soviet Union.
H (9, 2 and 1) are the sixteen viruses from eleven foxes, two
humans, two dogs and a bovine from East Germany and the 
Tula region of the Soviet Union.
*The reaction patterns of the prototypes of the serotypes are
grouped as follows:
Serotype 1 (CVS-24) = Gil; Serotype 2 (Lagos bat) = B19;
Serotype 3 (Mokola) = A24; Serotype 4 Duv. (Africa) = D27;
Serotype 4 Duv. (Europe) = D28; Serotype 5 Finman = C29.
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The majority of the reaction patterns of group G were 
observed in the "canine" type viruses of southern Africa and 
the Baltic region of the Soviet Union and although they were 
clearly distinguishable from them they were more closely 
related to those of the viruses from predominantly foxes of 
East Germany and the Tula region of the Soviet Union.
Despite the relatively small number (119) of serotype 1 
viruses tested in this work and the number of Mabs (16) which 
reacted with some or all of these viruses, the Clustan 
analysis did support the hypothesis that there may be more 
than one virus "type" within these serotype 1 viruses, at 
least at the N-protein level. One of these "types" is 
exemplified by the wildlife, that is, "mongoose" rabies of 
Africa (group E) and the wildlife, that is, foxes of Asian 
regions of the Soviet Union and West Germany (group F). The 
other "type" is exemplified by the "canine" viruses of Africa 
and foxes of East Germany and the Tula region of the Soviet 
Union. One is tempted to speculate that the first basic 
pattern described could be that of "old world" rabies and the 
second basic pattern could be that of "canine" rabies spread 
around the world by man's preoccupation with his best friend, 
his dog; in other words, man and his dog have put a confusing 
overlay over nature's original basic pattern and only by 
delineating the overall global picture will an understanding 
of rabies be achieved. Interestingly, the "canine" virus 
reaction pattern could not be distinguished from that of
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CVS-24, the prototype virus of Serotype 1, classical rabies, 
which is derived from Pasteur's original virus.
More meaningful information could be predicted to arise 
from further work on these two virus "types" were it to be 
undertaken. When the results of the sixteen Mabs tested 
against all of the viruses in this work were analysed, two 
Mabs, DB3 and DB4, reacted identically. This is not to say 
that they recognize the same epitope, which they may do, but 
it does mean that at least fifteen different epitopes are 
present within the N-proteins of these viruses. 
Unfortunately, none of these viruses has been sequenced and 
relatively little is known of the structure of their 
N-proteins.
However, as stated above, the N-protein of ERA and 
CVS-11 viruses have been sequenced and have been shown to 
possess remarkable homology, having a difference of only five 
of the 450 amino acid residues. These viruses were both 
derived from canines and an assumption could be made that the 
degree of homology between CVS-11 and CVS-24 viruses would be 
no less since they were derived from the same initial isolate 
of Pasteur.
An analysis of the amino acid sequence of CVS-11 virus 
allows the prediction of five antibody binding sites within 
the nucleoprotein. These putative linear epitopes are highly 
speculative and are based on turns which are hydrophobic, are 
potentially exposed on the surface of the nucleoprotein and
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have a high antigen index (Table 8.2.). Unfortunately there 
is no information available regarding the number of amino 
acid residues that are required to constitute one antibody 
binding site. It may be that four amino acids are sufficient 
and that residues 26 - 29 (Table 8.2.) form one site. If 
indeed such a small number is sufficient, then residues 154 - 
162 (Table 8.2.) may form a number of overlapping combining 
sites. Interestingly, only one of the N-protein substitution 
sites noted in the sequences deduced for PV and SAD B19 
viruses (serine and asparagine at amino acid position 157, 
Table 8.1.) falls within one of these predicted antibody 
binding sites.
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Footnote to Table 8.2.
The Table is an abstract from the University of Wisconsin GCG 
sequence analysis software package of the complete 
nucleoprotein sequence of CVS-11 rabies virus (print-out 
kindly provided by Dr G Hewinson of the CVL, Weybridge).
The following symbols were used:
Table Headings:
Pos = position in sequence; 
aa = amino acid 
Al-Ind = Antigenicity Index
Five groups of amino acids are predicted as ectodomain 
antigen binding sites. In the Table, with the exception of 
site 444 - 450, these sites are bounded by the amino acids 
which precede and follow the site, so that the ratios in the 
Al-Ind column are highlighted.
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Table 8.2. Prediction of Antibody Binding Sites of CVS-11
Pos AA Al-Ind
25 glutamine 0.075
26 tyrosine 1.150
27 glutamic acid 1.150
28 tyrosine 1.150
29 lysine 1.150
30 tyrosine 0.750
98 argenine 0.600
99 lysine 1.500
100 glycine 1.500
101 aspartic acid 1.500
102 lysine 1.300
103 isoleucine 0.900
153 isoleucine 0.450
154 serine 0.950
155 glycine 1.350
156 glutamine 1.200
157 serine 1.100
158 threonine 1.300
159 glycine 1.700
160 asparagine 1.700
161 tyrosine 1.500
162 lysine 0.900
163 threonine 0.900
389 serine 1.300
390 aspartic acid 1.700
391 aspartic acid 1.700
392 glutamic acid 1.700
393 aspartic acid 1.700
394 tyrosine 1.300
395 phenylalanine 1.300
396 serine 1.100
443 asparagine 1.300
444 lysine 1.700
445 threonine 1.700
446 tyrosine 1.300
447 serine 1.500
448 serine 1.700
449 aspartic acid 1.700
450 serine 0.900
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Future studies with the Mabs generated in this work 
should incorporate epitope mapping techniques to determine 
precisely where in the nucleoprotein that they bind. The 
elucidation of the amino acid sequence of the nucleoproteins 
of a "mongoose" virus and of the rabies-related serotype 2 - 
5 viruses might also be rewarding.
New information was gathered from examination of the 
rabies-related viruses with the Mabs generated in this work. 
If, as seems probable from the results, the Duvenhage viruses 
are the cause of rabies in insectivorous bats of Africa, on 
the basis of the Mab reactivity patterns the Lagos bat 
viruses are the cause of rabies in frugivorous bats of the 
same continent. The initial isolate of Lagos bat virus was 
made when a shotgun was discharged into a colony of 
apparently healthy Eidolon helvum, fruit eating bats, on 
Lagos Island (Boulger and Porterfield, 1958). The authors 
were aware of reports of rabies in insectivorous bats of 
America and were interested to see if they could recover the 
virus from fruit eating bats. One of the authors even today, 
however, does not consider that the virus which they isolated 
is rabies virus (J.S. Porterfield, pers. comm.). Since that 
time isolations of the virus have been made from as far 
afield as from an Eidolon helvum bat in Senegal on the west 
coast of Africa down to the southern parts of the Republic of 
South Africa, some 8000Km away, from an Epomophorus wahlbergi 
bat. A third fruit eating bat species, Micropterus pusilis.
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in the Central African Republic, has also been shown to be 
infected, and the virus has been isolated from cats (Foggin, 
1982). These latter isolations are of interest because they 
not only confirm the ability of Lagos bat virus to spill over 
into terrestrial animals but in these animals they caused a 
clinical disease which resembled that of classical rabies.
Mokola virus has been isolated on sixteen occassions (R 
Swanepoel, pers. conun.), although not all of these isolates 
have been retained for examination with Mabs. It has been 
isolated from at least four different African species and 
from five African countries. Whereas Lagos bat and Duvenhage 
viruses have been isolated from bats, this is not the case 
with Mokola virus. However, when the extent of the 
geographical area from which the viruses were isolated is 
taken into account (from Nigeria through Cameroun and 
Zimbabwe to the Republic of South Africa) with time span of 
only fourteen years (1968 - 1981), one can only speculate on 
what the reservoir species might be.
The virus was first isolated from shrews of Nigeria 
which were examined during the course of a surveillance 
programme (designed to detect viral infections in the 
wildlife) and within a short period further isolations were 
made from three other shrews (which were apparently healthy) 
and two human patients, also in Nigeria. In 1971 one other 
shrew was found to contain the virus (RV 39) by Le Gonidec in 
Cameroun, which is contiguous with Nigeria. These findings
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suggested that the reservoir species for Mokola virus might 
be rodents (although shrews are insectivores) and indeed a 
further isolation was made from a shrew by Saluzzo in the 
Central African Republic in 1981. This isolation, however, 
was the only occasion on which he was able to isolate virus 
from more than 3000 rodents and insectivores examined over a 
twenty year period, hardly suggestive of rodents or 
insectivores being the reservoir species. In the meantime 
Mokola had been isolated from a cat at Umhlanga Rocks in the 
Republic of South Africa, indicating that the virus was 
neither limited geographically to the northern parts of 
Africa nor of recent origin. Further isolations were made in 
1981 from cats in Zimbabwe by Foggin but despite intensive 
searches no further isolations have been made since 1981, 
although antibody was demonstrated in nearly 20% of the 
rodents examined (C.M. Foggin, pers. comm.).
This finding of antibody is interesting since Mokola 
virus antibodies were found in the serum of one of five 
Eidolon helvum bats shot near Sokoto in northern Nigeria, in 
several other mammalian species including man, and in a great 
reed warbler (Kemp et al., 1972). Since the authors also 
reported antibody to Lagos bat virus in the same species of 
bat, it must be assumed that at that time they were able to 
distinguish these virus antibodies sufficiently to be 
confident of their findings.
Although Mokola virus has never been isolated from a
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bat, the possibility that bats may be the reservoir species 
should not be overlooked. Mabs FI - F5, prepared against the 
human isolate from Finland, which is believed to be of bat 
origin, all recognized the M. dasycneme bat isolates from 
Holland and in addition Mabs FI, F2, F4 and F5 recognized the 
prototype Mokola virus; indeed, as shown above these 
antibodies allowed differentiation of the Mokola viruses 
into three antigenic reactivity patterns. Yet in tests 
against more than one hundred isolates described in this work 
and more than fifty other isolates (data not shown) they did 
not react with any rabies virus of terrestrial animal origin. 
Thus there is a relationship between the Finnish isolate, M. 
dasycneme bat isolates and Mokola virus. Bats of the Myotis 
genus are the most widely distributed group of bats and 
certainly inhabit Africa. From this it could be speculated 
that since the reservoir species of Mokola virus is as yet 
unknown, a bat species might be implicated; bats and rodents 
frequent the same territories and both rodents and 
insectivores are carnivorous. Should such an infected bat be 
found, the rabies-related viruses would all have been 
isolated from bats.
Because of the paucity of isolations of the African 
rabies-related viruses it is not possible to predict an 
association of a particular virus reaction pattern with a 
given species. It is possible, however, to use the 
distinctive Mab patterns of the European bat isolates
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described in this work as a means of predicting an 
association of a particular reaction pattern with a 
particular bat species (King and Smith, 1991). Two major 
reaction patterns were found in tests of forty four isolates 
from bats of Europe. The first and most frequently found 
pattern (in forty one of forty four isolates from at least 
four bat species) was found in isolates from seven European 
countries, in all of thirty six isolates from E. serotinus 
bats and from a human rabies case of bat origin in the Soviet 
Union. The second reaction pattern was found in all three 
isolates from M. dasycneme bats of Holland and in the human 
rabies case of Finland suspected to be of bat origin, but not 
in any of forty one isolates from other bats of Europe.
Bat rabies was first reported in Europe in 1954, but not 
until 1985 was the disease confirmed in a substantial number 
of bats. Indeed, between 1954 and 1985, only fourteen cases 
were reported, mainly from the maritime areas of northern 
Germany. This maritime association of the disease and the 
serological similarity of the virus with Duvenhage virus led 
to the supposition in 1985 that it was accidentally imported 
via an infected bat from Africa, possibly aboard a timber 
ship which docked at Hamburg, where the first infected bat 
was found (L. G. Schneider, pers. comm.). The relationship of 
the viruses was based on tests with polyclonal antisera and 
the supposition did not take into account the fact that bat 
rabies in Europe pre-dated insectivorous bat rabies
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(Duvenhage) of Africa by some sixteen years and that it is 
highly unlikely that a bat would survive the dehydration of a 
sea crossing (R. Stebbings, pers. comm.).
This work demonstrated that the European insectivorous 
bat viruses are clearly distinguishable from the African 
Duvenhage virus isolates. Moreover, the finding of serotine 
bats, infected with a virus with only minor variation in the 
reactivity patterns, from as far afield as the Ukraine to 
Spain is indicative of a long-standing infection of that host 
species; the serotine bat has a normal home range of no more 
than five miles, although on rare occassions it has been 
known to travel up to fifty miles (A. Hutson, pers. comm.).
The finding of a second rabies bio-type in Myotis 
dasycneme bats of Holland gives an indication of, compared 
with the information available from the Americas, how little 
is known about rabies in bats in Europe. As in the U.S.A., 
the disease in every affected European country came to light 
when a member of the public accidentally came into contact 
with an infected bat. Whereas in the U.S.A. the incident led 
to a nationwide search for the disease in bats and a 
re-examination of the records of death from rabies of 
"unexplained" origin, very little interest was generated in 
Europe. Only in Britain and Switzerland has any nationwide 
attempt been made to examine bat populations for the disease 
and in Denmark and Holland, where all animal deaths in bat 
rabies infected areas were examined, has the disease aroused
252
more than a cursory interest. One reason for this apparent 
lack of interest may be that rabies is endemic in most 
European countries and available resources are channelled 
towards solving the major problem of disease control.
In Britain, as throughout the rest of Europe, bats are 
classed as protected species. Of the thirty one bat species 
which inhabit mainland Europe, fifteen are also resident in 
Britain and two or three are classed as very rare or nearly 
extinct (Stebbings, 1986). Regular migration to and from the 
continent is not thought to occur, but vagrancy certainly 
does; high winds blow flying bats off course and 
occassionally they land exhausted on such places as oil-rigs. 
In Europe the great majority of infected bats have been 
serotines. These are relatively large bats which live almost 
exclusively in buildings and are fairly common in south-east 
England and are rare or absent elsewhere. Bat populations in 
Europe including Britain are declining and this may be the 
reason that so few (twenty nine) serotines were available for 
testing in this work. Certainly such a number is too small 
from which a conclusion regarding the presence or absence of 
rabies in the serotine bat population of Britain could be 
drawn.
Bats are gentle creatures which rarely attack humans, 
but like most other animals they will bite when provoked. 
Although some may survive for as long as thirty years their 
average lifespan is only four to five years and seldom do
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they have more than one offspring a year. In 1985 a dramatic 
increase in the number of rabies cases in European bats 
occurred; the reduction in numbers of cases since that time 
may be a reflection of the time taken for re-population to 
take place.
The primary aim of this thesis was to examine the 
antigenic relationships between rabies and rabies-related 
viruses from geographical areas where these are known to 
co-exist and this work is on-going. The results are by no 
means conclusive, indeed, as some answers to questions have 
been obtained, so have they posed more questions. For 
example, the reason for the examination of wildlife viruses 
from Zimbabwe was to predict the outcome of a campaign of 
jackal oral vaccination in the estate lands, leading to the 
control of jackal-induced bovine rabies. The finding that all 
viruses examined from that country were of "canine" type was 
encouraging. Recently, however, the finding of an infected 
mongoose east of Bulawayo {J. Bingham, pers. comm.) suggests 
that the objective may be more difficult to achieve; whilst 
the concurrent work on type of vaccine to be used and bait 
uptake has indicated that jackals could be successfully 
vaccinated, an underlying focus of mongoose rabies would 
suggest that successive generations of jackals would be at 
risk and the disease might reappear in that species.
The results chronicled in this work have rekindled an 
interest in the knowledge of the rabies viruses present in
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the wildlife of several southern African countries, notably 
the Republic of South Africa where a nationwide survey is
underway (R. Swanepoel, pers.comm.). Previous attempts to 
determine differences in the viruses using the Wistar 
Institute anti-N Mabs had been unsuccessful (C. D. Meredith, 
Pers. comm. ) but now the panel described in this work
together with the anti-N panel of the CDC Atlanta is in use
and one of these latter Mabs will also distinguish "mongoose" 
from "canine" rabies {R. Swanepoel, pers. comm.).
The same interest has been stimulated in the Soviet 
Union and the search for unusual or different rabies viruses 
is continuing and spreading to the People's Republic of China 
and the Indian sub-continent. The next steps will be to 
prepare Mabs from these wildlife viruses and already some
have been prepared from viruses of vampire bat from Brazil, 
Polar fox and raccoon-dog from the Soviet Union and a dog 
from China (data not shown).
Of course, one could be critical of the use of Mabs 
prepared solely against the nucleoprotein, but the results in 
this thesis indicate that this protein, although small in 
comparison with the remainder of the virus, displays a degree 
of variability which enables useful epidemiological 
conlusions to be drawn. The results of this work represent a 
starting point from which more fundamental knowledge of the 
disease of rabies may be obtained.
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